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Summary
Molecular modeling is an exciting new approach in the field of drug 
design. A molecule's activity as a drug is dependent upon its 
conformation i.e. the three dimensional arrangement of its functional 
groups.
Molecular mechanics coupled with interactive computer graphics is 
an excellent technique for studying the conformations of small molecules 
and this thesis presents a discussion of this technique and its 
application to some inhibitors of the enzymes Thermolysin and EC 
3.4.24.11 .
An introduction to the role of molecular mechanics in computer 
assisted drug design is given in Chapter One. Chapter Two describes the 
calculation of steric energies and the potential functions used to do 
this, while the procedures used for conformation generation and energy 
minimisation are discussed in Chapter Three (Appendix A lists one of the 
programs used for the conformation generation).
The MOL software package is an interactive modeling system for 
small molecules which has been developed at Glasgow and Chapter Four 
contains a description of this system and its options.
The structure and function of many enzymes is of prime importance 
in drug design since drugs often act by inhibition of enzymic pathways. 
Since very few enzyme structures are known from X-ray crystallography 
the primary source of information is enzyme kinetics and Chapter Five 
discusses some important properties of enzymes, such as their functions 
as catalysts, substrate and inhibitor kinetics and evolutionary pathways.
EC 3.4.24.11. (a mammalian enzyme) and Thermolysin (EC 3.4.24.4, a 
bacterial enzyme) have very similar substrate specificities and are 
inhibited at comparable rates by several inhibitors. Very little is known 
about the active site of EC 3.4.24.11., however, the structure of 
Thermolysin is well known from X-ray crystallography and in Chapter Six 
the known features of active sites of both enzymes are discussed and 
compared.
It is known that two isosteric inhibitors of Thermolysin, 
0-Phenylpropionyl-L-Phe and Carbobenzyoxy-L-Phe, bind in completely 
opposite orientations. This unexpected phenomenancan be explained by 
conformational studies on the two inhibitors. In both cases the enzyme 
does not bind the lowest energy conformer, however in each case it binds 
the conformer which has both low energy and gives a good fit to the 
active site.
The results of conformational studies of inhibitors of EC 
3.4.24.11. are also discussed in Chapter Six and comparison of the low 
energy conformers with inhibitors of Thermolysin (from X-ray data) point 
to differences in the positions and sizes of the S-j and S2' subsites of 
the two enzymes. Both enzymes are highly specific for hydrophobic groups 
in the S-| * site, with Phe being the most favoured residue. From the X^ray 
studies of Thermolysin it is known that the Phe side chain is bound with 
torsion angles of roughly 170° and 80°. It is interesting to note that 
these torsion angle values are very common in many of the low energy 
conformers and it seems reasonable to assume that the high level of 
specificity arises from the fact that the side chain of the Phe, Leu etc. 
are normally in the most favourable position for binding to the f 
hydrophobic pocket without rearrangement. Several other differences
x
between the two enzymes lead to the conclusion that their functional 
similarity is more likely to be a product of evolutionary convergence on 
function than of divergence from a common ancestor.
Chapter Seven contains a brief summary of the programming which was 
done during the course of this project paying particular attention to 
both the motivation and methods involved in programming an array 
processor and as previously mentioned Appendix A contains a listing of 
the GLOMIN program - a conformation generation program which was modified 
to run on an array processor during the course of this project.
Finally, Chapter Eight contains a discussion of work carried out in 
conjunction with Professor A.Y.Meyer while he was on sabbatical leave at 
Glasgow University. This work shows that force fields can be modified 
quite simply to give more transferable non-bonding parameters by the 
inclusion of an electrostatic term. A paper on this work has been 
published in the Journal of Computational Chemistry and a copy of this 
paper is given in Appendix B.
Chapter One
Introduction
In recent years there have been major advances in the field of
medical research. To keep pace with this progress the pharmaceutical
industry has invested vast resources in the field of drug research and
development. The industry has also responded to the growth in public
awareness about disease and medical treatment by attempting to improve
the range, potency and safety of many drugs.
The method most commonly used in drug design centres on an
'active analog' approach in which medicinal chemists use reasoning and
intuition to design new drugs by modifying existing potent compounds -
a time consuming and expensive process which is not always successful.
One of the failings of this approach is that, although it is
appreciated that the activity of a compound and its three dimensional
structure are directly related, the synthetic chemist generally deals
with two dimensional images of molecules which may not bear much
resemblance to their three dimensional structures.
An exciting new approach to drug design is currently being
developed which eliminates the 2-d, 3-d problem. This approach
involves the use of theoretical chemistry and interactive computer
1,2
graphics in the study of molecular properties and structures. High
resolution graphics terminals provide an excellent medium with which
3-6
to display large, or complex structures in three dimensions and 
various theoretical techniques exist with which structural properties 
can be calculated.
At the moment this approach is still relatively novel, but it is 
hoped that eventually the prediction of potent compounds using
1
computational techniques will be at least as reliable as the current 
trial and error methods. There is so much interest in the concept of 
computer-assisted drug design that many universities and most large 
pharmaceutical companies now have some form of molecular modeling 
facility.
The area to which computational chemistry has been applied in 
this project is the study of structure-activity relationships, which 
play a key role in drug design. The majority of drugs act by blocking 
metabolic pathways - usually by enzyme inhibition. The structures of 
the enzymes, inhibitors and their complexes are therefore very 
important. X-ray crystallography has provided us with highly accurate 
information on the binding of a few enzyme-inhibitor complexes and 
molecular modeling has enabled us to elucidate many of the pertinent 
features of the binding interactions. However, the structures of 
several enzyme-inhibitor systems remain undetermined and it is in this 
area that the predictive powers of computational chemistry may best be 
used.
There are several experimental and theoretical methods currently 
available with which information about molecular structure and energy 
can be determined. Experimental techniques include spectroscopic 
methods (such as nuclear magnetic resonance, infrared, ultraviolet, 
optical rotatory dispersion and circular dichroism) and diffraction 
methods (such as X-ray, electron and neutron diffraction). All of 
which will give highly accurate information about molecular geometry, 
but little information about thermodynamic properties. On the
other hand calorimetry will give good thermodynamic data, but little 
gecmetric information.
2
None of the individual experimental techniques can give reliable 
geometries and thermodynamic information , but such results can be 
obtained using the theoretical methods currently available. These 
include ab initio calculations and semi-empirical molecular orbital 
methods such as Extended Huckel Theory (EHT), neglect of non-bonded 
differential overlap (NNDO), intermediate neglect of differential 
overlap (INDO), modified intermediate neglect of differential overlap 
(MINDO), and complete neglect of differential overlap (CNDO). These 
methods are capable of giving reasonable geometries and thermodynamic 
data depending on their application. However, they are all highly 
c.p.u. intensive which restricts their use to small molecules.
Molecular mechanics ( or the force field method ) is much less 
demanding on computer time. It gives reasonable geometries and
. . 7thermodynamic information on the system by making good use of 
experimental data in conjunction with a mathematical representation of 
the system.
For the purpose of molecular mechanics a molecule is considered
as a collection of atoms held together by forces which can be
described using potential functions derived from classical mechanics.
The set of empirically derived potential functions chosen to reproduce
8
particular molecular properties is known as a ' force field1. Several 
force fields exist which employ different potential functions . The 
nature of the individual functions is not important so long as the set 
of functions chosen gives good agreement with experimental data. The 
overall energy of the molecule can be calculated using these potential 
functions with parameters which have been obtained from existing 
experimental data.
The structures of large molecules can therefore be modelled
3
using information derived from the observed properties of smaller 
molecules. The energy of the molecule is minimised by altering the 
positions of the atoms. The only disadvantage of this method is the 
large body of reliable experimental data needed to parameterise the 
force field as results of this method are only as reliable as the 
force field parameters being used. Many force fields exist which can 
be used for alkanes^, alkenes1®, hydrocarbons11, peptides12 and even 
proteins13» 1 4#
There are several reviews on molecular m e c h a n i c s 15“21 an(j COm-
22-27
puter assisted drug design which are relevant to this discussion.
Molecular Mechanics Studies
The compounds studied during the course of this project are 
either’inhibitors of the mammalian enzyme EC 3 . 4.24 .11 .2® or its 
bacterial equivalent, Thermolysin2^# The enzyme EC3.4.24.11. has 
been isolated from several tissues, most notably the kidney2  ^ and the 
brain^O, where its role is that of an endopeptidase cleaving small 
peptides at the N terminus of hydrophobic residues. In the kidney it 
has been shown to cleave peptides such as angiotensin and 
bradykinin^1 whereas in the brain it is thought to play a role in the 
degradation of naturally occurring e n k e p h a l i n s 3 2 . The inhibition of 
EC 3.4.24.11. is of interest to the pharmaceutical industry for 
several reasons, including the likelihood of inhibitors finding 
possible application as analgesics33.
Both Thermolysin and EC 3.4.24.11. are zinc metallo- 
endo pe p t i das es with similar substrate specificities, but with 
different sensitivities to certain inhibitors3i1. The two enzymes are
4
therefore not identical and we would like to compare features of 
their active sites to see how they differ. As yet the structure of 
EC 3*4.24.11. has not been solved; however, the X-ray structures of 
Thermolysin plus several i n h i b i t o r s 3 5 ~ 4 0  h a v e  been published.
With the known structure of Thermolysin as a starting point, it 
has been possible to use low energy conformers of the inhibitors with 
binding information to devise possible inhibitor-enzyme interactions 
for the unknown active site of EC 3.4.24.11. This binding informa­
tion may prove useful in the search for new, active compounds.
5
Chapter Two
Section 2.1 
Molecular Mechanics
One of the most important principles of molecular mechanics 
calculations is that for any molecule there is a minimum energy 
conformation for which there are optimal values for bond lengths, 
bond angles and torsion angles. Deviations from this equilibrium state 
are unfavourable and give rise to an increase in molecular potential 
energy.
For any conformation of a molecule the potential, or steric 
energy can be expressed in terms of the sum of the energies arising 
from several different types of intramolecular interactions i.e.:-
V_ = V, + Vft + V + V , + V + V + Vnmacs 1 0 w nb x q cross
The intramolecular interactions being considered are in order; 
bond stretching or compression, valence angle deviations (Baeyer 
strain), torsion angle variations (Pitzer strain), non-bonded (van der 
Waals) interactions, out-of-plane bending at trigonal, planar regions 
of the molecule, coulombic interactions and cross terms.
The first six terms are assumed to be independent of one another 
and cross terms, which express coupling between different components, 
tend to be ignored since they are small and only of real relevance in
the calculation of vibrational frequencies.
the absolute magnitude of
It is important to note that by itself V has no physical
A s
6
meaning. However, differences in Vg for different geometries of the 
same molecule are appropriate for comparison to experimentally 
observable physical properties such as rotational barriers, or 
conformer populations.
The empirically derived set of equations which are used to 
calculate each interaction's contribution to the steric energy and the 
derivation of the parameters used in these equations will be discussed 
in the rest of this chapter.
Section 2.2
Bond Stretching or Compression
The expression for evaluating the energy involved in the 
stretching, or compression of a bond can be derived from Hooke's Law, 
in which bonded atoms are considered to be two masses joined by a 
spring undergoing simple harmonic motion. This gives us the following 
equation:-
Vj_ = (1/2) (1 - 1Q)2
where is the bond stretching energy, k^ is the bond stretching 
force constant, 1 is the observed bond length and 1 is the calculated 
equilibrium bond length.
The force constant k^ has a range of values, typically between 
300 and 1200 kcal mol“*X“  ^and has a different value for every bond 
type in the molecule - the larger the bond order, the more strongly 
the atoms are held together and the larger is the value for k^. 
Stretching bonds is therefore a high energy process - indeed the
7
j c. 0deformation of a bond from equilibrium by 0.1A can cause an energy
increase of between 1.5 kcal mol  ^ and 6 kcal mol Since bond
stretching / compression is so energetically unfavourable it is 
reasonable to assume that bonds within a molecule will adopt values 
close to their equilibrium lengths.
Section 2.3
Angle Bending
Again Hooke's law is used to derive the expression for 
calculating the contribution bond angle bending makes to the total 
energy. For angles which deviate from the equilibrium value by up to 
15° the following equation is used:-
where Vg is the energy associated with angle bending, kg is the angle 
bending force constant, 9 is the observed angle and 0Q is the 
calculated angle which varies with the degree of substitution. The 
above equation gives good results for deviations of up to 15° from the 
equilibrium value, but as distortions become greater angle bending
cannot be described in terms of simple harmonics. For such cases a 
more elaborate equation must be used:-
(1/2) k0 (0 - eo)2
1
V,6 (1/2) kQ [ (0 - 0Q)2 - k0' (0 - 0Q)3 ]
where kg' is the anharmonicity force constant
8
Section 2.4
Torsion Angle Variations
The spatial relationship of any four consecutively bonded atoms 
in a molecule can be described by a torsicn angle.
A -----------v
D
Fig 2.1
The value of the torsion angle for A B C  and D can be defined as
the single w measured about B C from plane A B C to plane B C D i.e.
looking along B C the torsion angle is the angle through which A must
be rotated to eclipse D (see above diagram). According to the Prelog- 
2
Ingold convention the torsion angle is designated by a +ve or -ve sign 
depending on whether the direction of rotation is clockwise or anti­
clockwise , up to a value of 180°.
Variations in torsional values in a molecule (i.e. rotations 
about single bonds) give rise to changes in that component of the
3,4
molecule's steric energy known as the torsional strain. The energy 
arising from such torsion angle variations can be calculated using:-
Vw = (1/2) (1 + S cos n w )
9
where V is the torsional energy, k is a force constant known as thew W
barrier to free rotation, S has a value of +1 for eclipsed minima and 
-1 for staggered minima and accounts for vector direction, n is the 
periodicity of rotation (i.e. the number of times a minimum is found 
during a 360° rotation of the torsion angle) and w is the observed 
torsion angle.
Section 2.5
Non-bonded Interactions
The energy arising from non-bonded interactions is generally the 
most important component of the total energy since such interactions 
are a major factor in determining the stability of molecular 
conformations.
The concept of non-bonded, or van der Waals interactions is used 
to explain the interactions between atoms which are not joined to each 
other, or to a common atom.
The potential function which describes non-bonded interactions is 
derived from two independent forces which are related to interatomic 
separation (see Fig 2.2). There is a strong, repulsive force over 
short distances and a weaker, attractive force over larger distances.
The stronger force arises from the repulsion which occurs when 
the filled electronic orbitals of neighbouring atoms start to overlap. 
The expressions commonly used to describe this repulsion are:-
a )
R = Infinity
At large interatomic distances the weak attractive 
force predominates.
b)
c )
R = 5A
At a few Angstroms separation the attractive and 
repulsive forces begin to compete.
R=1A
At short interatomic separation the electron 
shells begin to overlap and the repulsive force 
predominates.
Fig.  2.2.
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where A and B are constants for two interacting atoms, r is the 
interatomic separation and n has a value of 12 although occasionaly 9 
is used.
Notice that the repulsion term is very large at small interatomic 
separations and very small at large interatomic separations. 
Therefore this force is oily of real consequence for small interatomic 
separations.
The second component of the non-bonded force is the weak
attractive force, or London dispersion force which results from
molecular
induced dipole / dipole coupling. Electrons in orbitals can
synchronise their motion giving rise to a weak attractive force known 
as the London energy. This attraction varies with the sixth power of 
the interatcmic separation and can be expressed by the function: -
V * -P / r6
where P is a constant related to the polarisability of the atoms and r 
is the interatcmic separation.
This 'inverse sixth' attractive energy decreases rapidly with 
increasing r, but not nearly as rapidly as the van der Waals repulsion 
energy.
The functions describing the attractive and repulsive forces can 
be combined to give a single potential function representing non- 
bonded energy. The general shape of this function is shown in Fig. 
2.3.
The non-bonded potential function can be described by either of 
two equations:-
12
E
N
E
R
G
Y
 
(
V
nb
)
INTERATOMIC  
DISTANCE (r)m
Van der Waals Interaction Energy
Rm is the minimum interatomic distance at which the 
attractive and repulsive forces are balanced and $n 
is the energy associated with this distance.
Fi g .  2.3.
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a) The Buckingham Potential
Vrf. = A e ^ *  - (p / r6)nb 
or
6
b) The Lennard-Jones 6 / 1 2  Potential
= (A / r12) - (P / r6)
6
In the Lennard-Jones potential A and P are related to the minimum 
energy point of the function and its associated distance and are 
defined by:
A = -E . (R . ) min nun
12
P = -2E ■ (R • )'min min'
For molecular mechanics calculations there are several problems 
arising from the use of these functions for the calculation of non­
bonded interactions. The first problem is that the above functions 
were derived to explain intermolecular interactions and not 
intramolecular interactions. The above functions adequately represent 
the interactions between two atoms in different molecules in the 
gaseous phase which are independent of any non-bonded interactions 
with other atoms. It is obvious however that this is a very simplistic 
approximation to apply to the the non-bonded interactions occuring
within a molecule, especially when we consider that the induced dipole
electrons
mcment from two interacting ^  may be considerably disturbed by
14
the dipole moments of other atoms within the molecule. It is also true 
that the functions do not take into account the fact that atoms on 
opposite sides of the molecule will be shielded from one another by 
the electron density of the molecule. This means that the calculated 
interaction between two atoms will remain constant regardless of
g
whether or not there is another atom directly between them.
Another problem that arises with this approach is that the atoms 
are regarded as being spherical and therefore they have a consistent 
van der Waals radius. Although this is generally true for large atoms 
it is not always the case for smaller atoms.
However despite the many failings of this approach it still 
appears to give relatively accurate results. This is probably due to 
the fact that any errors arising either cancel each other out or are 
averaged out over the whole molecule.
There is very little to chose between the two potential functions 
as they both appear to work equally well, however the Lennard-Jones 
potential has two distinct advantages over the Buckingham potential 
since a) it is quicker to compute a power than an exponential function 
and b) the Buckingham curve inverts at small distances and atoms which 
are too close together collapse into a common nucleus.
The function used for this work is a modified form of the 
Buckingham potential
However it is hoped that the Lennard-Jones function will be used 
for future work.
15
Section 2.6
Out-of-Plane Bending
trigonal planar
The minimum energy position for a atom (olefinic
carbon, carbonyl carbon) is where the central atom and its three 
substituents are all coplanar. Deformations within the plane are taken 
care of by the angle bending term (section 2.3) as they work against 
different restoring forces to out-of-plane deformations which distort
9
the pi electron system s energy.
Deviations from planarity can be measured by calculating the 
improper torsion angle for the molecule (see Fig. 2.4).
If the atoms are coplanar when we look along C=0 the angle 
between and R2 should be 180°. If there is any out-of-plane bending 
the improper torsion angle will be less than 180° and the following 
expression is used to calculate the out-of-plane bending energy:-
0
C
*2
Fig. 2.4
V.x (1/2) kx (180 - X)2
where kx is the out of plane bending force constant and X is the
calculated value of the improper torsion angle.
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Section 2.7
Coulcmbic Interactions
Since Rutherford first proposed his model of the atom in 1909 
there have been many theories as to the nature of the chemical bond 
from which have arisen the principles of Quantum Mechanics and 
Molecular Orbital Theory.
It is now generally accepted that when a bond is formed between 
two atoms the electronegativity of each atom is the factor which 
determines the nature of the bond which has been formed. The 
electronegativity of an atom is a function of the charge on the 
nucleus and the size of the atomic radius and can be taken as a 
measure of the atom's ability to attract free electrons. The larger 
the charge on the nucleus and the smaller the atomic radius the larger 
will be the atom's electronegativity and the more readily will the 
atcm be able to attract electrons.
Differences in the electronegativities of the atoms forming a 
bond give rise to various degrees of bonding of which there are two 
extremes, pure covalent bonds and ionic bonds.
A pure covalent bond is formed between two identical atoms. In 
this type of bond both atoms will attract the bonding electrons 
equally well, so the electrons will be shared equally between the 
atoms. Good examples of this type of bonding are homonuclear diatomic 
gases such as C>2 and Hj.
In ionic bonding one atom has a much greater electron affinity 
than the other and there is a complete transfer of one electron from 
one atcm to the other. Ionic bonding occurs in salts such as Na+ Cl".
17
The bonding which occurs in organic molecules is generally 
somewhere between the two extremes described above. The atoms forming 
bonds in a molecule tend to be similar, but not identical. The 
electron density of the bond tends to be concentrated towards the atom 
which is able to exert the stronger attraction resulting in the bond 
having polarity (see Fig. 2.5). The atoms in a molecule tend to have 
partial charges. Interactions between these partial charges give rise 
to the coulombic component of the steric energy and the equation used 
to calculate this interaction is derived from Coulomb's Law:-
Vq = (332 qt q.. / D r ^ )
where and q^ are the partial charges for atoms i and j and r ^  is 
the interatomic separation between i and j. The conversion factor 332 
is included to give the coulombic energy, V^, units of kcal mol-  ^so 
that it is compatible with the other energy terms. D is a scaling 
factor used to account for the dielectric permittivity of the medium 
separating i and j, in vacuo the dielectric constant is used and this 
has a value of one, in bulk solution in water a value of D = 80 is 
used and to represent a microenvironment dielectric permittivity D = 4 
is used as this has been shown to reproduce certain properties in 
enzyme active sites and gives good structures for amino-acid crystals. 
A value of four was used throughout this work.
When calculating the coulombic energy the molecule is split into 
charge groups (eg. amide groups, carboxylate groups, protonated 
nitrogens etc.) and intra group interactions are ignored. The partial 
charges for such calculations can be obtained from CNDO / CND02 type
ia
Bond Categories
a) A pure covalent bond - electron pair are shared 
equally by the two atoms.
b) A polar covalent bond - electron pair are shared 
unequally by the two atoms giving rise to a 
dipole.
c ) An ionic bond - electron transfer has occurred 
giving rise to charged atoms (ions).
F i g .  2 . 5 .
19
calculations.
Section 2.8 
Cross Terms
Many different force fields have been developed by individual 
groups and there are no strict rules governing how many or what types 
of potential energy functions should be used. Several existing force 
fields employ cross terms eg.
Bond-Bond terms
V11 = kll (1 - 1o) (1‘ - 1i)
Bond-Angle terms
V10 = ki0 ^  W  9o}
Torsion-Angle terms
vwe = ’'we (w " wo> (e - V
Angle-Angle-Torsion terms
veew = ’'eew (e “ eo> (0‘- eo ‘> (w " wo>
In general these cross terms have been introduced to overcome 
specific weaknesses in existing force fields especially when dealing 
with strained structures. However, it has been found that cross terms
20
play a larger role in the calculation of vibrational frequencies than 
for general molecular structure and they have not been used for this 
work.
Section 2.9
The Force Field Method
Force Fields and Vibrational Analysis
The force field method originated in vibrational spectroscopy where it 
was developed in an attempt to predict vibrational frequencies from a 
simple mathematical model.
The principles of the force field method were derived from the 
assumption that a molecule with N atoms (i.e. 3N coordinates) has a 
strain free geometry, XQ, at which its potential energy is zero. 
Deviations from this strain free state result in an increase in 
potential energy, V^, which can be expressed in terms of a Taylor 
expansion series
where x., x. and xv represent small displacements in atomic 
i 2 K
coordinates.
the first derivatives disappear from the above equation. A harmonic 
approximation can be obtained by truncating to the quadratic terms.
V,s o + +
+  h ig h er term s
V is by definition, zero at the potential energy minimum where 
o J
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Til© second derivatives are expressed as force constants giving:—
3n
V S =  ( 1 / 2 >  X X i  A x i A x j
i,j = i
Vibrational frequencies can then be calculated from the force 
constants using the secular determinant derived from Newton's Laws of 
motion.
The first step in developing a force field is the selection of a 
set of potential functions with which certain molecular properties can 
be described. The parameters for such functions must then be chosen 
from reliable existing experimental data such that they reproduce 
observable properties for a group of test compounds, with the ultimate 
goal that the force field can be applied to additional compounds for 
which there are no experimental data.
The first force field formulated along these lines was the 
Central Force Field, in which the potential functions were defined in 
terms of interatomic distances. This method gave good results for 
ionic compounds, but was of very little use for organic compounds and 
is used very rarely today.
The two types of force fields commonly used in vibrational
10
spectroscopy today are the Valence Force Field and the Urey-Bradley 
11
Force Field. With both force fields the potential functions are 
derived from classical mechanics eg. Hooke's Law and are formulated 
for the molecule's internal coordinates i.e. bonds, valence angles and 
torsion angles. The main difference between the two force fields is 
that the Urey-Bradley force field also includes 1,3 non-bonded terms. 
Although, in theory, each molecule should have its own force field,
22
when the Valence force field was extended to include cross terms it 
was found to be transferable within a group of molecules with 
reasonably accurate results.
Force Fields and Molecular Mechanics
Once the force field method had become established in vibrational 
spectroscopy its potential application to other areas became noticed. 
Various force field methods have now been developed for molecular 
mechanics calculations by individual groups using a range of 
different potential functions and parameters. Several of the force 
fields currently in use appear to be converging and it is possible 
that a single force field will eventually be attained capable of 
accurately reproducing molecular properties.
Although the potential functions may differ, most molecular 
mechanics calculations employ modified versions of the Valence or 
Urey-Bradley type force fields. A Valence force field was used for 
this work which included non-bonded interactions for atoms which were 
not bonded to each other, or to a common atom, unlike the Urey-Bradley 
force field which does include geminal interactions. The Valence force 
field used also included an out-of-plane bending term and a coulombic 
term, but emitted any cross terms which were felt to be more relevant 
for the calculation of vibrational frequencies.
The parameterisaticn of a force field relies heavily on existing 
experimental data from several sources. Vibrational analysis can 
provide the force constants for bond length deformations, valence 
angle distortions and out-of-plane bending. Diffraction experiments 
can provide equilibrium bond lengths and angles as can microwave 
spectroscopy which also provides torsional barriers. It is important
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that the initial parameterisation should involve a range of structures
from aliphatic compounds to highly strained systems if the force field
is to be able to cope with unusual steric constraints. The parameters
must be carefully chosen using reliable experimental data since the
force field can only be as accurate as the parameters it contains.
Once a force field has been designed the parameters and potential
functions will need to be refined to give better agreement with
observed structural properties. There are two methods of refinement -
12
a trial and error method and a least squares procedure.
With the trial and error method the force field parameters are
varied logically by the user to give more accurate results. Whereas
12
the least squares procedure/ which was designed by Lifson and Warshel,
involves comparing the results given by a particular parameter set
with experimentally obtained data. Any differences between the
observed and calculated properties are noted and the sums of the
squares of these differences are minimised by iteratively varying the
potential constants. Neither approach seems to offer a significant
10
advantage over the other since they both appear to work equally well. 
Force Fields and Thermodynamics
So far we have only discussed force fields in their roles in 
vibrational spectroscopy and molecular mechanics giving vibrational 
frequencies/ molecular geometries and their relative conformational 
energies. However force fields have also been parameterised to give 
heats of formation/ crystal packing arrangements and transition state
structures and reactivities.
From molecular mechanics we get the hypothetical potential energy
24
associated with a motionless molecule. However, the molecule also has 
rotational, vibrational and translational energy. To calculate the 
heat of formation, or enthalpy of the molecule we must add the 
energies arising from such motions to the potential energy.
The enthalpy associated with full excitation of rotational
and translational degrees of freedom is given by:-
Hrt = 3RT
where R is the gas constant and T is the absolute temperature in K.
Vibrational modes are only partially excited and the enthalpy 
associated with vibration Hv is given by:-
3n-s
Hv = RT u! / ((eui) - 1)
L = 1
where u.^  = hv^./kT, k = Boltzmann's constant, h = Planck's constant, 
N = the number of atoms in the molecule and the are the fundamental 
vibrational frequencies.
A correction must also be made to include the molecular zero 
point vibrational energy E° which can be calculated using the 
function
30-6
E° = N° (1/2) h yt
i = 1
where N° is Avogadro's number.
Once the molecule's heat of formation has been calculated the 
calculation of its other thermodynamic properties is fairly 
straightforward.
25
The current approach to force field development is to design a
force field which will give the best overall agreement between
calculated and observed geometric, vibrational and thermodynamic
properties even if some accuracy is lost in any one area. This is
13known as the Consistent Force Field method.
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Chapter Three 
Conformation Generation and Energy Minimisation 
Section 3.1.
Introduction
A molecule's steric energy is dependent upon the positions of its 
i.e. its conformation 
atoms,^therefore before we begin any molecular mechanics calculations
we must first ascertain its three dimensional structure.
For any molecule containing N atoms the relationship between the
steric energy and the atomic positions can be represented by a 3N+1 -
dimensional energy hypersurface, from which can be found all the
minimum positions for the molecule. The lowest energy minimum is known
as the Global Minimum Energy Conformer (GMEC).
For a simple molecule there will probably be a few well defined
minima, however for a large molecule the energy hypersurface may
contain several hundred (or even thousand) minima.
The energy hypersurface can be represented by a function f(x)
where x  is the vector representing the position of the molecule on the
hypersurface and the variables of x are the atomic coordinates. ‘The
ideal method of locating all the minima on the hyper surface would be
1
to use a Grid Search procedure, which involves evaluating the function 
f(x) at a series of points covering the molecule's conformational 
space and examining the function values to find the low energy 
positions.
This method is not practicable to use for a large molecule due to 
the complexity of the functions and the large number of variables 
which would have to be computed. It can however be applied where only
27
one torsion angle in a molecule is being varied and is commonly used 
to study the backbone torsion angles in amino acids and peptide^*^
The most common method used to locate the minima involves a two 
stage process of conformation selection and energy minimisation. Two 
stages are required because trial structures from, for example, 
molecular modeling very rarely correspond to conformers which exist at 
the minima of a hypersurface.
f(x)
From the above diagram positions A and C on the hyper surface are 
likely to correspond to trial structures whose energies must be 
minimised to give structures which correspond to the minima at B and D 
respectively.
Locating the GMEC can prove very difficult for large molecules 
which have several minima. If B corresponds to the GMEC its location 
depends on starting from a conformation which is close to it eg. the 
conformation which exists at A. Whereas minimisation of the 
conformation which exists at C will lead to the conformer existing at 
the local minimum position D. No minimisation procedure exists which 
can take us from position C to the GMEC at B.
The minima reached using the two stage process will be those
28
minima closest to the starting conformations and it is highly likely 
that low energy conformers found using this process will correspond to 
local minima like D. The selection of starting conformations is 
therefore a very important process.
Section 3.2.
Trial Conformation Selection
Although the energy hypersurface for the molecule is defined in 
terms of atomic coordinates for conformation selection, it is much 
easier to use the variables involved in the molecular mechanics 
potential functions i.e. the molecule's internal coordinates. However, 
bond lengths and angles are represented by relatively 'hard' 
functions, so, on the assumption that they will adopt positions close 
to their optimal values, the main variable determining molecular 
conformation will be the value of the torsion angles.
The torsion angle values within any molecule will be determined 
by the types of bonds involved. It has long been understood that 
rotation could occur about single bonds. Originally it was thought 
that such rotation was free from any constraints, but by the 1940's it 
had been demonstrated that there were energy barriers involved giving
rise to restricted rotation.
Restricted rotation can be easily demonstrated with a simple
molecule such as ethane.
29
The barrier to rotation about the carbon — carbon bond is best 
described in terms of the changes in energy which arise as the torsion 
angle HI - Cl - C2 - H4 is rotated through 360° (see Fig 3.1).
As the torsion angle is rotated from 0° — 360° three minima and 
three maxima are encountered. The energy maxima occur where the 
hydrogens of Cl are eclipsing the hydrogens of C2 i.e. where there is 
the shortest possible distance between the two sets of hydrogens. The 
energy minima occur where the hydrogens of Cl are in a staggered 
relationship with the hydrogens of C2 i.e. where there is the greatest 
seperation between the two sets of hydrogens.
The torsional barrier to rotation about the carbon - carbon bond 
is approximately 3 kcal mol- *. This energy is readily available at 
room temperature and the molecule will undergo rapid rotation passing 
between the two extremes of maxima and minima and giving an infinite 
number of conformations.
How then are the conformations which are to be minimised 
selected? The answer is very simple. Molecular mechanics deals with 
molecules at absolute zero i.e. when they are motionless, so the 
conformations which are selected should be those which accurately 
represent the molecule's structure at low temperatures.
In ethane the barrier to rotation is small, therefore at room 
temperature interconversion between the different minima is rapid and 
there is no way of measuring how long the molecule spends in each of 
its conformations. However , lowering the temperature of the 
surroundings slows down rotation and several low temperature NMR 
studies have shown that when a molecule has a rotatable bond it will 
tend to spend most of its time in the low energy conformers 
corresponding to the minimum energy positions for the torsion angles.
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It is these conformations which must be identified for molecular 
mechanics studies* For ethane this is a relatively simple task since 
it has only one rotatable bond giving rise to three minima, which due 
to the symmetry of the molecule are identical stereoisomers. This 
means there is only one low energy conformation to study and since it 
is the lowest possible energy conformation it will be the GMEC.
Finding the GMEC for other molecules is not nearly so easy. If, 
for example, there is asymmetry across the rotatable bond eg. 1- 
chloro-l-bromo-2-bromo-ethane there will be three distinct low energy 
conformers which will be populated according to their relative 
energies, the GMEC being the most highly populated state.
CH.
C H 3 Br H
In general most molecules have more than one rotatable bond and 
such bonds are generally asymmetric. This makes it very difficult to 
locate low energy conformations. To gain some idea of the complexity 
of the task imagine that if a molecule has 5 rotatable bonds each 
having a possible 3 minima this would give 35 = 243 low energy 
conformers. If the molecule has 10 rotatable bonds there would be 310 
possible low energy conformations on which to perform molecular 
mechanics calculations - obviously a difficult if not impossible task.
Since most of the molecules studied in this project had upwards 
of 10 rotatable bonds it was necessary to define certain criteria
32
with which sensible starting conformations could be generated. Two 
distinct approaches were used to generate the trial structures studied 
and these methods will now be described in more detail.
The GLOMIN program
This program was originally designed to fold peptide chains to 
give cyclic compounds. The program was rewritten during the course of 
this project to run in the array processor and a program listing is. 
given in Appendix A.
The function of the program is to set designated torsion angles 
to values which have been input by the user. If there are four torsion
angles and the user inputs a set of torsion angle values eg. 60°, 180°
0 4and -60 , the program will generate a total of 3 conformations having
every possible permutation of torsion angle values from 60° 60° 60°
60° to -60° -60° -60° -60°.
Before the program can be used the torsion angles and a set of
torsion angle values must be chosen. Since most of the molecules
studied in this project had several rotatable bonds, certain criteria
were employed to restrict the number of torsion angles of interest.
The following is a worked example for Phe-[N]-L-Phe-pAB (see Fig.3.2)
and the method was employed for several other compounds.
It can be seen from Fig. 3.2 that the conformation of Phe-[N]-L-
Phe-pAB can be described by 11 torsion angles namely:-
1) C37 C39 C40 C2 2) C39 C40 C2 N6 3) C40 C2 N6 C13
4) C2 N6 C13 C9 5) N6 C13 C9 N10 6) C13 C9 N10 C51
7) C9 N10 C51 C52 6) C54 C46 C43 044 9) C40 C2 Cl 03
10) N6 C13 C26 C25 11) C13 C26 C25 C23
33
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To restrict the number of torsion angles we must locate those 
torsion angles which by their nature can be discounted, or set to 
favourable positions. Initially all the torsion angles are set to 
180°. From Fig 3.3 it can be seen that torsion angle 6, an amide bond 
has a well defined minimu«\at 180° so it can be left at 180°. From Fig 
3.4 torsion angle 7 has a minimumat 160° and the carboxylate group 
defined by torsion angle 8 will tend to lie approximately planar with 
the phenyl ring so it can be set at 180°. Fig 3.5 shows that torsion 
angle 1 has a minimum value at approximately 90® (phenyl rings tend to 
have minima between 70° and 110°) and finally from Fig. 3.6 we see 
that torsion angle 9 has a minimum position at 60° (which again tends 
to be favourable for a carboxylate group in the middle of a chain 
whereas torsion angle values of 120° tend to be more favourable for 
terminal carboxylate groups).
Setting all the above torsion angles to their favourable 
positions leaves 6 Torsion angles which is still too many for this 
method. The next criterion used is to separate the back bone torsion 
angles from the side chain torsion angles. From Figs. 3.7 and 3.8 it 
can be seen that the minimum positions for torsion angles 10 and 11 
are at 170° and 70° respectively so they are set to these values.
All but four torsion angles have now been eliminated and Figs. 
3.9 - 3.12 give the minima for these four:-
C39 C40 C2 N6 290° (-170°)
C40 C2 N6 C13 60° to 140°
C2 N6 C13 C9 240° to 290°
N6 C13 C9 N10 300° 120°
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from which four torsion angle values were chosen namely 60°, 120°, 
180° and -70°.
The GLOMIN program accepts as input a single backbone chain (see 
Fig 3.13), the torsion angles to be altered, specified by four atom 
names and a set of torsion angle values, or generators. It will then 
alter the designated torsion angles, in this case 2, 3, 4 and 5, 
to give all possible permutations of the generators chosen.
As output the program produces a file containing all the 
conformations produced, in this case 4^ = 256 conformations.
Individual systems format files are then created from this output 
file. These systems format files are initially in the form of a single 
unbranched chain and the full molecule can be built using the MOL 
graphics system, (see Chapter 4) building on any groups or side chains 
into favourable positions.
The ESCAN program
This program is slightly more sophisticated than the GLOMIN 
routine. It generates conformations by progressively altering 
nominated torsion angles in the molecule stepwise until all possible 
conformations have been generated. As it generates each conformation 
it roughly calculates the energy, stores the low energy conformations 
and finally crudely minimises them using torsional parameters. One 
advantage of this method is that it generates the complete 
conformation with a crude energy and only saves those conformations 
which are below a specified energy value. The main disadvantage with 
the method is that although we would like to rotate each bond through 
360° in say 10° steps - this is only feasible for molecules with up to 
four rotatable bonds, above this number it takes up too much computer
46
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time. Once again we have to define criteria with which we can restrict 
the values of certain torsion angles. Once these torsion angles have 
been set the program gives the user the option of setting those bonds 
which are being rotated in a particular conformation, or using a 
random starting point generated by the computer.
Once again it is perhaps easier to describe the procedure with a 
worked example for one of the inhibitors of Thermolysin, the molecule 
j3-phenylpropionyl-L-Phe (see Fig. 3.14).
The overall conformation of this molecule can be described by 
eight torsion angle values.
1) Cl C6 C7 C8 2) C6 C7 C8 N9 3) C7 C8 N9 CIO
4) C8 N9 CIO Cll 5) N9 CIO Cll C12 6) CIO Cll C12 C13
7) Cll C12 C13 C14 8) C7 C8 C9 01
Once again we must restrict the number of torsion angles we are 
interested in. For this molecule the amide bond can be set to 180° 
leaving us with seven rotatable bonds. Ideally we would like to rotate 
all seven in 10° steps, however since this is not possible the best we 
can manage is to fix two torsion angles in favourable positions and 
allow the remaining five to be rotated through 360° in 30° steps.
/3-PPP was run in ESCAN twice, on the first occasion torsion 
angles 7 and 8 were set at values of 90° and 120° since these were 
found to be favourable, the remaining five torsion angles were rotated 
through 360° in 30° steps from a randomly generated starting 
conformation, this gave seven conformations. On the second occasion 
torsion angles 7 and 8 were set at -110° and 80° respectively - these 
being the values found from the X-ray studies of the binding
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conformation, again the five remaining bonds were rotated through 360° 
in 30° steps from a random starting point, this gave a further 13 
conformations.
Obviously there are drawbacks with both GLOMIN and ESCAN - the 
main one being that restricting any torsion angle to a certain value 
will automatically influence the conformation of the rest of the 
molecule. This means that although several conformations have been 
generated there is no certainty that any of them can be minimised to 
give the Global Minimum Energy Conformer. In fact such are the 
limitations of both methods when dealing with large molecules that it 
is likely that several low energy conformations are overlooked. This 
can be partially overcome by the use of routines ALTER and RAMMAPfrom 
the MOL graphics system (see Chapter 4 sections 4.4.12 and 4.4.13). 
These routines can be used to generate more low energy conformations 
by improving upon the positions of various torsion angles within the 
molecule. The routines can act as a safety net to locate . low energy 
conformations which would otherwise be ignored.
Section 3.3.
Energy Minimisation
Once we have generated our starting conformations we require to 
minimise the structures to give the conformers which exist at the 
minima of the molecule's energy hyper surf ace.
As previously discussed the energy hypersurface can be 
represented by a function f(x) the variables for which are the 
Cartesian coordinates of the atoms. Location of the minima depends 
upon optimisation of the function and since there are no constraints
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imposed upon the values of the atomic coordinates the procedure is one 
of unconstrained optimisation.
It must be noted that, although the optimisation procedure 
involves the use of Cartesian coordinates, they must be converted to 
internal coordinates for the calculation of steric energy since these 
are the variables involved in the potential energy functions (see 
Chapter 2).
The optimisation of the function which represents the molecular 
potential energy hypersurface is a fairly difficult task due to the 
complexity of the function and the large number of variables involved. 
Several optimisation procedures have been developed, however none 
exists which can handle conformational energy minimisation from the 
trial starting structure to the final minimised conformer. In general 
two different techniques are used - direct search methods which can 
cope with trial structures which are far from the minima and gradient 
methods which can be applied to structures which are closer to the 
minima.
Direct Search Techniques
With direct search methods the location of minima relies heavily 
on evaluating the function f(x) at a series of points covering a 
specified region of the energy hypersurface. This is followed by 
examination of the function values to locate the minima.
Direct search methods are typically used for functions which are 
discontinuous or non differentiable, see fig 3.15.
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or where the computational method chosen is dependent upon the amount 
of computer time available. They can also be used on occasions where a 
crude answer may be required at any particular instance throughout the 
calculation.
Direct search methods include the Grid Search method mentioned in 
the introduction. This is probably the simplest method since it is 
non-iterative. It has the disadvantages of only being useful in the 
regions near the minima due to the large number of function values 
which have to be calculated and also it does not use any information 
about favourable moves to speed up the calculation.
Other direct search methods, include Hooke and Jeeves' method,
5
Rosenbrock's method and the modified simplex method of Nelder and 
6
Meade, which is based on the simplex method of Spendley, Hext and
7
Himsworth. All these methods avoid the second disadvantage of the Grid 
Search method in that they all employ pattern techniques. This 
involves a series of explanatory moves from which is constructed a 
table of favourable / unfavourable moves. An attempt to speed up the 
minimisation procedure is then made by doing a pattern move the 
direction of which is determined from the table of sucessful moves. 
The method used for this work was the Hooke and Jeeves' method.
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Hooke and Jeeves' Method
Hooke and Jeeves' method is one of the most straightforward 
direct search techniques for optimising the function f(x) which 
describes the molecule's energy hypersurface.
The method involves a series of exploratory and pattern moves and 
requires a starting (or base) point described by the vector x^ and a 
set of step lengths h^ for all th.e variables x^ (i.e. the Cartesian 
coordinates of the atoms), a consistant step length is frequently used 
for all the variables.
The exploratory moves provide information about the locality of 
the starting point x^ and are carried out as follows
El) Evaluate the function for x^
E2) Increment x^ by h^ and evaluate f(x^). If the energy has 
decreased save the new coordinate, if not decrement x^ by h^ and 
evaluate f(x^) save the new coordinate if the energy has decreased if 
not keep the original coordinate.
E3) Repeat step E2 for all the variables x^ and step lengths h^. 
This will give a new base point 3^.
E4) If the new point arrived at, is different to x^, proceed 
to the pattern moves, otherwise halve the steplengths and return to 
step E2.
Pattern moves decrease calculation time by utilising information 
obtained about f(x) in the region of x.
PI) The sucessful exploratory moves which produced x  ^from x^ are
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reapplied to give point p^.
P2) A series of exploratory moves are then carried out about p^.
If the energy has decreased during either step PI or step P2 a 
point X£ has been reached and this point is then subjected to more 
pattern moves.
If the energy has not decreased a further set of exploratory 
moves are carried out about point *2* ^he procedure ends when the
step lengths have been halved a set number of times.
Gradient Methods
The position of a minimum on the potential energy hypersurface is 
that point at which by definition the first derivative of the 
potential energy function is equal to zero:-
L L  = o
d x
Several gradient methods exist for locating this position and 
they can be divided into methods which:-
a) do not require any derivative calculation.
b) use the gradient of the potential energy surface to locate the
minima (1st derivative methods).
c) use information about the gradient and curvature of the potential 
energy hypersurface to locate the minima (1st and 2nd derivative 
methods).
8 \9
Smith's method of conjugate directions and Powell's method of 
conjugate directions are both descent methods which do not require the
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calculation of derivatives*
1°
First derivative techniques include the Steepest Descent method,
11
the Pattern Search method of Schleyer and the Davidon - Fletcher -
12,13
Powell Variable Matrix method.
14,15
The Newton - Raphson method involves the calculation of both 1st 
and 2nd derivatives and is commonly used for conformational energy 
minimisation calculations.
The Newton ^  Raphson Method
First derivative methods use the gradient of the potential energy 
function to calculate the size and direction of the correction step 
required to move from the current base point x towards the nearest 
minimum point. The gradient is, of course, calculated from the 1st 
derivatives of the function f(x). As with all the gradient methods we 
are unlikely to reach the minimum in one step so this process must be 
iterative.
The Newton - Raphson method relies heavily on the expansion of 
the first derivatives g(x) = f'(x) to a Taylor series
f(x + 5x) = f(x) + (5x)g + (l/2)(6x)^H + etc.
where g is the 1st derivative (or gradient) vector, H is the second 
derivative matrix, and 6x is the increment applied to x.
The series is truncated to the quadratic - the simplest function 
giving a strong minimum. Since the first derivatives are equal to zero 
at the minimum differentiating the above equation gives
g + (6x) fl = 0
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where H is the Hessian matrix. From this equation we get the iterative 
formula:-
* k + l  =  * k  "  H _ 1 8
where is the current point, 3^ 44 is the next current point and 
is the inverse of the Hessian matrix.
When dealing with Cartesian coordinates problems arise with 
inversion of the 3N x 3N Hessian matrix. These problems arise because 
the matrix is sixfold singular due to the three rotational and 
translational degrees of freedom which do not affect the molecules 
energy. This problem can be overcome in one of the following ways:-
1) Conversion from Cartesian coordinates to internal coordinates.
2) Rotation and translation of the molecule can be prevented by fixing 
6 atomic coordinates. This is generally done by fixing one atom such 
that x = y = z = 0, a second such that x = y = 0 and a third such that 
x =■ 0. This will remove six rows and columns from the 3N x 3N matrix 
and it will no longer be singular. However, care must be taken that 
no bond lengths or bond angles are being restricted.
16,17
3) The generation of a generalised inverse matrix. This can be done by 
using the six zero eigenvectors and their corresponding eigenvalues 
which are calculated from the diagonalised matrix.
18,19
4) The use of Eckert constraints which fix the centre of mass in space 
and constrain infinitesimal rotations about the molecule.
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5) The generation of a non-unique reciprocal matrix using modified
20, 21
Choleski procedures such that the resultant matrix is dependent upon 
the initial orientation of the molecule.
The first two procedures give problems if used alone so various 
combinations of the above procedures are quite often used.
The Newton - Raphson method converges more rapidly than the 1st 
derivative methods due to its use of curvature information, however, 
it has major drawbacks in that the calculation of 1st and 2nd 
derivatives involves large amounts of computer time as does inversion 
of the Hessian matrix. This has led to the development of several 
faster techniques in which different approximations are made to the 
Hessian matrix.
1) The Block Diagonal Method
With the Block Diagonal method the matrix is split into 3 x 3  
submatrices x ^  ^  such that i,j=l,3 for each atom. The submatrices 
along the diagonal contain large values related to the energy changes 
brought about by movement of an individual atom in the Cartesian 
direction. The off diagonal submatrices are related to cross terms 
between pairs of atoms and tend to be small. If these off diagonal 
submatrices are set to zero far less computer time is required for the 
calculation.
2) The Pure Diagonal Method.
With the Pure Diagonal method all of the off diagonal elements 
of the matrix are set to zero. This again speeds up the calculation.
The Full Matrix method is the one discussed previously where all 
the elements of the matrix are left intact. Obviously it is the
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slowest method for each individual iteration, however it converges 
very rapidly in 5 - 6 iterations, but is very intolerant of poor 
starting structures and requires starting structures close to the 
minimum.
The Block Diagonal method is much faster to compute and can
tolerate slightly poorer starting structures than the Full Matrix
method, however, convergence is slower and elements of symmetry can be
lost with this method.
The Pure Diagonal method is the fastest variant of the Newton -
Raphson method used for this work. It is very tolerant of poor
22
starting structures, but is slow to converge and again symmetry 
elements may be lost.
No one minimisation procedure can cope with full minimisation of 
a trial structure. The general procedure found to be best for the 
minimisation of trial conformations is:-
1) 2 - 5 cycles of Hooke and Jeeves' pattern search minimisation.
2) Pure Diagonal minimisation until the 1st derivatives are of the 
order of 0.1, usually 500 or more cycles for the larger molecules.
3) Approximately 5 cycles of Full Matrix minimisation - this takes
— —7
the derivatives down to 10” - 10 , gives the best representation of
the molecule and recovers any elements of symmetry which may have been 
lost during the Pure Diagonal minimisation. With Full Matrix 
minimisation the energy of the molecule may not be lowered 
significantly, but the geometry of the molecule can be substantially 
altered due to torsion angle changes.
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CHAPTER FOUR
Section 4.1.
Molecular Modeling and Interactive Computer Graphics
The way in which the majority of people relate to their 
surroundings is by their perception of three dimensional images which 
are constantly being processed by the brain. Since people are adapted 
to respond to visual stimuli it is convenient to illustrate 
theoretical models pictorially, where possible. Interactive computer 
graphics is therefore an ideal way in which to present vast amounts of 
computer generated data, to the user, in a mode which is both easy to 
interpret and comprehend.
For a long time after the birth of computer graphics in the 
1
1950's the vast resources it required, both for the hardware and high 
quality output devices, kept it outwith the reach of the average 
computer user. However, in recent years graphics has benefited from a 
tremendous reduction in the price/performance ratio for hardware and 
interactive graphics is now feasible and practical for the vast 
majority of applications that require only a modest processor and 
display resources.
In molecular mechanics we are interested in studying the 
relationship between some of the physical properties of molecules and 
their three dimensional structures. In particular we are interested in 
examining low energy conformations of molecules. Interactive computer 
graphics is an exceptionally useful tool for molecular mechanics as it 
allows us to observe and investigate how changes in the spatial
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arrangement of a molecule will affect its molecular energy.
Section 4.2.
The Hardware
A diagram of the hardware on which our molecular mechanics 
programs are implemented is shown in Fig. 4.1. The system consists of 
a DEC PDP 11/40 minicomputer with 128 kbytes of memory operating under 
RT11 Version IV, two RK05 2.5 Mbyte disc drives, a Megatek 7000 series 
graphics processor with a calligraphic display terminal, an FPS 100 
array processor for number crunching operations, a Thom EMI printer 
plotter, a Tektronix electrostatic plotter, a VT100 visual display 
unit, a high speed paper tape reader, a Diablo daisywheel printer and 
a 300 baud modem.
There is a second PDP 11/40 with 256 kbytes memory, a 40 Mbyte 
Plessey disc drive, a Fungus v.d.u., a Systime SYSTAPE II magnetic 
tape drive, a VT11 graphics terminal and a Decwriter. This system is 
mainly used as a file storage unit, as cn it is kept the source code 
for the original and the Megatek versions of the molecular mechanics 
programs.
We also have access to the University's mainframe, an ICL 2988 
and, due to their size, a few minimisation routines are implemented on 
it.
The focal point of the system is the Megatek 7000 series refresh 
graphics. This has a high resolution (4096 x 4096) monochrome, 
calligraphic display terminal, the programs for which operate with the 
Megatek MGS graphics software package. The calligraphic terminal has 
the advantage of being a good medium with which to display large
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molecules at high resolution. However, it has the disadvantages of not 
having the facility to shade areas of the screen, or use different 
colours to designate different atom types. More and more we are seeing 
the use of high resolution colour, calligraphic and raster terminals 
to display complex molecular structures.
Section 4.3.
The Software
Most theoretical calculations cn molecules require as input a set 
of Cartesian coordinates. Previous to the advent of interactive 
computer graphics, the user would have had to wade through large 
amounts of numerical data, with only mechanical models and two 
dimensional drawings to give him any idea of molecular conformation. 
As discussed in section 4.1, for certain applications, interactive 
computer graphics is currently one of the best methods of 
communicating directly with a computer, especially for the 
interpretation of output.
The MOL chemical graphics system is an interactive system which 
has been developed with the average chemist in mind. With MOL the user 
is able to peform various types of geometry measurements, energy 
calculations and manipulation to molecules while viewing a three 
dimensional molecular image. It is a user friendly system with easily 
understood input/output, the input being interpreted by text handling 
routines which allow input to be entered in relatively free format 
and report any input format and subject errors.
The system is built as a series of individual programs controlled 
by a root segment, which selects any program required by the user and
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chains to and from it. Each individual program resides on a disc until 
it is selected by the root segment. Only the program in current use 
occupies core memory, but to the user chaining is totally transparent 
and is analogous to subroutine usage. Thus, once the MOL system has 
been initiated it behaves as if it were one large program. Chaining 
therefore gives the advantage of being able to incorporate several 
large programs into the graphics system without exceeding the memory. 
The main disadvantage with this method of program management is that 
chaining to the individual programs is relatively slow. It must also 
be noted that the individual programs are structured such that most of 
their subroutines may be overlaid.
The programs make good use of the RT11 memory management facility 
and some of the programs may be used in stand alone mode.
Section 4.4.
MOL and its Options
The MOL system is capable of handling up to 500 atoms (this does 
not apply to certain options), either in the form of one molecule, or 
as several fragments. The system has two modes of operation, SINGLE 
mode and MULTIPLE mode. In SINGLE mode all atoms in the picture 
display list are treated as belonging to the same fragment and any 
calculations (eg. rotation, minimisation) are carried out on all the 
atoms present. In MULTIPLE mode there may be up to 127 fragments 
present in the system and various operations may be carried out on 
each individual fragment.
The atoms in each fragment are basically stored in arrays
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connectivity. Most input to the system is therefore in the form of 
numerical data and/or atom names and error checking is an integral 
part of the system.
On entering the system the user is presented with a menu of 39 
options any of which may be selected using a crosshair cursor 
controlled by a joystick. Initially the cursor is limited to those 
options which load a molecule into the system (i.e. the first five).
Once the molecule is in the workspace it is drawn as a stick 
diagram (see Fig.4.2). An attempt is made to represent three 
dimensionality by depth cueing the molecule. This is done by drawing 
bonds to the front of the molecule ( +ve z coordinates) at a higher 
intensity than bonds to the back of the molecule (-ve z coordinates). 
In addition each bond is composed of two vectors which can be drawn 
with different intensities. The user gains the best idea of the three 
dimensional arrangement of the molecule when it is undergoing dynamic 
rotation (see section 4. 4. 18.).
Section 4.4.1.
GET FILE
This option allows the user to read an ASCII file from a disc 
into the graphics system. These files are structured in one of two 
formats - a numeric format and a non-numeric format. Figs 4.3. and 4.4 
give examples of these formats for a propanol molecule.
There are ten separate sections within the system format file, 
making it quite an inefficient way of storing data as a lot of the 
information is duplicated. It is hoped that in the near future a 
standard file format will be introduced for use by the Molecular
64
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— MOL CHEMICAL GRAPHICS SYSTEM F3XE- 
TITLE
Propan-1-ol 
**
DATE
03-AUG-85
**
CCMMENTS
**
UNIT CELL
1 1 1  
**
90 90 90
COORDINATES
Cl 1.50000 1.50000 1.50000
C2 3.04100 1.50000 1.50000
C3 3.55464 2.95288 1.50000
04 4.98464 2.95288 1.50000
HI _ 3.40569 0.98431 2.39326
H2 3.40569 0.98431 0.60674
H3 3.19000 3.46860 0.60674
H4 3.18999 3.46860 2.39325
H5 1.13536 2.01572 0.60675
H6 1.13536 2.01572 2.39325
H7 1.13536 0.46856 1.50000
H8 5.30956 2.50652 0.72690
**
CONNECTIVITY
Cl C2 H5 H6 H7
C2 Cl C3 HI H2
C3 C2 04 H3 H4
04 C3 H8
HI C2
H2 C2
H3 C3
H4 C3
H5 Cl
H6 Cl
H7 Cl
H8 . 04
**
ATOM TYPES
1 Cl C2 C3
10 04
15 HI H2 H3 H4 H5 H6 H7 H8
*★
CHARGED ATOMS 
**
END
F i g .  £.3.
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— MOL CHEMICAL GRAPHICS SYSTEM FILE—  
TITLE
Propan-l-ol 
**
DATE
03-AUG-85 
**
COMMENTS
**
UNIT CELL
1 1 1 90 90 90
**
COORDINATES
Cl 1.50000 1.50000 1.50000
C2 3.04100 1.50000 1.50000
C3 3.55464 2.95288 1.50000
04 4.98464 2.95288 1.50000
HI 3.40569 0.98431 2.39326
H2 3.40569 0.98431 0.60674
H3 3.19000 3.46860 0.60674
H4 3.18999 3.46860 2.39325
H5 1.13536 2.01572 0.60675
H6 1.13536 2.01572 2.39325
H7 1.13536 0.46856 1.50000
H8 5.30956 2.50652 0.72690
**
CONNECTIVITY
1 2 9 10 11
2 1 3 5 6
3 2 4 7 8
4 3 12
5 2
6 2
7 3
8 3
9 1
10 1
11 1
12 4
**
ATOM TYPES
1 1 2  3
10 4
15 5 6 7 8 9 10 11 12
**
CHARGED ATOMS 
**
END
F i g .  U.U.
Graphics fraternity. This format should prove a more efficient method 
of storing data, while remaining flexible enough for use in the many 
different areas of computational chemistry.
The first six sections of the file contain the title for the file 
of upto eighty alphanumeric characters, the date the file was created, 
any references, comments and space group information and the unit cell 
parameters
In the numeric format atoms are stored by number and in the non­
numeric format they are stored as atom names. Files are more normally 
stored in the non-numeric format. The coordinate section holds the 
atoms by name or number and their x, y and z coordinates. From the 
connectivity section we can determine which atoms are bonded to which. 
Each atom can have a maximum of four substituents, depending on type 
and the atoms are listed in lines with their substituents.
In the MOL graphics system we wish to be able to identify 
different types of atoms. Names are not necessarily enough, for 
example Cl could be an sp, sp2 or sp3 type of carbon, so numbers are 
used to designate atom type (a list of these is given in Fig. 4.5). 
The atom types section holds the atcm type of each of the atoms in the 
molecule.
The final section is the partial charges section. This contains a 
list of any charged atcms and the charges on than.
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Type Number Description
1 Carbon (sp^)
2 Carbon (sp^)
3 Carbon (aromatic)
4 Carbon (sp)
5 -N (+) R R 1R "
6 -NRR1 (tetrahedral)
7 N (aromatic)
8 N(-) (aromatic)
9 N (trigonal)
10 Oxygen (single)
11 Oxygen (double)
12 Sulphur (diagonal)
13 Sulphur (tetrahedral)
<14 Protonated nitrogen
15 Hydrogen
16 Fluorine
17 Chlorine
18 Bromine
19 Iodine
20 Metal
MOL Atom Types 
Fig. A.5.
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Section 4.4.2.
NEW FILE
Structures may be input from the keyboard with this option in the 
form of names, atomic coordinates etc. This is very useful for 
entering crystallographic data. It is essential that the user inputs a 
title, a unit cell and the atcm names and coordinates. Any remaining 
information such as connectivity, atcm types and partial charges can 
also be entered in NEW FILE, but these data can be entered via other 
MOL routines. NEW FILE cannot be used to add to another molecule since 
any existing structures are deleted as socn as the option is chosen.
Section 4.4.3.
DATABASE
A component of the MOL graphics system is a database, containing 
the structures of a few small hydrocarbons which may be used as 
fragments when building larger molecules. ' To select a structure the 
user must give the database name and the file name, the program will 
then search the database for the file and if it is found it is loaded 
into the system.
Section 4.4.4.
CSSR
The Crystal Structure Search and Retrieval systems database is 
maintained by the Science and Engineering Research Council on various 
computers including one in Edinburgh which we are able to access with
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a 300 baud telephone modem. Files which are in the CSSR format may 
then be read into the system using this option.
Section 4.4.5.
QUICK BUILD
It is of prime importance in any interactive molecular modeling 
system that the user can generate molecules without too much 
difficulty. The QUICK BUILD routine allows the user quickly to build a 
new molecule, add on to an existing molecule, or in multiple mode, 
build a new fragment. If there are no atoms in the workspace, or if a 
new fragment is to be created, the user is asked for an atom name and 
type. Once there are atoms present the user is asked for an existing 
atcm name and the name, type and optionally partial charge of the new 
atom to be connected to it. This new atom is then built on to the 
existing structure using standard bond lengths, angles etc. Carbon 
chains are built as open chains (i.e. all trans). The program will 
check the existing atcm to make sure that it does not already have its 
maximum number of substituents and it will also check the new atom 
name to make sure that this name is not already in existence.
Section 4.4.6.
PUT FILE
A systems format file of the current display structure may be 
written to a disc file with this option. The user is prompted for an 
output file name, the program then checks the disc and if a file of 
that name already exists the user can either overwrite it or chose a
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new file name. The option also allows the user to put comments in the 
file and dictate whether the file is to be in numeric or non-numeric 
format.
Section 4.4.7.
JOIN
There are two modes of operation in this option. It can either be 
used to join all non-bonded atoms within a certain distance of one 
another, or, the option may be used to form (or break) a bond between 
specified atcm pairs. The option checks carefully the valency of the 
atoms. At cots which have their maximum number of substituents cannot 
form any new bonds. If one atcm of a specified pair has a full valency 
the user is given the option of making a one way join from the other 
atom. This can be useful for displaying metal-ligand complexes and 
other inorganic structures. JOIN may also be used to join two atoms in 
different fragments to make a larger molecule. In this case all 
existing fragment numbers are updated.
Section 4.4.8.
BUILD
The current display structure can be altered or augmented with 
this routine. It is similar to QUICK BUILD except it does not use 
tables of standard bond lengths etc. Instead the user is asked for 
four atcm names (three existing atcms plus a new one), a bond length, 
a bond angle, a torsion angle, an atom type and optionally a partial 
charge for the atom. Obviously it is a much slower routine to use than
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QUICK BUILD, however it is exceptionally useful for building 
structures where standard bond lengths, and angles do not apply eg. 
heterocyclic compounds, or, when building rings since using QUICK 
BUILD would result in a straight chain Which would need to be modified 
in ALTER.
Section 4.4.9.
FBUILD
With FBUILD the user can combine two fragments. As input the 
routine requires four atom names in the format
atom A - atom HI atom H2 - atom B 
Where atcm A and atom B are the two atcms to be joined and atcm HI and 
atom H2 are the two hydrogen atoms which will be eliminated. The 
routine positions the fragments containing atcms A and B so that the 
bond to be formed between them will have the correct length and 
valence angle. The hydrogens are eliminated and a bond is formed, the 
length is taken from a table of standard bend lengths according to the 
atom types. This routine is very effective for building large 
molecules (eg. polymers) from smaller substituents.
Section 4.4.10.
REMOVE
The remove option allows the user to remove one, or more atoms 
from the current display structure, in MULTIPLE mode whole fragments 
may be removed. The program deletes atoms, or fragments by editing the 
relevent vectors from the display list, without rescaling, or
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redrawing the picture. The same method is used for deleting bonds in
routine JOIN when breaking bonds. All data concerning the deleted 
atoms is removed from the relevent storage arrays (eg. atom names, 
coordinates etc). Existing structures may be easily modified by simply 
removing unwanted atoms and building on new ones with, for example 
QUICK BUILD or BUILD.
Section 4.4.11.
ADD H'S
Any missing hydrogens may be added to a structure with this 
facility. The program will add hydrogens to any atom which does not 
have its full number of substituents determined by the atom type. The 
hydrogen atoms are added according to a standard geometry, so most 
hydrogens may be added without any user interaction. However, where 
these rules are not applicable (eg. in a methyl group) the user is 
prompted for a torsion angle value.
Section 4.4.12.
ALTER
ALTER can be used in one of two ways. Either interactively to 
alter the value of a specified torsion angle, while monitoring the 
variation in distance between two named atoms. Or, alternatively, it 
can be used to determine which are the most and least energetically 
favourable positions for a given torsion angle. This is achieved by 
calculating changes in the torsional, van der Waals and coulombic 
components of the potential energy, relative to the changing torsion
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angle as it proceeds from 0° to 360° in user specified steps (eg. 
10°). A scaled plot of the potential energy versus the torsion angle 
is then drawn and a hardcopy of this is available (see Fig.4.6). The 
energy scale for the plot has a cut off value of 200 kcal mol-1 since 
we are more interested in the minima than the maxima.
Section 4.4.13.
RftfrMAP
With this routine the user can calculate and plot Ramachandran
2,3
maps. The plotting routine may be used in stand alone mode. 
Ramachandran maps enable the minimum positions of two torsion angles 
to be determined. The user is prompted for the two torsion angles of 
interest (by atom names) and a step size for the 0° to 360° rotation 
of each torsion angle. The program then sets each torsion angle to 0° 
and holds torsion angle 1 at this while rotating torsion angle two 
stepwise from 0° to 360°. Torsion angle 1 is then incremented by the 
value of the step and torsion angle 2 is again rotated stepwise from 
0° to 360° until all possible permutations have been covered. With 
each step the program calculates and stores the potential energy 
changes involved using the same parameters as ALTER.
Once the routine is finished the user is given the option of 
plotting a grid, or a contour map of the variation of potential energy 
against the two torsion angles (see Figs. 4.7 and 4.8). From these 
plots we can determine the minimum energy positions for the torsion 
angle pair.
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RAMMAP - Contour Plot.
Section 4.4.14.
CLOSE
One of the most frustrating problems that arises while building 
rings is that the ends of the chain are invariably the wrong distance 
apart to make a ring. CLOSE will produce a more favourable end to end 
distance by tweaking each of the ring torsicn angles by a maximum of + 
or - 10°. Bond lengths and angles are unaffected.
As input the user must enter the two atom names and the target 
end to end distance. In some cases it is not possible to attain this 
distance with one cycle of CLOSE and the whole procedure must be 
repeated.
Section 4.4.15.
DISTANCE
This is the first of three options which perform geometry 
calculations on the display structure. As its name implies the 
DISTANCE option calculates distances between specified atom pairs. The 
input is either in the form of atom names, or if more than one 
distance is required wild cards may be entered instead of atom names, 
when wild cards are used the user may specify whether he requires the 
program to calculate and list only bonded distances, or all 
interatomic distances. This data can be relayed to the line printer, a 
disc file, the v.d.u., or the Megatek screen.
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Section 4.4.16.
ANGLE
Any angle in the molecule may be calculated with this option. The 
user is asked to specify three atcms by name and like DISTANCE one or 
more atoms may be replaced by wild cards. When wild cards are used 
this routine will only calculate angles between bonded atoms - a 
listing of which may be sent to a user specified device. Angles which 
are not bond angles have to be specifically requested.
Section 4.4.17.
TOR ANGLE
This is the third option which performs calculations on the 
geometry of the structure in the workspace. It enables any torsion 
angle in the structure to be calculated. The names of the four atoms 
defining a torsion angle have to be entered. If wild cards are used a 
list of all torsion angles between bonded atoms (including those 
containing hydrogen atcms if requested) is again relayed to the user 
specified device. Torsion angles including non-bonded atoms must be 
explicitly specified.
Section 4.4.18.
R D FUNC
This option plots a radial distribution function for the current 
structure. That is to say it produces a plot of the number of non- 
bcnded atoms which are a given distance apart versus that distance and
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is useful for comparing molecules which have similar activities. A 
hardcopy of the plot is available (see Fig. 4.9).
Section 4.4.19.
ROTATE
ROTATE enables the user interactively to rotate a molecule, or 
fragment, about the X and Y axes using the joystick and the Z axis 
using the letters P and N for clockwise (positive) and anticlockwise 
(negative) rotation, any other key will stop the rotation. Although 
a Megatek graphics sytem is available with a hardware rotate our 
particular system does not have it and this rotation option uses 
software routines. The X and Y axes rotation is achieved by 
calculating a rotation matrix from the position of the joystick and 
the multiplying the atomic coordinates by it. To prevent a staggering 
effect during the rotation double buffering is used. This involves 
using two of the eight picture planes in the Megatek. Each plane can 
hold a separate picture and may be switched on or off. The picture of 
the current structure is held in cne plane, which is switched on. The 
structure is rotated and the new picture is drawn in the second plane 
which is switched off. As the first picture is switched off the second 
picture is switched on etc.
Depth cueing is maintained during the rotation and this proves 
very helpful in giving an idea of which part of the structure is 
rotating towards the user and which parts are moving away.
As part of this project it had been hoped to rewrite this routine 
to run on the array processor, however, it was found that there was
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not enough memory available on the system to link the array processor 
version with all the library subroutines it required.
The array processor version was however sent to Floating Point 
Systems in Bracknell where it has been implemented on a Vax 11/780.
Section 4.4.20.
TRANSLATE
There are two parts to TRANSLATE in the MOL graphics system. A 
hardware translate involving the X-Y plane and a software translate 
involving the Z direction. With this option one can translate a 
fragment with respect to the rest of the display and if required the 
program can monitor the distance between an atom from each fragment as 
the translation proceeds. This enables the user to maneouvre two 
fragments to the correct distance apart for, say BUILD. The system 
must be in MULTIPLE mode for translation
Section 4.4.21.
VPERP
As its name implies this option gives a view perpendicular to a 
plane which has been specified by entering three atcm names.
Section 4.4.22.
ARBROT
This option allows the user interactively to rotate the current 
structure about an arbitrary axis which has been defined by any two 
atom names - not necessarily in the same fragment. The rotation is
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carried out using the joystick.
Section 4.4.23.
BEST VIEW
The best view of any molecule, or fragment, in the current 
display may be obtained using this very useful routine. The definition 
of the best view is the view which has the sum of the squares of the 
distances of atoms from the plane of the screen as a minimum. 
Hopefully this gives the user a view of the molecule with as few 
overlapping atoms as possible.
Section 4.4.24.
S'IMPOS
The superimpose option facilitates the super imposition of one 
fragment on another. As input the program requires as many pairs of 
corresponding atoms, one frcm each fragment, as will define the region 
of overlap. The program then superimposes the two fragments using a 
least squares fit technique and then calculates the RMS fit for the 
two structures. Finally the two superimposed fragments are redrawn on 
the display. This option can only be used in multiple mode and is 
mainly useful for comparing regions of structural similarity in 
different molecules.
Section 4.4.25.
HIDE H'S / SHOW H'S
This is one of four toggle type options (ie. on / off). On
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entering the system it is set to show hydrogens, however to clarify a 
complex structure it may be desired to ignore temporarily the hydrogen 
atoms and this option can be used to hide or display them at will.
The program does not remove, or add, hydrogens from the structure 
it simply prevents, or enables their being displayed. While the 
hydrogens are not being displayed their coordinates, names etc. are 
still held in the storage arrays and any operations carried out on the 
structure (eg. rotation) are carried out cn the hidden hydrogens. Show 
H's will simply return the hydrogens to the display picture in their 
correct positions. As with the next three options only one of the two 
routines is in the menu at any one time and when it is selected the 
menu is redrawn with the other option now available.
Section 4.4.26.
NO LABELS / LABELS
Again to clarify a structure NO LABELS can be used to switch off 
the atcm names. Option LABELS restores the atcm names to the display 
picture.
Section 4.4.27.
CUE OFF j_ CUE ON
In the MOL graphics system an attempt is made to represent a 
three dimensional image by depth cueing the picture (see section 
4.3). This feature can be disabled with CUE OFF and all atom names and 
bonds are then drawn at the same intensity.
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Section 4.4.28.
MULTIPLE / SINGLE
This option acts as a switch for the corresponding modes. In 
SINGLE mode operations are performed cn the whole display structure as 
if it were one fragment. Whereas in MULTIPLE mode operations can be 
performed on individual fragments within the display picture. MULTIPLE 
mode also allows the user to load several molecules into the workspace 
at once.
Section 4.4.29.
CHANGE
If new molecule has been created from a previously existing file 
it may be desirable to change the title of the file before storing it 
on a disc, this option allows the user to do this. It also gives the 
user the opportunity to change the name, type or partial charge of any 
atcm in the current display.
Section 4.4.30.
OKl'EP
A specially modified version of the Oakridge thermal ellipsoidal
4
plot program has been implemented as part of the graphics system. The 
atoms are plotted as spheres not as ellipsoidal structures and there 
is no hidden line removal in the routine as this would make the 
program too large for the PDP 11 's memory. Depending on the size of 
the molecule an Ortep diagram of the current display structure,
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adequate for most uses can be produced by the system without user 
intervention. A hardcopy of the Ortep diagram can be plotted on the 
Tektronix plotter (see Fig. 4.10).
Section 4.4.31.
SPACEFILL
A spacefilled diagram of the current display picture can be drawn 
with this option. Since the Megatek has a calligraphic terminal curved 
lines are represented by many short vectors - a total circle is 
replaced by a 25 sided polygon. The user has the option of using his 
own table of van der Waals radii, or a default table of standard van 
der Waals radii, which has been incorporated into the system. A stick 
model of the structure may be superimposed on the spacefilled 
structure and a hardcopy is available (see Fig. 4.11).
Section 4.4.32.
PD MIN
This option is used to minimise the energy of a molecule. It uses 
the variant of the Newton Raphson minimisation method in which the 
Hessian matrix is approximated to a pure diagonal.
There are two versions of this routine, one which runs in the PDP 
11 and one which runs in the array processor. They differ in that the 
one which runs in the PDP 11 is very slow, will not calculate 
ooulombic interactions for partial charges and can take upto 80 atoms, 
whereas the array processor version is a lot faster (ca. 30 - 40 
times), will calculate coulombic interactions for partial charges and 
can only be used for molecules which have 65 or less atoms.
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As input the user must enter a device name for the program 
output, a force field file name, the number of iterations for the 
minimisation and whether long ,or short, output is required.
Firstly the program checks the force field to see if it has the 
correct parameters for the molecule. If any are missing it will report 
them and the program may either be abandoned, or the interactions for 
which the parameters are missing will be set to zero. With long output 
the program list all the individual energy interactions followed by 
the total contribution of each type of interaction to the total 
potential energy this is done after each iteration. With short output 
the program lists the components of the initial and final total 
energies in the following form.
TOTAL E(BONDED) =
TOTAL E(VAN DER WAALS) =
TOTAL E(ANGLES) =
TOTAL E(TORSION) =
TOTAL E(OUT-OF-PLANE BENDING) =
TOTAL E(COULOMB) =
TOTAL POTENTIAL ENERGY =
R.M.S. MAGNITUDE OF FIRST DERIVS=
NUMBER OF CYCLES =
The program then lists the RMS derivative for the energy. 
Structures which are far from a minimum have a high RMS and could 
cause the program to fail, so these structures should be minimised 
using QUICK MIN before being entered into PD MIN. Occasionally during
K.CAL PER MOLE 
K.CAL PER MOLE 
K.CAL PER MOLE 
K.CAL PER MOLE 
K.CAL PER MOLE 
K.CAL PER MOLE
K.CAL PER MOLE
K.CAL. MOLE-1 A-l
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the course of minimisation errors such as a floating point overflow or 
a floating zero divide may occur. These errors are flagged by the 
program and the use is informed - the minimsed structure can then be 
kept or abandoned.
Section 4.4.33.
QUICK MIN
QUICK MIN is based on a modified Hooke and Jeeves pattern search 
algorithm. It is useful for minimising structures Which are fair from a 
minimum energy conformation and may fail when minimised in PD MIN. 
Again there is a PDP 11 version and an array processor version, which 
have the same limitations as the PD MIN routines. The input and output 
for QUICK MIN are exactly the same as for PD MIN since it is called 
and written by the same subroutines. It does , however, differ in two 
ways. QUICK MIN requires the user to input a step length for its 
pattern search (standard values are normally between O.lA and O.OOlA) 
and it does not calculate an RMS derivative for the minimisation.
Section 4.4.34.
CONGEST
5,6
A modified version of the algorithm of Wipke and Gund is used to 
predict the outcome of stereoselective attack at trigonal at cm s. The 
names of the two trigonal atoms forming the double bond and the centre 
at which the attack is to take place must be given. The program then 
calculates and lists the total steric congestion for each side of the 
attack centre mean plane and the structure is redrawn so that the
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attack centre mean plane and the plane of the screen are coincident, 
with +ve Z direction towards the viewer.
Section 4.4.35.
ZOOM IN _/ OUT
When examining large or crowded structures it is useful to be 
able to consider only a part of the structure at higher resolution. 
The ZOOM option allows the user to do this by entering an atom name 
and a sphere radius. The named atcm is then redrawn at the centre of a 
sphere of the given radius - any other atoms within the sphere are 
also displayed. The atoms in this picture are stored in temporary 
arrays, modifications may be made to the picture, but when the user 
zooms out again the original structure is returned. The option may 
also be used to zoom in cn specific fragments when in MULTIPLE mode.
Section 4.4.36.
LOCATE
As its name implies this option can be used to locate any atom in 
the current display structure. Again this facility is very useful when 
dealing with large moleclues. On entering an atom name the program 
locates the atom and causes its label to flash brightly making it 
immediately identifiable.
Section 4.4.37.
HARDCOPY
Selecting HARDCOPY relays a picture of the current display to the
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Tektronix plotter which is attached to the system.
Section 4.4 38.
RESTART
RESTART simply resets the system to its original state by 
removing any current structure, setting the options to show hydrogens, 
cue on, single mode, labels on, redrawing the menu and limiting the 
crosshair cursor to the first five options.
Section 4.4.39.
QUIT
QUIT enables the user to exit tidily from the MOL system.
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Chapter Five
Section 5.1.
Introduction
Enzymes are macromolecules which enable living organisms to 
actively mould and use their environment. They are specific proteins 
which catalyse the biological reactions which constitute metabolic
pathways. As catalysts they are far more efficient than any man made
2 ncompounds, increasing reaction rates by 10 to 10 , at moderate
temperatures and pressures, in aqueous solution and at physiological 
1 , 2
pH. Indeed in the absence of enzymes the rates of most biological 
reactions would be too slow to be observed.
Enzymes are also more efficient than their synthetic counterparts
3
in the area of substrate specificity. Chemical catalysts rarely 
possess substrate specificity, whereas all enzymes are highly 
substrate specific and will catalyse a single chemical reaction, or a 
group of related chemical reactions.
The degree of substrate specificity shown by an enzyme arises 
from the three dimensional nature of its active site, which is where 
the reaction being catalysed occurs. The structure of the active site 
is in turn dependent upon both the amino acid sequence of the protein 
(the primary structure) and the way in which it is folded (secondary 
and tertiary structure). In general the active site of an enzyme takes 
the form of a cleft, or crevice, and some of the amino acid residues 
forming this cleft are involved in binding to the substrate. These
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functional groups, which are required both for binding and for 
catalytic activity, are usually found in different areas of the linear 
sequence of amino acids and are brought together by the folding of the 
chain. For example the binding groups in the active site of lysozome 
are provided by residues 35, 52, 62, 63 and 101 from a linear sequence 
of 129 amino acids.
As well as being highly substrate specific many enzymes are also 
highly stereospecific, catalysing reactions involving say the L-form 
of a compound, but not the D-form. In such cases the isomer which is 
not a substrate often acts as an inhibitor to the reaction.
The function of many enzymes is dependent upon the presence of 
small amounts of chemical agents other than the reactants of the
4
catalysed reaction. These compounds are called cofactors and may
2+ 2+ 5,6simply be metal ions (Mg , Fe etc.), more complex organic
7
compounds, or even other enzymes. Among these cofactors, some may be 
regarded as integral parts of the enzymes and are known as prosthetic 
groups. Others may act as substrates in that they combine with the 
enzyme and leave it again unchanged in the course of a single 
catalytic cycle - these are called coenzymes.
Section 5.2.
Enzyme Nomenclature
There exists a vast number of enzymes, each catalysing a specific 
reaction, whose activities cover a whole range of anabolic and 
catabolic reactions. In order to reduce the confusion and 
misunderstanding which arose from the trivial naming of these enzymes 
a Commission on Enzymes was set up in 1955 with the purpose of
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devising a method of systematic nomenclature for enzymes. This 
produced a system in which enzymes are separated into six classes 
depending upon the type of reaction they catalyse, namely:-
Class Enzymes (by reaction type)
1 • Oxidoreductases
2. Transferases
3. Hydrolases
4. Lysases
5. Isomerases
6. Ligases
Each class is then divided into subclasses and sub-subclasses 
which further define the nature of the reaction being catalysed. Each 
enzyme is then given a unique number within its sub-subclass.
The application of this nomenclature system can be demonstrated 
with the enzyme Creatine kinase, a muscle enzyme which catalyses the 
reaction:-
Creatine + ATP —* Creatine phosphate + ADP
This enzyme has the following unique number:-
EC 2. 7. 3. 2.
Enzyme Comission J  I I I I
Transferase Class _ _
Phosphotransferase subclass -1 
Sub—subclass of phosphotransferases 
with a’ nitrogenous group as an acceptor 
Enzyme number within sub—subclass i
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Using this system of nomenclature each enzyme is given a unique 
number with which it can be identified. This system is flexible enough 
to allow the naming of newly identified enzymes and it also allows the 
introduction of new subclasses and sub-subclasses should they be 
required.
Section 5.3.
Enzyme Regulation
Since enzymes are such efficient biological catalysts a mechanism 
is often required by which their activity can be regulated. In some 
cases this is done by synthesising the enzyme in an inactive precursor 
form which can then be activated at the physiologically appropriate
8*9
time and place.
Another regulatory mechanism involving structural change is that 
10
of covalent modification. With this control mechanism a small group is
covalently inserted into the enzyme rendering it inactive. This
modification can be reversed by hydrolysis.
Other enzymes are under physiological control. For example it has
been observed that hormones can exert physiological effects on certain
11
enzymes by altering the specificity of the enzyme.
However the method of control which is probably the most common 
in metabolic pathways involves inhibition of the enzyme by one or more 
of the products of the pathway in which it is involved. This type of
12-15
enzyme regulation is called feedback inhibition.
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Section 5.4.
Enzymes as Catalysts
For any reversible chemical reaction:-
kl
S P
k2
the rate of the reaction, v, can be given by the rate of appearance of 
product per unit time, or the rate of disappearance of substrate per 
unit time:-
v = -d [S± = d [P] 
d t d t
and once equilibrium has been achieved the equilibrium constant, K, is 
given by:-
K = _[P]_ = k,
[s]
The variation of the equilibrium constant, K, with temperature 
can be deduced from classical thermodynamics:-
In K = - A G °
R T
where A G °  is Gibb's free energy for the reaction, R is the gas 
constant and T is the temperature in degrees Kelvin.
From this can be derived the equation for the rate constant, k.
In k = Ea + constant 
R T
Another important equation is:- 
k = Ae-<Ea > RT>
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where A is a frequency factor and the term e”^Ea  ^ RT  ^ is the
Boltzmann expression for the fraction of molecules having an energy in
excess of E& where E& is the energy of activation for the reaction
i.e. the minimum energy which must be acquired by the molecules before
16
the reaction can take place.
The energy involved in the reaction can be plotted as a function 
of Gibb's free energy versus progress of reaction, see Figure 5.1.
(S..P)* Transition state complex
Reactant
Product
Reaction Progress
Figure 5.1
From the above figure it can be seen that the reaction proceeds 
via a transition state and for the reaction to occur the molecule must 
achieve that energy of activation associated with the transition 
state.
The reaction rate is proportional to the fraction of
molecules having a free energy greater than, or equal to the energy of
17
activation ( the proportion of molecules in this position increases 
with temperature ). Consequently if the E& is very large the reaction
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rate will be slow and if E is small the reaction rate will be fast.
a
Catalysts do not alter the position of equilibrium for a 
reaction, but instead they speed up the rate of attainment of this 
equilibrium by lowering the activation for the reaction, see Figure 
5.2.
(S..P)* Transition state complex
Oeo
§u.
Reactant
Product
Progress of Reaction 
Figure 5.2
Therefore catalysts create a new reaction pathway whose 
transition state energy is lower than it would be in the absence of 
the catalyst.
Enzymes act as catalysts, however Figure 5.3 more accurately 
represents the changes in energy which occur when an enzyme reacts 
with a single substrate.
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E + S
ES
EP
E +  P
Progress of Reaction
Figure 5.3
With enzymes the reaction rate can be increased in many ways. For 
example enzymes bind substrates in their optimal positions for
1 8 , 1 9
reacting. This can include a) the precise orientation of binding
20
orbitals to give maximum chance of reaction, b) increasing the
effective concentration of the substrates by binding the reacting
21
molecules in close proximity, c) binding the substrate in a strained
22
conformation which is more likely to react.
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Section 5.5.
Enzyme Kinetics
The study of the mechanism of enzyme action can be carried out 
using various techniques. These include X-ray crystallography, 
electron microscopy, amino acid sequencing, substrate modification and 
molecular modeling. However the first technique that is usually used 
is enzyme kinetics.
There is no single kinetic expression which can be used to 
describe all enzymic reactions. This is due to the many different 
mechanisms involved which include single substrate reactions, more 
than one substrate reactions, reactions involving more than one 
intermediate step and reactions involving allosteric enzymes.
Three mentioned enzyme classes fall into the catagory of single 
substrate reactions, they are:-
1) Isomerases which catalyse A -4 B
2) Lysases which catalyse A —^ B + C
3) Hydrolases which catalyse B - A + ^ 0  — > A-OH + B-H
Although hydrolases are only honorary single substrate reactions 
due to the the fact that water is present at such high concentration 
that the reaction is presumed to be independent of [ ^ 0].
Kinetics of single substrate reactions
Initially it was thought that enzymic reactions could be 
expressed in terms of the equation:-
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k3
E + S — » E + P
The rate of this reaction would be proportional to the
concentration of each of the reactants E and S.
reaction rate = -d [S] = -d [E] = k^ [S] [E]
d t d t
and a plot of initial rate against substrate concentration would give 
a straight line (see Figure 5.4).
V
[S]
Fig. 5.4
However, it was found that for many enzymes a plot of the 
reaction rate versus substrate concentration for a set amount of 
enzyme gives a rectangular hyperbola (see Fig 5.5).
23
This discrepancy was explained by A.J. Brown in 1902 when he 
proposed the formation of a discrete Enzyme-substrate complex as part 
of the reaction mechanism:-
E + S — ♦ E S  - » E  + P
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V[S]Fig. 5.5
From the above equation the substrate concentration / reaction 
rate relatioship can now be rationally explained. At small substrate 
concentrations the reaction rate is almost linearly proportional to 
the substrate concentration, but at high substrate concentration the 
enzyme becomes fully saturated and the reaction rate reaches its 
maximal value.
24
In 1913 Michaelis and Menten proposed a simple model to explain 
the kinetic properties of single substrate enzyme systems
Free enzyme, E, and substrate, S, are in rapid equilibrium with 
the enzyme substrate complex, E S, which can also react to give 
product, P. Since enzymes are highly substrate specific and P is 
initially at low concentrations it is assumed that none of the product 
can be converted back into enzyme substrate complex.
If k3 is the slow, or rate determining step, the rate of the
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reaction is equal to the rate of appearance of product
d [P] = k~ [ES] 5.2
d t
The concentration of the ES complex is in turn dependent on the 
rate of formation and dissociation of the ES complex:-
rate of formation of ES = [E] [S] 5.3
rate of breakdown of ES = k2 [ES] + k^ [ES] 5.4
At equilibrium the rate of formation of the ES complex will equal
the rate of breakdown, so the concentration of ES will be constant
d [ES] = kx [E] [S] - k2 [ES] - k3 [ES] = 0 5.5
d t
therefore
kl [E] [S] * k2 [ES] + k3 [ES] 5.6
The concentration of free enzyme [E] is given by:-
[£ 1 - [EtotaJ - [ESI 5.7
substitution and rearrangement in equation 5.6 then gives
. , kl [S1 [EtotaJ 5*8
[ES]  ------------------
(k2 + k3) + k^[S]
and from equation 5.2 the reaction rate then becomes
k3 kj [S] [Etotall 5.9
v =
(k2 + k3) + k^ [S]
if Km is the defined as k2 + k3
kl
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the reaction rate can be expressed as:-
k3 [S1 tEtotall 5*n
Km + ISI
The maximal rate of reaction. V „ . occurs when the enzyme is* max’ J
fully saturated with substrate i.e. when [S] is high (see Fig.5.5). At 
this point [S] / (Km + [S]) approaches unity and this gives:-
V = k0 [E„ . . ] 5.12max 3 L total1
substituting this into equation 5.11 gives the Michaelis - Menten 
equation:-
v - vmax [S] 5-13
r p r j s ]
From the Michaelis - Menten equation it can be seen that for low 
substrate concentration, i.e. when [S] «  Km
’ - Vma* M  5“14
m
that is to say the rate is directly proportional to substrate 
concentration • For high substrate concentration, where [S] »  the 
rate becomes maximal and therefore independent of the substrate 
concentration. Finally where [S] = Km
V 5.15max
2
Thus Km is equal to that concentration at which the reaction rate 
is half its maximal value.
The equation of a rectangular hyperbola is not a convenient form
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for evaluating the kinetic constants K and V . However the Michaelisin max
- Menten equation can be transformed into an equation which gives a
25
straight line using a procedure designed by Lineweaver and Burk:-
1
max
+ Ln ■
[S]max
A plot of 1 / V versus 1 / [S] will give a straight line with a
gradient K / V and an intercept on the y axis of 1 / V seem max * ■' max
Fig. 5.6.
i/v,max
/ [S]-1/K,
/ V.max
Figure 5.6
For those enzymes following Michaelis — Menten kinetics the Km 
value for the enzyme is dependent upon the nature of the substrate and 
also on reaction conditions, like temperature, pH etc. In general Km 
gives two pieces of information about the system. Firstly it is the
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concentration at which half of the enzyme's active sites are filled. 
From this we can calculate the fraction of active sites filled, fES, 
for any particular substrate concentration using the equation:-
fES - J L _  - [SI 15.17
Vmax t s T + K ^
Secondly Km is related to the individual rate constants for the 
reaction:-
k2 + k2
K ------  7----  5.18m
The apparent dissociation constant for the ES complex is:-
K, - [E] [S] 5.19
[ES]
For the circumstance where the formation of product is the rate 
determining step (which was assumed for the derivation of the 
Michaelis - Menten equation) k2 will be much larger than k^. This 
gives
Km ~  ^2 Kd 5,20
kl
Thus is approximately equal to when k2 >> k^. Under these 
conditions is a measure of the strength of the ES complex, a large 
Km indicating weak binding and a small Km indicating strong binding. 
It must be noted that the condition k2 >> k^ does not hold for all 
single substrate systems.
The maximal rate of reaction, Vm Q . gives the turnover number for
UlOA
the reaction where the concentration of the enzyme is known:-
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Vmax - k3 [Etotal] 5-21
where k^ is the turnover number , that is the number of substrate
molecules converted into product per unit time at full saturation of
the enzyme. Turnover numbers are normally in the range 1 - 10,000.
In-vivo conditions are rarely the same as in vitro conditions.
Most enzymes are not normally fully saturated under physiological
conditions and the [S] / Km ratio is typically between 0.01 and 1.0.
This means that the enzymic turnover number in the cell is less than
its maximum value, k3, due to the fact that the active sites of the
enzyme molecules are only partially occupied.-The kinetics of the
enzyme under such conditions can be given by:-
V = k3 [E] [S] 5.22
Km
when [S] «  K [E] is nearly [Etota ]^ therefore:-
V = kj lEtotail [S] 5.23
K»
The reaction rate is therefore dependent upon k^ / and [S],
substituting for gives 
ko k<5 k.
— : = — -----—  5.24
K k0 + kom 2 J
The reaction rate is therefore set by k^, the rate of formation 
of the [ES] complex. The value of kj^  is limited by the rate of 
diffusion since the rate of formation of the ES complex cannot occur 
any faster than the diffusion controlled substrate - enzyme 
encounters. Therefore the maximum value of k^ as set by diffusion is 
108 - 109 mol” 1 sec” 1. The upper limit upon k3 / Km is therefore
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between 10® and 10^ mol-1 sec”'1'
Several enzymes do not obey Michaelis - Menten kinetics due to 
the fact that their reaction pathways are more complicated than the 
above example of a single substrate system for which the rate 
determining step is that of formation of product. For such enzymes the 
maximal catalytic rate at full substrate saturation is denoted by k t 
which may be dependent upon several other rate constants eg, for the 
three step mechanism
Under such conditions it is impossible to calculate the
equation 5.25 and is in fact equivalent to the turnover number for the
reaction. Since K gives a measure of how well a substrate binds to m
the enzyme the kcat / ratio gives a good indication of the 
effectiveness of the substrate. This ratio is known as the specificity 
constant and the higher the value of the specificity constant the 
better is the substrate for the enzyme.
E + S
k.3
E + P2 5.25
Assuming that ^  and k^ are the rate determining steps
V kcat ^total 5.26
where
k 5.27cat
k2 + k3
individual rate constants, but ^cat can be readily calculated from
110
Section 5.6.
Enzyme Substrate Complexes
The existence of enzyme substrate complexes, first proposed by 
23
Brown in 1902, has been shown in a variety of ways such as electron 
microscopy, X-ray crystallography, changes in physical properties such 
as heat stability, spectroscopic studies and isolation of pure forms 
of ES complexes.
The specificity of binding to a substrate will be determined by 
the shape of the active site. A large number of enzyme - substrate 
interactions can be envisaged in terms of a lock and key arrangement, 
for which the the shape of the substrate must match the shape of the 
active site. With some enzymes, however, the active site may not be 
totally rigid and in such cases the active site shape only matches the 
substrate shape, once the substrate has been bound. This is known as 
induced fit.
The structures of active sites are of prime importance to the 
pharmaceutical industry since many drugs and toxic compounds inhibit 
enzymes by binding to the active site, or binding elsewhere on the 
enzyme causing conformational changes which alter the structure of the 
active site (allosteric inhibition).
Section 5.7.1.
Enzyme Inhibition
Enzymes can be inactivated by many compounds which will disrupt 
protein structure (eg. acid, alkali etc.). However there are many 
selective compounds which will inhibit enzymes by binding at strategic 
sites without actually disrupting the proteins three dimensional
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structure.
Within this category are two different kinds of inhibitor: those 
which are responsible for reversible inhibition2  ^amd those which are 
responsible for irreversible inhibition2?.
With irreversible inhibition the inhibitor is bound covalently, 
or else bound so tightly to the enzyme that its dissociation is 
extremely slow. It is characterised by complete loss of enzyme 
activity which cannot be regained by physical treatment and is 
generally quantified in terms of the loss of enzyme activity, or 
velocity of inhibition.
With reversible inhibition the activity of the enzyme can be 
regained by the removal of the inhibitor. This is possible due to 
the rapid equilibrium which exists between the free enzyme, free 
inhibitor and the enzyme-inhibitor complex. Reversible inhibition 
can be separated into different types, namely competitive inhibition, 
non-competitive inhibition, uncompetitive inhibition and mixed inhibi­
tion. These types of inhibition can be distinguished kinetically and 
the type of inhibition involved with EC 3.4.24.11., namely competi­
tive inhibition, is described in more detail in the following 
section.
Section 5.7.2.
Competitive Inhibition
With competitive inhibition the inhibitor often resembles the 
natural substrate, or more effectively the substrate transition state. 
The inhibitor and the substrate are therefore in direct competition
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for the same binding site in the molecule. The rate of catalysis is 
reduced because the binding of a competitive inhibitor decreases the 
proportion of available active sites.
The simplest mechanism for competitive inhibition can be 
described by the following equations:
E + S ^ * E S ^ E  + P
E + I JzH* El
K* - EE3 [I] ]<£ po
Kl ' [El] " kC 5‘28
where [I] is the concentration of inhibitor and is the dissocia- 
dissociation constant of the enzyme-inhibitor complex.
The reaction rate in
the presence of a competitive inhibitor can then be given by:
v . Uglax [S] 5 2Q
v Km (1 + [I]/Ki) + [S]
Inversion of this equation gives a Lineweaver-Burk type equation 
of the form:
+ m (1 + [I]) 1
v vmax vmax Ki tS]
A plot of 1/V versus 1/[S] can be compared to the normal plot 
(see Fig. 5.7). Vmax is given by the intercept on the ordinal axis 
and is unaltered by competitive inhibition. However, the gradient is 
increased by a factor of (1 + [I]/K^) and Km is also altered. Com­
petitive inhibition can be overcome at large substrate concentrations
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where [S] >> [I] since under these conditions virtually all the 
active sites are occupied by substrate. The increase in the gradient 
gives an indication of the affinity with which the inhibitor is 
binding to the enzyme.
Inhibition constants can be calculated in a similar manner for 
all other types of reversible inhibition.
114
COMPETITIVE INHIBITION
[I]
[1 1 = 0
1 / [S]
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Section 5.7.3.
Determination of Ns
values provide a useful measure for comparing the relative 
potency of different inhibitors. The simplest way of measuring a is 
to measure the initial reaction rate with various substrate 
concentrations and then remeasure the rates at the same concentrations 
with a known concentration of inhibitor. Depending upon the type of 
inhibition taking place the gradient of the resulting Lineweaver - 
Burk plots may be affected by a value of ( 1 + [I] / ) and since
[I] is known can be calculated. This method would not however 
detect non-linear inhibition and it is better to repeat the above 
process with several different inhibitor concentrations. can then 
be obtained graphically in one of two ways.
a) By plotting slope versus [I] for competitive inhibition, intercepts 
versus [I] for uncompetitive inhibition, slope, or intercepts vs [I] 
for non-competitive inhibition and both slope versus [I] (gives K. )
X 6
and intercepts versus [I] (gives K^es) f°r mixed inhibition. All the
above plots should result in a straight line plot with an intercept on
the abscissal axis equal to -K. , see Fig. 5. 8.
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b) Dixons method can be used for competitive and non - competitive 
inhibition this involves plotting 1 / V versus [I] for different 
substrate concentrations, see Fig. 5. 9. can be determined from the 
intercept of the lines.
The amount of inhibition occuring for any inhibitor is often 
reported in terms of an IC5q value. This is the concentration of an 
unlabeled inhibitor which causes 50% inhibition of the binding of a 
labeled substrate and this can be converted into a using the Cheng
116
Inhibition Constant Determination using Lineweaver-
Burk plots.
\
F i g .  5.8.
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Inhibition Constant Detormination using Dixon 1s method.
I SI
[SI
[S]
IIIK.
Fig. 5.9.
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29
- Prusoff equation:-
Ki " IC50 / ( 1 + D / Kd )
where D is the concentration of the labeled substrate and is its 
dissociation constant.
Section 5.8.
Protein Evolution
From the study of evolution it can be seen that there has been
much diversification from the original gene pool giving rise to the
vast number of existing species. The evolution of proteins occured in
conjunction with the evolution of species and protein diversity is a
direct result of this evolution. The most basic evolutionary change
occuring in protein structures is the substitution of amino acid
residues. Larger structural changes can be brought about by insertion
of one or more amino acid residues and major structural modifications
occur as a result of gene fusion and duplication. Such structural
changes accumulate over time resulting in major differences between
the initial and final structures. This causes great difficulties for
30
sequence comparisons of distantly related proteins.
The amino acid sequence of a protein is coded for by certain 
regions of the DNA of the organism. In general only about 10% of the
32,33
DNA actually codes for proteins - the remainder takes the form of 
spacer DNA separating the coding regions. Mutations occur with fairly 
high frequency in DNA and changes in the amino acid sequence can occur 
as a direct result of mutations in the coding regions. However, due to 
the degeneracy of the genetic code only about 75% of mutations
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occuring in the structural zones actually give rise to changes to 
amino acid residues* The remaining 25% are silent mutations which do 
not produce any structural change to the protein being coded for.
Studies of protein evolution can provide an invaluable source of 
knowledge for analysing biological and evolutionary relationships. 
Protein evolution can be split into two distinct categories, protein 
speciation and protein differentiation.
Section 5.8.2.
Protein Speciation
Protein speciation involves the evolution of homologous proteins 
within different organisms, having a common function. The evolution of 
such proteins involves a process of random mutation and selection.
In general the amino acid sequence and chainfold are well enough 
conserved to make direct comparison of the proteins of genetically 
different organisms. This has shown that the function of the protein 
is conserved by the natural selection of structures for which the 
residues involved in the function of the protein are not altered too 
drastically. In fact it has been shown for families of related enzymes 
changes in the residues at the protein surface occur much more 
frequently than changes in internal residues ( except where the 
surface is involved in the active site). This is favoured since 
internal residues play a more important role in stabilising the 
folding of the protein and also in the function of the protein. It has 
also been shown that the secondary structure of the protein tends to 
be conserved, changes in internal residues which would cause instability 
are often compensated for by changes in neighbouring residues and
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substitution between residues of similar type is found to occur more 
frequently than with residues possessing different functionalities.
The genetic, or evolutionary distance between two proteins can be 
measured in terms of the % of accepted point mutations (PAM) per codon
Q
per 10 years and for human DNA this is of the order of 45% - 50%
8substitution of codons per 10 years. Another unit occasionally used 
is the unit evolutionary period which is defined as the number of 
years for one accepted codon change to occur per 100 residues.
Section 5.8.3.
Protein Differentiation
Protein differentiation involves the functional diversification 
of homologous proteins within say one organism and reflects the 
evolution of biochemical pathways.
Unlike speciation the function of the protein is not conserved 
since differentiation involves the adaptation of an enzyme to perform 
a new function. In general this involves the substitution of one or 
more amino acid residues which gives rise to a change in substrate
34
specificity. A good example of protein differentiation is the 
heritable resistance to antibiotics found in bacteria.
Section 5.8.4.
Evolutionary Convergence
At first glance it would seem that the number of possible amino 
acid sequences and chainfolds is vast and it would be reasonable to 
assume that proteins which have similar functions are likely to have 
evolved from a common origin.
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However, one factor which could limit the range of protein 
structures would be selection of favoured types of fold (eg. 
helices, (3 sheets) which would impart greater stability on the 
protein structure.
This view is however too simplistic to explain the discovery of a 
number of structurally unrelated proteins which have evolved common 
functions. The active sites of these proteins involve different amino 
acid residues, however they all provide the optimum binding and
35
catalytic conditions for the substrates. This is done by having 
similar active site architectures, such that chemically important 
groups show equivalent functionality and spatial arrangement.
36
Such evolutionary convergence on function is very common and can 
be expressed as a natural selection of those proteins whose catalytic 
sites fulfil all the functional requirements for the catalysis of a 
specific reaction. Such proteins are analogous rather than homologous. 
Even proteins derived from a common ancestor can display both 
convergence and divergence simultaneously and when comparing two 
proteins which have similar functions it can be difficult to tell the 
difference between homologous and analogous features.
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Chapter Six
Section 6.1
Investigations into the actions of analgesic drugs such as 
morphine and pethidine led to the discovery of opiate receptors in 
the CNS* . Figure 6.1 shows how these receptors are distributed in 
the brain and correlates this with the effects of opiate administra- 
tion^.
Further binding studies have identified at least three different 
opiate receptors each having a unique specificity3. The exact 
physiological significance of these multiple receptors is not yet 
fully•understood, but it is known that they have different 
distributions in various regions of the brain.
Although many detailed studies have been carried out on opiate 
action the mechanism by which analgesia occurs remains unclear. How­
ever, it is known that the binding of opiates to the receptors in 
some way supresses the transmission of signals across the synapses1*»5
After the discovery of opiate receptors in the brain it was 
postulated that compounds should exist within the body which could 
bind to these receptors. This led to the discovery of a large number 
of naturally occurring opioid peptides (see Figure 6.2)6, perhaps the 
most important of which were [Leu]- and [Met]-enkephalin^»^. These 
naturally occurring opiates were found to be released in response to 
stressful and painful stimuli, giving rise to a weak analgesia. 
However, the analgesia produced was short-lived since the enkephalins 
were rapidly broken down _i_n v ivo  ^~ ^ ^  by several different
123
O pioid  effect Location of op io id  receptors
Analgesia 
Spinal (body) 
Trigeminal (face) 
Supraspinal
Autonomic reflexes 
Suppression of cough, orthostatic 
hypotension, inhibition of gastric 
secretion 
Respiratory depression 
Nausea and vomiting 
Meiosis 
Endocrine effects
Inhibition of vasopressin secretion 
Hormonal effects
Behavioural and mood effects
Motor rigidity
Laminae I and II of dorsal horn 
Substantia geiatinosa of trigeminal nerve 
Periaqueductal grey matter, medial thalamic 
nuclei, intralaminar thalamic nuclei, 
? striatum
Nuclei tractus solitarius, commisuralis. 
ambiguous, and locus coeruleus
Nucleus tractus solitarius, parabrachial nuclei 
Area postrema
Superior colliculus, pretectal nuclei 
Posterior pituitary
Hypothalamic infundibulum, hypothalamic  
nuclei, accessory optic system, ? amygdala 
Amygdala, nucleus stria terminalis, hippo­
campus, cortex, medial thalamic nuclei, 
nucleus accumbens, ? basal ganglia 
Striatum
Location of opioid receptors proposed to  
mediate specific opioid effects
Figure 6♦1
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enzymes13“16. was therefore apparent that inhibition of this
degradation would give rise to a prolonged and perhaps increased 
analgesia and might therefore provide new analgesic compounds which 
would be free from the side effects associated with the 
administration of opiates, eg, dependency.
At least three enzymes have been shown to be involved in the 
inactivation of opioid peptides17. These are angiotensin converting 
enzyme (ACE), a neutral endopeptidase (EC 3.4.24.11.) and an amino 
peptidase which has not yet been fully characterised. These enzymes 
appear to complement each other's actions, not only in the 
inactivation of opioid peptides, but also in the degradation of 
neuropeptides (see Figure 6.3)1 .^
As a target for drug action an enzyme requires to be well 
characterised in terms of function, substrate specificity and role in 
metabolism. This is the case for both ACE and the neutral endo­
peptidase. Enzyme kinetic studies have shown that _in vitro both ACE 
and EC 3.4. 24.11. seem to be implicated in the early stages of 
enkephalin activation and it would therefore appear that both these 
enzymes could be useful targets19. However, ACE is unsuitable for 
two reasons. Firstly, it is an exopeptidase which plays an important 
role in blood pressure regulation^ by generating the potent vaso­
constrictor, Angiotensin II, from Angiotensin I and by the degrada­
tion of the vasodilator, bradykinin. Secondly, in vivo studies have 
shown that inhibition of ACE makes very little difference to the 
striatial levels of enkephalins1?.
It appears that EC 3.4.24.11. plays a more major role in 
enkephalin inactivation in vivo. This may be due to differences in
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substrate specificity between the two enzymes; however, EC 3.4.24.11. 
does not have a high specificity for either [Leu]- or [Met]- 
enkephalin^l . A more likely explanation is that the distribution of 
EC 3.4.24.11. closely parallels that of the opiate receptors^,22 
which ACE does not, ie, EC 3.4.24.11. is more highly localised in 
those regions where opiod peptides will be found.
Therefore EC 3.4.24.11. has become a target in the search for 
novel analgesics and several inhibitors of this enzyme have been 
shown to possess analgesic p r o p e r t i e s ^  “25,
Section 6.2.
Endopeptidase 24.11.
EC 3.4.24.11. is a neutral endopeptidase first isolated from the 
brush border of rabbit k i d n e y ^ 6  and thought to be one of the 
principal enzymes involved in the degradation of naturally occurring, 
biologically active peptides. The enzyme has a substrate specificity 
very similar to that of the bac.terial enzyme Thermolysin in that it 
specifically cleaves peptide bonds for which the amino group has been 
provided by a hydrophobic residue^ >27,28 SUCh as phenylalanine, 
valine, leucine, etc.
Enzymes with an identical substrate specificity have been 
isolated from a range of tissues including b r a i n 2 9 } pituitary3°, 
lung31 and spleen3"' and a similar enzyme has also been identified at 
high concentrations in the serum of patients with sarcoidosis31.
The majority of experiments have been carried out on enzyme 
isolated from brain and kidney due to their relative abundance.
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However, there is probably more interest in the enzyme isolated from 
the brain where it is thought to be involved in the degradation of
neuropeptides ^ ,21.
These two enzymes have been found to be almost identical with 
regard to molecular weight (app. 95,000), substrate specificity and 
pH optimum32,33. However, they are inhibited at slightly different 
rates by the same inhibitors'^>35 autocatalytic immunoinhibition 
studies36 have shown that the kidney enzyme has different antigenic 
determinants from the brain enzyme. One explanation for this could 
be that in both organs the enzyme is a membrane bound glycoprotein 
and as such its carbohydrate component could differ. This may result 
in small changes in the protein’s conformation which, although not 
affecting substrate specificity, could alter the binding of inhibi­
tors. However, differences in the amino acid sequences of the two 
enzymes cannot be ruled out.
As mentioned in the previous section, EC 3.4.24.11. is of 
interest to the pharmaceutical industry due to the likelihood of 
inhibitors finding applications as analgesics. However, Pfizer are 
interested in the enzyme for other reasons which cannot be disclosed 
in this thesis.
The design of potent inhibitors of this enzyme has been hampered 
by the fact that very little is known about the structure of its 
active site, nor is the binding mode of inhibitors understood. This 
is due to the fact that EC 3.4.24.11. is a glycoprotein and as such 
is resistant to crystallisation. However, EC 3.4.24.11. belongs to a 
group of metalloproteases and has a very similar activity to the
129
bacterial enzyme Thermolysin, whose structure is well known from 
X-ray crystallography37.
As discussed in Chapter -5, convergence on function is quite 
common and many enzymes possessing similar function and substrate 
specificities have very similar active sites. Super impositions of 
the active sites of Thermolysin, carbonic anhydrase, liver alcohol 
dehydrogenase and carboxypeptidase^-A have shown that there is a 
marked similarity in the structures of their active sites, especially 
in the regions of the zinc atoms38.
Therefore, the main objective of this project was to try to 
predict some of the features of the active site of EC 3.4.24.11. from 
the active site of Thermolysin using information from substrate and 
inhibitor studies, molecular mechanics calculations and quantitative 
structure activity relationships.
The first stage of the project involved the comparison of low 
energy conformers of inhibitors with the binding conformations and 
investigating whether or not this could be related to the potency of 
the inhibitor.
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Section 6.3.
Conformational S tudies of ffi-phenylpr opionyl-L-phenyl alanine and 
Carbobenzoxy-L-phenylalanine.
For any molecule to bind in an active site it must be able to 
arrange its spatial geometry to fit the active site. If in doing this 
the molecule has to adopt a high energy conformation it is likely that 
it will not be as potent as expected, conversely, if it can maximise 
binding with the active site while remaining in a low energy 
conformation it is likely to be a potent inhibitor.
Inhibition constants cannot solely be relied upon as a measure of 
how well a drug binds to an active site, unless they can be compared 
with how well it would be expected to bind. Dr.P.Andrews has devised a
39
method, for calculating the average binding energy for any molecule, 
by assuming that each group in a molecule will contribute on average a 
certain amount of energy to the total binding energy. Summation of 
these contributions gives an average binding energy for the molecule 
from which can be derived an average K^, or for the molecule. If 
the observed is larger than expected we could predict that the 
molecule is not able to utilise all of its groups in binding to the 
active site and may be binding in a higher energy conformation. 
Conversely if the observed is much smaller than the average the 
molecule is binding more strongly than expected and is able to utilise 
most or all of the binding potential of its functional groups and may 
be binding in a low energy conformation.
The two molecules studied are /J-phenylpropionyl-L-phenylalanine 
and carbobenzoxy-L-phenylalanine, which are both inhibitors of the
131
bacterial enzyme, Thermolysin. Although these molecules are very
similar (isosteric), X-ray studies have shown their binding
40
conformations to be very different and this can be explained using 
molecular mechanics studies.
fl-Phenylpropionyl-L-phenylalanine
U 01 02
971
17
Using Andrew's method it is calculated that p-PPP has an average 
binding energy of 5.5 kCal mol""*- and an average of 9.265 x 10” .^
_3
Since the observed is 1.6 x 10 it is apparent that the molecule 
is not binding to the active site as well as expected,but since it is 
known from X-ray crystallography that the majority of the functional 
groups are being used it is possible that it is binding in a high 
energy conformation. In p-PPP there are eight torsion angles which 
determine the overall conformation of the molecule, 
n a m e l y :-
TA1 Cl C6 C7 C8 TA2 C6 C7 C8 N9 TA3 C7 C8 N9 CIO
TA4 C8 N9 CIO Cll TA5 N9 CIO Cll C12 TA6 CIO Cll C12 C13
TA7 Cll C12 C13 C14 TA8 C7 C8 C9 01
Since the amide bond is relatively rigid there are only seven 
bonds that need to be considered around which restricted rotation can 
occur.
Several low energy conformations were generated for p-PPP (for a
132
description of this procedure see chapter 3). These conformations were 
then minimised and the torsion angles of the resulting structures are 
shown in Table 6.1. File PPP.TLN is the minimised form of the binding 
conformation from the X-ray study.
How then does the binding conformation differ from the other low 
energy conformations found ? The first obvious difference is that the 
binding conformation even after minimisation is much higher in energy 
than the other conformers. Table 6.1 shows that for the binding 
conformation torsion angles 1 and 2 have values in the same range as 
conformations of similar energies. Torsion angles 4, 5, 7 and 8 have 
values in the same range as conformations with a spread of energies. 
However torsion angles 3 and 6 have values unlike anything found for 
the other low energy conformations.
The reason for this is apparent on examining the binding scheme 
for /3-PPP and Thermolysin (see Fig. 6.4). From this diagram it can be 
seen that the differences occuring between /J-PPP and the other low 
energy conformations arise because:-
1) Torsion angles 1 and 2 adopt values associated with higher energy 
conformations in order to allow the phenyl ring access to the 
hydrophobic pocket.
2) Torsion angle 3 has a value completely different from those found 
in other low energy conformations since its value determines the 
spatial relationship between the carboxylate group and the amide group 
and the value it adopts in the binding conformation is such that it 
maximises binding of these groups with the active site. Torsion angle 
values commonly found in lower energy conformations would not do this.
3) The position of the phenylalanine phenyl ring is determined by
133
TABLE 6.1
TORSION ANGLES
FILE 2 3 4 2 2 I 2 ENERGY
(kCal mol 1
PPMN3 -83 -54 100 -178 -72 57 -108 59 6.949
PPMN1 -80 58 92 -178 -68 59 -110 64 7.020
PPMIN2 -83 -60 102 177 -95 57 -105 66 7.114
PPMIN9 -60 -72 94 173 66 65 -120 62 7.335
PPMN4 -95 -169 91 179 -72 58 -108 61 7.461
PPMN13 -48 -64 101 171 60 62 -119 112 7.840
PPMN7 -76 -49 106 -177 64 176 -107 63 7.906
PPMIN3 -89 56 75 178 -75 59 -101 102 7.988
PPMIN5 -77 -48 107 -177 65 178 -91 112 8.225
PPMN5 -71 -62 98 -177 67 -91 -103 62 8.579
PPMN10 -82 -55 95 -176 -70 -178 -108 62 8.648
PPMIN7 -84 -54 96 -176 -69 177 -94 113 8.852
PPMN9 -96 -168 89 -177 62 178 -104 62 9.008
PPMN11 -96 -167 82 -177 -68 -179 -105 62 9.258
PPMN12 -88 54 72 -176 -68 179 -109 73 9.497
PPMN8 -98 45 72 -178 74 -96 -113 79 9.534
PPMN6 -95 28 75 179 -63 -61 -86 65 9.799
PPMN2 -130 -175 69 -172 55 16 -112 61 10.392
PPP.TLN -118 -177 141 -178 -62 143 -102 65 10.710
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the value of torsion angle 6. We see that instead of taking up a 
more favourable value torsion angle 6 adopts a value which places the 
phenyl ring in a better position for stacking with Phe 114.
In summary it can be said that p-PPP is much less active than 
expected (it has only .057 of its expected activity) since it is 
binding in a relatively high energy conformation. This is due to the 
fact that it is unable to bind successfully to the active site in one 
of its lowest energy forms.
Carbobenzoxy-L-phenylalanine
4 01 02
3
2
971
1 6
Comparing diagrams it can be seen that carbobenzoxy-L- 
phenylalanine is isosteric to p-PPP, however X-ray crystallography 
studies have shown that it binds to Thermolysin in a completely 
different orientation to p-PPP. Using Andrew's method we calculate 
an average binding energy for carbobenzoxy-L-phenylalanine of 5.8 kCal 
mol-  ^ which is equivalent to an average of 5.6 x 10~^. The observed
for the molecule is 5.1 x 10 So the molecule is only 0.109 times 
as potent as expected ( p-PPP was only .057 times as potent as 
expected).
Again there are eight torsion angles of interest, but 
particularly the values associated with the seven rotatable bonds.
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These torsion angles are:-
TA1 Cl C6 C7 C8 TA2 C6 C7 C8 N9 TA3 C7 C8 N9 CIO
TA4 C8 N9 CIO 03 TA5 N9 CIO 03 Cll TA6 CIO 03 Cll C12
TA7 03 Cll C12 C13 TA8 C7 C8 C9 01.
Low energy conformers of CBZ were generated using the same method 
as described for p-PPP. The torsion angles for the resulting low 
energy conformers are shown in Table 6.2. File CBZTLN gives the 
torsion angles for the minimised form of the bound structure from the 
X-ray data.
Table 6.2 shows that there is only an energy difference of 1.2 
kCal mol- * between the lowest energy conformation found and the 
minimised form of the binding conformation. Examination of this table 
shows the torsional values in the binding conformation agree well with 
torsion angle values found for other low energy minima. From this it 
can be seen that although carbobenzoxy -L- Phe is less potent than 
predicted it is relatively more potent than p-PPP since it is able to 
bind in the active site in a relatively low energy conformation. The 
binding of carbobenzoxy-L-Phe is shown in Fig 6.5.
If the torsion angles in p-PPP are set to the values found in the 
binding conformation of CBZ and the structure is minimised a p-PPP 
conformation is obtained with an energy of 9.153 kCal mol-* which is 
lower than the p-PPP binding conformation. However, p-PPP is unable to 
bind to Thermolysin in the same manner as CBZ since there is only 3.0A 
separating the ester oxygen of CBZ and Asn 112 of Thermolysin and 
there is not enough room for a methylene group in this position.
This result is in agreement with NMR studies carried out on the 
two molecules in that it demonstrates that the enzyme does not
TABLE 6.2
TORSION ANGLES
FILE 1 2 3 4 5 6 7 8 ENERGY 
{kCal mol
CRMN7 -95 52 129 178 0 -79 113 115 8.729
CM IN 9 -96 51 141 178 0 -89 97 113 9.272
CMIN12 -99 67 85 174 -4 88 75 112 9.532
CBZTLN -77 -77 97 178 -2 -90 104 -119 9.960
CRMN3 -103 -173 79 173 -2 -63 126 -121 10.099
CMIN1 -78 -61 153 174 -169 75 66 115 10.234
CMIN6 -82 71 90 172 0 -64 155 113 10.353
CMIN5 -64 -74 125 177 8 101 74 118 10.386
CRMN4 -90 62 67 174 -3 -68 129 114 10.466
CRMN19 -89 63 67 174 -4 -67 129 114 10.519
CRMN20 -80 -59 149 174 -169 99 115 115 10.622
CMIN2 -110 -147 141 179 8 -57 112 112 10.688
CRMN15 -98 59 159 174 -172 95 105 113 10.762
CRMN8 -90 62 138 179 1 110 115 115 10.797
CRMN10 -101 -166 121 -177 3 -175 129 -115 10.991
CRMN17 -93 45 109 -177 3 -168 132 116 11.031
CMIN4 -57 70 61 -163 157 -82 91 115 11.072
CRMN12 -84 59 -134 173 -170 100 130 -115 11.100
CMIN10 -92 62 59 173 -6 -75 116 112 11.117
CRMN11 -101 -166 127 -175 4 98 108 -115 11.305
CRMN2 -65 81 -133 -179 4 -70 121 -117 11.495
CRMN5 -104 -175 73 179 -3 141 75 -119 11.530
CRMN13 -103 -165 140 169 -165 93 112 110 11.544
CMIN7 -64 -73 77 175 -11 -82 106 102 11.896
CRMN6 -93 63 53 175 -7 141 72 114 12.520
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necessarily bind to the conformations of lowest energy, but rather it 
binds those conformations which give the best fit and this results in 
a drop in the potency of the compounds*
Section 6.4.
Thermolysin and its Active Site
Therraolysin is a thermostable endopeptidase which has been 
isolated from the bacterium Bacillus Thermopr o teoly ticus. As 
previously discussed it belongs to a group of zinc dependent proteases 
and both its amino acid sequence and its three dimensional structure 
are known.
Substrate studies have shown that Thermolysin specifically
cleaves peptide bonds on the amino side of a hydrophobic residue i.e.
a hydrophobic residue in the P^' position. The size of the hydrophobic
group is crucial and Phe is the most favoured residue , the pocket is
too small for larger residues such as Trp and Tyr and they cannot be
accomodated as well. Conversely smaller residues do not maximise
binding with the pocket and are therefore poorer substrates.
The enzyme structure is not thought to alter radically on
crystallisation and indeed the crystal structure of the enzyme has
hi*
been shown to hydrolyse substrates.
X-ray studies on inhibitor complexes have given a major insight
into the dimensions and natures of the functional groups which make up
the S^, Sj' and S2' subsites of the active site and Figures 6.4 to
6.11 show details of the way in which the inhibitors (3-
40 4 0
phenylpropiony 1-L-Phe ( jS-PPP), carbobenzoxy-L-Phe (CBZ),
41 42
phosphoramidon, L-benzylsuccinic acid, (2-benzyl-3-mercaptopropanyl)-
43 44
L-Ala-glycinamide (BAG), L-Leu-NHOH, HONH-benzylmalonyl-L-Ala-Gly-p-
44
nitroanilide (Bzm-AGNA) and N-(l-carboxy-3-phenylpropyl)-L-Leu-L-Trp
45
(CLT) bind to the active site.
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These diagrams show the presence of a hydrophobic binding region 
in the position along side Phe 114, a well defined hydrophobic 
pocket in the S^' subsite (as predicted by the substrate studies) 
surrounded by residues Val 139, Phe 130, Leu 133, lie 188, Gly 189, 
Val 192 and Leu 202 and a further nonspecific hydrophobic region in 
the S2' position which can accomodate large hydrophobic groups. The 
diagrams also show the positions of the residues which would be 
expected to bind to the backbone of the peptide chain i.e. Ala 113 
hydrogen bonding to the nitrogen of the scissile bond, Asn 111 
possibly H-bonding to the protonated nitrogen of the scissile bond, 
Arg 203 hydrogen bonding to the P^' carbonyl (or forming a salt 
linkeage to the terminal carboxylate) and Asn 112 hydrogen bonding to 
both the nitrogen and the carbonyl (or free terminal carboxylate) of 
the P2' residue. When the P2' position is occupied by a tryptophan 
residue the indole nitrogen of the side chain appears to be able to 
H-bond to Asn 111.
The first five of the inhibitors listed above all provide one 
ligand to bind to the zinc and since inhibitors tend to resemble the 
transition state of the substrate it was originally felt that the 
transition state intermediate would also involve a tetrahedral complex
40,41
and a mechanism for catalysis was postulated from this (see Fig. 
6.12). Three groups were presumed to play a major role in hydrolysis 
namely Glu 143, His 231 and the zinc atom. This mechanism involved the 
carbonyl group of the scissile bond binding to the zinc. Glu 143 then 
acts as a base to promote attack on the carbonyl carbon by a water 
molecule, at the same time His 231 donates a proton to the peptide 
nitrogen giving an intermediate which is tetrahedral at both the 
carbon and nitrogen of the scissile bond, which then breaks to yield
1 / ’ 7
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the products.
However, with the discovery of the pentavalent zinc coordination found 
for the hydroxamic inhibitors and for the N-(lcarboxy—3—phenylpropyl)—
4 4 , 4 6 , 4 7
L—Leu—L—Trp , a new mechanism has #been proposed involving the 
pentacoordination of the zinc by a hydrated peptide bond and a diagram 
of this is shown in Fig. 6.13. This mechanism involves the addition of 
a water molecule across the petide bond, this tetrahedral structure 
then ligands to the zinc with both oxygens of the hydrated carbonyl 
followed by cleavage of the scissile bond. Glu 143 is again involved 
in hydrating the peptide bond, stabilising the tetrahedral 
intermediate and may also act as a proton shuttle - i.e. delivering 
back the proton to the N of the scissile bond.
Regardless of the mechanism of peptide cleavage the torsion 
angles associated with the binding inhibitors provide a vital source 
of information as to how the substrates would be expected to bind to 
Thermolysin. The structures of the inhibitors vary greatly, however 
they all have one thing in common and that is a hydrophobic residue at 
the Pj' position . Several of the inhibitors also have a peptide chain 
which extends as far as the P-j' position and a few also have groups 
which are binding in the subsite. From these structures comparisons 
can be made of the torsion angles involved in binding to the active 
site.
Figures 6.4 to 6.11 give details of the torsion angle numbering 
schemes of the inhibitors and Table 6.3 shows a diagram of a model 
substrate molecule binding to the S^', S2' and S^' active site with 
numbered torsion angles and a listing of the comparable torsion angles 
of the inhibitors as they bind to Thermolysin. The first obvious
149
Proposed Mechanism for the Cleavage of Peptides by 
Thermolysin Involving Pentacoordination of the Zinc
Michaelis Complex
Bottom of 
v Cleft
Tyr-157 f - V T
' Bottom
»"ae" kT 2J.
o
Tetrahedral Intermediate 
Trp-115
CO*H
Bottom of 
Cleft
His-231
Figure 6.13
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Product Release Mechanism
Glu-143
Bottom of 
CleftTyr-
His-231
Glu-143
Tyr-157
His-231
Glu-143
O -H,-0
Tyr-157 N
His-231
o
Released Products and Regenerated Native Enzyme
y
Figure 6,13 (cont.)
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similarity is in the torsion angles associated with the groups which
are binding in the hydrophobic pocket of the subsite (columns 10
and 11), excluding the hydroxamic acid inhibitors the two relevant
torsion angles appear to have values in the regions -160° to 180° and
35° to 60° respectivly.
Columns 6, 7 and 8 contain the backbone torsion angles as the
inhibitors bind from the S^' subsite to the S2' and these (again
excluding the torsion angles associated with hydroxamic acid
inhibitors) are also in good agreement being in the regions -40° to -
70°, -176° to 1640 and -106° to -146°. Column 9 contains the torsion
angle which determines the position of the P2' carbonyl or carboxylate
which binds to Asn 112 and again for those molecules which contain
this group the torsion angles are in fairly good agreement being in
the order of 8° to.-24°
Columns 12 and 13 contain the torsion angles associated with the
positioning of the tryptophan residue of the two inhibitors which
contain this group and these torsion angles have values of 62° to 76° 
0 o
and -49 to -66 respectively. Finally the torsion angles round for
the extended chain of Bzra-AGNA and BAG , columns 14 and 15, are found
0 0  0 0
to be in the region -176 to 177 and -146 to -164 respectively* 
None of the torsion angles involving the binding of the hydrophobic 
residue in the subsite can be directly compared since they are so 
dissimilar.
From the similarities found in the torsion angle values for the 
inhibitors binding in the S^', S2' and S^' subsites it is possible to 
predict ranges for the torsion angles found in the substrate for the 
Pl'» P2% and P3% residues and these are given in Table 6.4.
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Section 6*5.
The Active Site of EC 3.4.24.11.
All the information currently known about the active site of EC
3.4.24.11 has come from substrate and inhibitor studies. The enzyme 
obeys Michaelis - Menten kinetics and substrate specificities have 
shown much about subsites within the enzyme.
Inhibitor studies have shown that the enzyme is neither a serine,
or a thiol protease, nor is it a carboxyl protease. The enzyme is
however inhibited by various metal chelating agents and loses all
activity on centrifugation with EDTA. Since activity can be regained
with zinc the enzyme is infact a member of the class of zinc 
30
proteases.
As yet the residues preferred for substrate binding and catalysis 
have only been determined for subsites S2, and S^'. Table 6.5 shows 
the activity of the enzyme with naturally occuring peptides. From this 
it can be seen that, like Thermolysin the enzyme is highly specific 
for a bulky, hydrophobic residue at the P^' position with 
Phenylalanine being preferred over Leucine, Isoleucine, Valine and 
Histidine. With this in mind several synthetic substrates have been
35
made with a Phe in position P^' (see Table 6.6) and by varying those 
residues in the P^ and P£ positions it has been found that the best 
catalysis is obtained with an Ala residue at P^ and high rates of 
hydrolysis are also observed with a Phe in P2 coupled to a Gly, or an 
Ala in P ^  The presence of a Phe residue in the P^ position seems to 
give better binding (lower K^'s) but not better catalysis. Arg-Arg and 
Ala-Ala in the and P2 also give good hydrolysis and although the
155
Table 6.5
Cleavage of Naturally Occuring Peptides by EC 3.4.24.11.
Compound Structure
Met-Enkephalin Tyr-Gly-Gly-Phe-Me t
Leu-Enkephalin Tyr-Gly-Gly-Phe-Leu
Met-Enkephalinamide Tyr-Gly-Gly-Phe-Met-NI^
Leu-Enkephalinamide Tyr-Gly-Gly-Phe-Leu-NH^
Angiotensin I 
Angiotensin II 
Bradyklnln
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
v v
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe
v v
Arg-Pro-Phe-Gly-Phe-Ser-Pro-Phe-Arg
Renin substrate 
tetradecapeptlde
v v v v
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu- 
v
Leu-Val-Tyr-Ser
v indicates a primary site of cleavage 
v indicates a secondary site of cleavage
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TABLE 6.6
SUBSTRATES
P3 P2 P1 P1 ’ P2 ’ 
Git - Gly - Gly - Phe - X
Git - Gly - Ala - Phe - X
Git - Gly - Phe - Phe - X
Git - Ala - Gly - Phe - X
Git - Ala - Ala - Phe - X
Git - Ala - Phe - Phe - X
Git - Phe - Gly - Phe - X
Git - Phe - Ala - Phe - X
Git - Phe - Phe - Phe - X
Figures show in parenthesis are for Thermolysin
Km
(mM)
kcat
(s-1)
X=pAb X=2NA X=pAB
0.071
(2.9)
0.092 3-3
(0.72)
0.19
(3.6)
0.49 9.3
(6.1)
0.19
(0.94)
0.042 6.9
(36.2)
0.15
(1.5)
0.074 11.7
(22.7)
0.13
(2.6)
0.20 12.6
(132.0)
0.21
(0.92)
0.036 13.1
(367.0)
0.14
(0.71)
0.01 14.0
(23.0)
0.19
(1.1)
0.058 17.0
(161.0)
0.09
(0.44)
0.021 11.0 
(339.0)
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rate of hydrolysis increases with longer chains implying the presence 
of an extended binding site it would appear that the enzyme can 
accommodate a large range of residues in the P^ and P2 subsites without 
losing too much activity. The residue which plays the most important 
role in the function of the enzyme is the one occupying the S^' 
subsite .
Initially it was thought that although the enzyme could act as an 
endopeptidase its function was primarily that of a carboxy 
dipeptidase, similar to ACE . This was proposed for three reasons.
1) Studies of the substrate specificity of the brain enzyme showed
/
that it cleaved Leu- and Met-enkephalin at the Gly -Phe bond (see 
21
Table 6.5)
2) It had been noted that a free carboxyl in the P^ position enhanced
the rate of hydrolysis since amidated derivatives were hydrolysed much
48
more slowly than the natural substrates (see Table 6.7).
3) Inhibition studies with butanedione, a compound which binds 
strongly to arginine residues, indicated the presence of an arginine 
residue at the S2' subsite since the enzyme lost about 80% of its 
activity with natural substrates, only 50% of its activity with 
amidated derivates and 20% of its activity with napthylamide 
derivitives (see Table 6.8). Therefore it was proposed that the free 
carboxylate of the natural substrate was binding to this arginine 
(perhaps as a salt linkage) giving an increase in catalysis and 
blocking this arginine residue results in a loss in activity.
It is now accepted that the primary function of the enzyme is 
that of an endopeptidase and that the carboxy dipeptidase activity is 
only apparent when the penultimate amino acid of the substrate is a 
hydrophobic residue.
158
Table 6»7
Reactivities of Various Peptides with EC 3.4.24.11.
Cogpoynj Km kcat kcat/Km
(um) (min-*)
[Leu^] -Enkephalin *86 3781 43.9
[Leu^]-Enkephalinamide 680 1129 1.7
[ D.A1 a ^ ,Met^]-Enkephalin 13 1044 80
[D.Ala^,Met^]-Enkephalinamide 320 2512 8
Substance P 31 5o<o‘i 158
Substance P deaminated 37 7766 202
159
Comparison of the Degradation of Various Enkephalin Analogs per unit 
time by EC 3.4.24.11. from Brain and Kidney.
Table 6.8 (a )
Compound %_ degraded
kidney brain
Tyr-Gly-Gly-Phe-Leu 20 25
Tyr-Gly-Gly-Phe-Leu-NI^ 2 4
Tyr-D. Ala-Gly-Phe-Leu-NH^ 3 3
Tyr-Gly-Gly-Phe-Met 22 31
Tyr-Gly-Gly-Phe-Met-NH2 12 18
Tyr-D. Ala-Gly-Phe-Met-Nl^ 10 14
Tyr-Gly-Gly-Phe-Met-Arg-Phe 18 26
Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2 7 11
Phe-Met-Arg-Phe-NH2 2 1
D.Ala-Gly-Phe-Met-NH2 0 10
Tyr-Gly-Gly-Phe-Met-Arg-Arg 5 9
Tyr-Gly-Gly-Phe-Leu-Arg 5 8
N-acetyl-Tyr-Gly-Gly-Phe-Leu 15 5
(continued overleaf)
1 6 0
Table 6.8 (b )
Activity of Free Enzyme and Butanedlone Treated Enzyme with Various
Substrates
Substrate Activity ( umole/mg/min )
Control Butanedlone %decreased 
treated
Tyr-Gly-Gly-Phe-Met 4.9 0.83 83
Tyr-Gly-Gly-Phe-Leu 2.2 0.46 79
Tyr-D. Ala-Gly-Phe-Leu 1.6 0.27 83
Tyr-D. Ala-Gly-Phe-Met-NI^ .64 0.3 53
Hip-Arg-Leu-Leu-j^NA 1720 1324 23
t6l
Section 6.6.
Inhibitor Studies
The substrate studies have lead to predictions as to the binding 
modes of the inhibitors and Fig. 6.14 shows the predicted binding of 
several of the inhibitors. However, this is only a two dimensional 
scheme and the design of a three dimensional active site requires more 
information.
Many of the inhibitors of the enzyme closely resemble the natural 
substrates (or their transition states) and the three dimensional 
structures of these inhibitors can be used to gain information about 
the active site. However, it is not enough to generate low energy 
conformers of the inhibitors since it was shown in section 6.3. that 
the enzyme does not necessarily bind the lowest energy conformation 
of the molecule instead it binds the conformation which gives the best 
fit.
The first stage in elucidating the active site must therefore 
involve predicting which compounds are binding in low energy forms by 
comparing their expected, or average Ki's with their actual K^s.
Tables 6.9 and 6.10 list several of the more potent inhibitors 
with their average and observed Ki's (the average Ki's being 
calculated in the same manner as in section 6.3). It must be noted 
that the average K^ for the compound Phe-N-L-Phe-pAB was calculated 
without including the contribution made to binding by the terminal 
carboxylate group (see Fig. 6.14). This contribution was omitted 
because the para-aminobenzoate group is totally rigid group and 
modifications to the position and functionality of the carboxylate
162
S'\ Zn S 1' S 21
0
P h e - N - L - P he - p  - AB
COO"
HomoPhe - N - L - P h e  - L - Gl y
‘COO‘
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COO
HomoPhe-N-L -Phe - 7  ABA
COO"
H o m o P h e - N  - L - Phe - 5A V A
Figure 6*14
T hiorpha n
COO
Retr ot hio r phan
CH-
OH
OH
COO'
P hosph ora m i d on
Figure 6*14 (cont.)
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made little difference to the potency of the compounds (Pfizer’s 
unpublished results) therefore the carboxylate is not thought to be 
involved in binding to the active site. This does not agree with 
published data which suggest that the carboxylate of the 
Phe-[N]-L-Phe-pAB is binding to an arginine at the S2 ' subsite. 
However, the compounds Phe-pAB and Phe-Ala both inhibit with similar 
potencies (see table 6 .10), with Kj/s of 1.9 x 10“5m and 2.1 x 10“5m 
respectively. Assuming that for each inhibitor the phenylalanine is 
occupying the f binding site then the terminal carboxylate of Phe-Ala 
should be in the correct position to bind to the residue (possibly 
arginine) at the S2 ’ subsite, but it is highly unlikely that the 
terminal carboxylate of the Phe-pAb is able to bind to the same residue 
since the para-aminobenzoate group is totally rigid and in terms of a 
substrate backbone chain (nitrogen, carbon, carbonyl repeat unit) is 
separated from the P-| ’ carbonyl by six atoms corresponding to the P3 1 
carbonyl position of a substrate.
Table 6.9 shows a comparison of the average Kj_’s and observed 
ID5q ’s for a series of Phe-[N]-L-Phe type inhibitors. As for the 
Thermolysin inhibitors 3-PPP and CBZ (see section 6.3) the average Kj_'s 
were calculated using Andrew’s method. It is interesting to note 
that the expected potencies are far larger than the observed potencies. 
This is probably due to the fact that all the molecules were treated as 
being fully dissociated and it is likely that Andrew’s method 
overestimates the contributions made by the charge groups under such 
circumstances. However, all the compounds contain the same number of 
charge groups and although the average Kj_’s do not compare in any way 
with the observed potencies, they may be useful for comparing the 
relative potencies of the compounds.
Table 6.11 lists the expected order of potencies of the 
Phe-[N]-L-Phe type compounds and their observed
165
TABLE 6.9
1)HomoPhe-N-L-Phe-Gly
2)HomoPhe^N-L-Phe- /3Ala
3 )HomoPhe-N-L-Phe- 7 ABA
4 ) Homo Phe-N-L-Phe- <5AVA 
5 )HomoTyr-N-L-Phe- /3 A la
6 )HomoPhe-N-L-Phe-IsoAsn
7 )HomoPhe-N-L-pClPhe- /3Ala
8 )Met-N-L-Phe- 0Ala
9 )Phe-N-L-Phe- jSAla
ID50 Ki (average)
4.5 x 10-7 2.4 X 10'18
3.2 x 10-7 2 . 1 X 10'18
2.0 x 1 0 “ 7 1.7 X 10'18
7.0 x 10-7 1.5 X 10"18
2.7 x 10“7 1.0 X 10-19
4.5 x 10~7 9.5 X 10-21
2.5 x 10-7 2.4 X 10-19
7.5 x 10“7 1.0 X 1Cf16
6.5 x 10"7 2.5 X 10-18
( all inhibitors have S,S geometry )
ID50 = Inhibitory dosage giving 5096 inhibition
TABLE 6.10
(S)-Phe-N-L-Phe-pAB 
(R )-Phe-N-L-Phe-pAB
Ki
(observed) 
2.9 x 10 
2.4 x 10
Ki
(expected)
-8
-7
9.7 x 10
9.7 x 10
-15
-15
(S)-Thiorphan 
(R)-Thiorphan 
Retrothiorphan
IC50
2.1 x 10 
3.6 x 10~9
-9
6.0 x 10-9
2.4 x 10 - 1 0
Phe-Ala
Phe-pAB
Ki (observed) 
>-52.1 x 10 
1.9 x 10-5
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Expected Observed
Potency Potency
Homo-Phe- [ N ] -L-Phe-IsoAsn 9.48 X 10-21 4.5 X 10“
Homo-Tyr- [ N ] -L-Phe- Ala 1.0 X 10-19 2.7 X 10"
Homo-Phe- [N ] -L-pCl-Phe- @  Ala 2.35 X 1 0-19 2.5 X 10"
Homo-Phe- [ N] -L-Phe- <5 AVA 1.5 X lO"18 7.0 X 10"
Homo-Phe- [ N ] -L-Phe- 7  ABA 1.78 X 10“ 18 2.0 X 10"
Homo-Phe-[N]-L-Phe- /^Ala 2.1 X
0010H
3.2 X 10"
Homo-Phe-[N]-L-Phe-Gly 2.49 X 10"18 4.5 X 10"
Phe-[N]-L-Phe- (3 Ala 2.49 X 10"18 6.5 X 10"
Met- [N] -L-Phe- (3 Ala 1.0 X 10"16 7.5 X 10"
Table 6.11
The two most noticable discrepancies between the expected 
inhibition constants and the observed ID^q's are for Homo-Phe-[N]-L- 
Phe-IsoAsn and Met- [N] -L-Phe- Ala. Homo-Phe-[N ]-L-Phe-IsoAsn is 
expected to be the most potent inhibitor, however instead of 
increasing the potency of the compound the presence of the IsoAsn side 
chain actually decreases potency. This implies that the side chain of 
the IsoAsn is not actually involved in binding to the active site and 
could be lying in a hydrophobic area similar to the S2' site in 
Thermolysin. The other major difference noted with this series of 
inhibitors is that Met-[N]-L-Phe- (3 Ala although still the poorest 
inhibitor is binding relatively better than the rest of the compounds.
Compounds 1 to 4 of Table 6.9 belong to a series of compounds of 
the type Homo-Phe-[N]-L-(CH2)n”C02’* in which the carbon chain length 
increases from 1 to 4. From the calculated K^'s compound 4 would be 
expected to be the most potent with a stepwise decrease in activity 
to compound 1. However from the Table 6.12 it can be seen that this 
does not happen.
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Expected Order of Activity Observed Order of Activity
x lO"18 x 10~7
4) 1.5 3)
o.CM
3) 1.78 2) 3.2
2) 2.10 1) 4.5
1) 2.49 4) 7.0
Table 6.12
With each increase in the chain length the potency of the 
compound is expected to increase by a factor of roughly 1.2 .The 
observed values closely mirror this fact upto n=3. Increasing the 
chain length from 1 to 2 gives an increase of the order of 1.4, 
increasing the chain length from 2 to 3 gives an increase in potency 
of the order of 1.6, however increasing the chain length to 4 gives a 
dramatic decrease in the potency. This can be explained in one of two 
ways, either the loss of a good interaction (i.e. carboxylate binding 
) which, with corresponding of entropy leads to a loss in binding
energy, or the introduction of a bad interaction causing rearrangement 
of the carbon chain and a resulting loss in binding energy.
There is also a series of (3"Ala derivatives whose activities can 
be compared.
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Expected Order of potency Observed Order of Potency
5) 1.0 x 10“19 7) 2.5 x 10~7
7) 2.35 x 10-19 5) 2.7 x 10~7
2) 2.10 x 10"18 2) 3.2 x 10"7
9) 2.49 x 10“18 9) 6.5 x 10"7
8) 1.02 x 10~16 8) 7.5 o
1 '-J
Table 6.13
The order does not differ significantly, but the relative 
activities are quite different. Compounds 5 and 7 are expected to be 
an order of magnitude more potent than compound 2. This is not the 
case and it can therefore be assumed that neither the hydroxyl of the 
Tyr (compound 5) or the chlorine of the pCl-Phe (compound 7) are 
actually contributing much to the binding energies. The slight 
increase observed in the potencies of these two compounds when 
compared with the Homo-Phe-[N]-L-Phe- (3 Ala could be explained by the 
fact that both the and the S^' hydrophobic pockets are of limited 
size. The introduction of a Tyr, or a pCl-Phe into either pocket may 
prevent the phenyl fully penetrating into the pocket, causing a slight 
alteration in the orientation of the other binding groups giving rise 
to an increase in the binding energy. Alternatively the site may be
not so much a pocket as a patch of limited surface. Compound 2 is 
expected to be approximately 1.2 times as potent as compound 9 and 
infact there is a twofold increase in the observed potencies of these 
inhibitors. Finally it can be seen that compound 8 is indeed 
relatively more potent than the other compounds since it is expected 
to have 0.024 times the activity of compound 9 and in fact it has 0.8
170
times the activity of compound 9.
From Table 6.10 it can be seen that the para-Aminobenzoate 
derivatives of the Phe— [N]—X type compounds, although not as potent as 
expected are relatively more potent than the compounds of Table 6.9.
It can also be seen from this table that Thiorphan appears to be 
the most potent inhibitor relative to its expected potency.
The Phe-[N]-L-X type compounds are thought to be good inhibitors
50
since they mimic the transition state of the substrates (see Fig 
6.15). It is expected that these inhibitors will bind to EC 3.4.24.11.
45
in similar conformations to CLT binding in Thermolysin. The Homo-Phe 
derivatives are preferred since the N linkage shortens the chain 
length to the P^ Phenyl group which means that it is not so well 
placed for binding in the hydrophobic pocket (or patch) as the 
natural substrate would be (see Fig. 6.16). It is also interesting to
note that the N linkage gives the P^ an apparent R configuration with
50
respect to the the natural substrate (see Fig. 6.16). Thermolysin and 
EC 3.4.24.11. have been shown to have almost identical substrate 
specificities and are inhibited at similar rates by various inhibitors 
(see Tables 6.6 and 6.11) and even although Thermolysin is not 
inhibited at the same rates by the para-aminobenzoate inhibitors it 
shows more or less the same inhibition rates across this series of
35
inhibitors.
Therefore when designing the active site of EC 3.4.24.11. it was 
assumed that the and S^' hydrophobic pockets of the two enzymes 
were in the same three-dimensional arrangements. It was also assumed 
that the S^' pocket was the same size in Thermolysin and EC 3.4.24.11. 
since both enzymes have a maximum action when a Phe group occupies
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this pocket and activity is lost when larger residues such as Tyr and 
Trp are introduced in this position. The poc'ket of EC 3.4.24.11, 
would appear to be slightly smaller than that of Thermolysin since 
substrates having a Phe residue in the position are hydrolysed well 
by Thermolysin, however in EC 3.4.24.11 such substrates bind very 
well, but tend to cause a decrease in catalytic rate. Since 
phosphoramidon is a potent inhibitor of both compounds there must also 
be a hydrophobic binding site at the S2' subsite of EC 3.4.24.11. in 
which the Trp residue side chain can be accomodated. The other obvious 
difference between the two enzymes is that Thermolysin has an arginine 
residue (Arg-203) in its active site which, depending upon the
substrate involved, binds to the P^' terminal carboxylate, or
4 2
carbonyl group. Thermolysin can therefore act as an exopeptidase, 
whereas EC 3.4.24.11. is unable to cleave substrates at the final 
peptide bond. This implies that EC 3.4.24.11. requires residues in the 
Sj' and S2' subsites before cleavage can occur and it is unlikely that 
there is a functional group in EC 3.4.24.11. similar to Arg-203 of 
Thermolysin.
EC 3.4.24.11. has however shown dipeptidase action and it has 
been proposed that this enzyme has an arginine residue at the S2' 
subsite. This may well be the case however it is possible that 
previous researchers have been reading too much into their results. 
The presence of the arginine residue was proposed for two reasons a) 
amidated compounds are hydrolysed at lower rates than those with a 
free terminal carboxylate and b) butanedione studies showed that 
inhibition with butandedione caused a loss of 80% activity with 
substrates which had a free carboxylate terminal, 50% loss with 
amidated derivatives and only 20% loss with naphthlyamide derivatives.
1 7 4
However on closer examination of these data (see Table 6.8) it can
be seen that [Met^J-enkephalin-Arg-Phe-N^ which has its amide group
in the S^' subsite is also hydrolysed much more slowly than the
natural substrate which has a free terminal carboxylate. This could
indicate that amidated compounds are in general poorer substrates and
this could be due to the fact that the entrance to the active site
cleft is more accessible to anionic, or neutral groups. The
butanedione study is not conclusive either since, although the loss of
5 2activity with [Leu , D-Ala ]-enkephalin is shown the loss of activity 
5 2with [Met ,D-Ala ]-enkephalin is not mentioned and it is not good
practise to cite the loss of activity which occurs with the amidated
5 2form [Met D-Ala ]-enkephalin when no mention is made of the loss in
5 2activity with [Met , D-Ala ]-enkephalin. Also although there may be a 
20% loss in activity with the napthylamide derivative no mention is 
made of the drop in activity for Hip-Arg-Arg-Leu and this substrate 
appears to have a much higher activity than the enkephalin derivatives 
and it is possible that it is binding in a completely different 
orientation to these compounds. However it is expected that there 
will be a functional group at the S2' subsite capable of binding to 
carbonyl, or carboxlate groups and for the sake of argument this will 
be considered to be a arginine residue.
Low energy conformers of several of the inhibitors of EC 
3.4.24.11. were generated using the procedures described in chapter 3 
(see Tables 6.14 to 6.24). Since the Phe-[N]-L-X type inhibitors are 
expected to bind in a similar manner to CLT in Thermolysin, comparing 
the low energy conformers with the binding conformation of CLT may 
give some insight into the differences between the two enzymes. Table
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O^si/CU 2
37
Phe - [N l -L -  Phe - 0 A I a
M5
TORSION ANGLES
1) 037 
4) C2 
7) C9 
10) C40
C39 C40 C2 
N6 C13 09 
N10 C11 C12 
C2 C1 03
2)
5)
8)
11)
C39
N6
N10
N6
C40
013
C11
013
C2
C9
C12
C26
N6
N10
C14
C25
3)
6)
9)
12)
C40 02 N6 C13 
C13 C9 N10 C11 
C11 C12 C14 015 
C13 026 C25 023
MINIMA ENERGY
kCAL/MOL 1 2 3 4
TORSION 
5 6
ANGLES 
7 8 9 10 11 12
1 5.250 85 -68 159 -64 -53 178 131 63 114 -118 -168 75
2 5.415 84 -69 158 -63 -53 179 131 63 114 -118 -70 93
3 5.626 83 -75 168 -34 118 -178 103 -56 120 -118 -167 -104
4 6.100 95 -69 159 -78 118 -177 -124 67 116 -118 -179 -115
5 6.464 84 -68 159 -65 119 -178 111 62 115 -118 -69 92
6 6.600 89 -66 146 -83 116 -178 113 59 117 -120 62 -68
7 6.605 94 -74 161 -76 118 -176 109 61 116 -119 -178 -115
a 6.683 83 -74 166 -84 -52 -178 130 -57 120 -118 -166 -105
9 6.846 94 -74 164 -82 115 -175 100 • 65 117 -118 -165 -106
10 6.936 94 -70 163 -83 115 -175 -120 68 116 -118 -165 -107
11 7.041 74 174 159 79 116 -177 -124 681 116 -119 -179 -115
12 7.569 74 174 159 -79 116 -177 113 68 116 -119 179 -115
13 7.672 95 -62 165 -85 -115 -177 -117 61 115 -118 -164 77
14 7.692 75 176 162 -84 114 -175 -119 69 116 -118 -165 -107
15 7.711 73 175 164 -83 114 -175 101 66 117 -118 -165 -106
16 7.802 99 50 140 -81 3 178 133 76 116 -116 57 94
17 7.849 73 179 155 -77 115 -174 112 63 116 -188 57 -79
18 7.907 77 -179 156 -82 -6 178 -120 70 117 -119 -135 75
19 7.994 81 -171 157 -62 -53 179 131 65 117 -118 -70 93
20 8.998 89 -63 144 -83 119 -179 75 61 117 -119 62 -67
21 9.299 75 179 153 -79 108 -175 -148 64 116 -118 56 -78
22 9.375 72 173 154 -76 120 178 -121 66 117 -120 -68 172
23 9.687 92 -62 163 -86 -117 -178 110 64 116 -118 -161 -7
24 9.935 119 -46 ■70 -90 127 176 175 178 -179 -171 -173 78
25 9.984 123 -83 109 -92 130 173 173 -178 -179 -175 -174 77
26 10.551 121 -47 -71 -103 129 174 174 178 -179 -172 -171 5
TABLE 6.1U
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37
0(S) - P h e - ( N ] - L - P h e  - pAminobenzoate
TORSION ANGLES
1) C37 C39 C40 C2 2) C39 C40 C2 N6 3) C40 C? N6 C13
4) C2 N6 C13 C9 5) N6 C13 C9 N10 6) C13 C9 N10 C51
7) C9 N10 C51 C52 8) C40 C2 01 03 9) N6 C13 C26 C25
10) C13 C26 C25 C23
TORSION ANCLES
MINIMA ENERGY
kCAL/MOL 1 2 ' 3 4 5 6 7 8 9 10
1 12.889 94 -67 162 -68 -56 -178 22 61 174~ 64
2 12.928 92 -67 163 -69 -54 179 21 62 -72 98
3 13-833 93 -66 161 -67 125 179 21 61 175 64
4 13.977 125 -84 107 -88 128 175 176 60 -175 77
5 14.131 92 -67 163 -70 127 179 21 62 -71 97
6 14.567 112 -82 119 -86 -86 -174 21 61 177 61
7 14.684 126 -81 111 -101 123 -177 10 60 -167 81
8 14.721 126 -85 108 -88 128 175 176 60 -175 77
9 14.930 116 -87 118 -83 -80 -174 34 -178 179 63
10 14.953 133 -88 107 -94 122 -175 5 60 -172 74
11 15.341 -167 50 74 -86 -57 179 -161 124 -173 75
12 15.726 -170 51 74 -86 -59 179 -162 -176 -172 74
13 15.893 131 -82 114 -101 120 -175 17 -124 -168 80
14 16.043 154 -83 70 -99 136 179 178 -118 -173 79
15 16.165 140 67 73 -90 -61 179 -167 -116 -178 71
16 16.227 135 -89 111 -97 117 -173 10 -175 -174 73
17 16.390 179 54 62 -93 112 -172 -173 -175 -171 -95
18 16.686 103 59 107 -82 112 -178 -164 -118 -164 -100
19 16.692 174 58 60 -90 122 -177 -158 -176 -70 -77
20 16.785 -92 66 -93 -87 120 -178 -171 58 -176 77
21 16.957 110 80 124 -77 -65 -175 -159 119 175 62
22 16.959 125 -66 100 -146 61 177 149 -118 -165 83
23 17.292 95 71 -100 -80 129 -178 -149 -125 174 67
24 17.324 158 -83 68 -97 137 -179 174 -173 175 78
25 17.446 139 68 72 -90 -61 -179 -169 -174 177 71
26 17.451 108 81 127 -80 -62 -176 -161 119 175 62
'•27 17.638 121 65 86 -83 -65 179 -156 -176 -79 105
TABLE 6.15
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( R ) -Phe- l N l - L -  Phe- pAminobenzoate
TORSION ANGLES
1) C5 C4 C3 C2 2) C4 C3 C2 N6 3) C3 C2 N6 013
4) C2 N6 C13 C9 5) N6 C13 C9 N10 6) C13 C9 N10 C51
7) C9 N10 C51 C52 8) C3 C2 C1 03 9) N6 C13 C26 C25
10) C13 C2S C25 C23
TORSION ANCLES
MINIMA ENERGY
kCAL/MOL 1 2 3 4 5 6 7 8 9 10
1 14.155 91 -48 -177 -91 -20 178 -175 -63 59 86
2 15.002 • 81 38 -177 -176 -24 -175 174 -61 57 79
3 15.595 97 168 -168 -91 -16 179 -179 -57 61 83
4 15.630 86 51 -174 -101 175 173 173 -59 59 80
5 15.755 97 168 -164 -152 -13 -179 176 -61 88 88
6 15.964 94 65 -139 -63 -58 -174 -167 -62 150 72
7 16.016 90 -49 -177 -93 169 174 177 -64 61 85
8 16.086 98 170 -165 -156 172 176 172 -61 60 89
9 16.173 100 66 -157 -170 -56 -176 -171 -61 145 72
10 16.175 101 70 179 -100 169 175 176 -54 120 110
11 16.428 86 63 -153 -151 -7 -172 -179 -62 86 136
12 16.468 97 169 -169 -93 -172 174 175 -58 62 83
13 16.772 88 39 -174 -179 173 171 171 -61 58 79
14 17.882 87 64 -146 -156 -172 164 -175 -61 95 129
15 18.046 100 63 -178 -87 -44 179 -166 -59 129 92
16 18.540 83 -71 175 -169 175 174 179 -73 -145 81
17 18.996 101 65 -175 -169 168 169 178 -61 126 101
18 19.115 94 166 -178
9
-95 167 169 179 -57 125 100
19 19.394 101 160 -119 99 -19 175 176 54 120 110
20 19.495 95 160 -170 -170 -36 -176 -177 -61 129 58
21 19.889 96 158 -173 -173 168 168 176 -61 125 104
22 20.564 101 159 -124 -124 -21 -174 174 -61 115 109
23 20.573 98 162 -122 -122 17 169 179 -60 128 100
24 • 20.884 101 158 -121 -121 173 168 178 -60 117 109
TABLE 6.16
178
37
0
39
2 ^  ' \ z ' "  013
N 6 " X 1 3 ^ ^ N 1 0 n ! > ^ 1 2 \  qo
H o m o -  Phe - IN] - L - Phe - Gly
TORSION ANGLES
1) C37 C38 C39 C40 2) C38 C39 C40 C2 3) C39 C40 C2 N6
4) C40 C2 N6 C13 5) C2 N6 C13 C9 6) N6 C13 C9 N10
7) C13 C9 N10 C11 8) C9 N10 C11 C12 9) N10 C11 C12 013
10) C40 Cp C1 03 11) N6 C13 C26 C25 12)C13 C26 C25 C23
MINIMA ENERGY
kCAL/MOL 1 2 3 4 5 6 7 8 9 10 11 12
1 5.568 110 -62 -69 172 -70 110 -172 113 179 -118 -162 -103
2 6.359 68 65 -71 174 -64 111 -171 116 178 -118 -166 78
3 7.032 80 65 -176 174 -66 120 -179 154 179 60 -169 76
4 7.144 62 67 -67 175 -66 -70 179 176 179 -118 -163 79
5 7.352 108 -66 -69 178 -71 -59 -178 175 -179 -118 -161 -94
6 7.688 80 66 -176 175 -68 -60 -178 163 179 60 -170 76
7 7.759 66 61 -174 178 -71 76 -178 172 -177 62 -168 70
8 7.831 71 62 -179 82 -89 129 177 -126 -117 60 -161 87
9 8.072 86 179 -176 173 -67 112 -173 118 178 -119 -162 76
10 8.204 ' 68 58 -177 87 -76 -56 -179 149 178 60 -175 83
11 8.474 105 -65 68 65 71 -60 -177 158 179 120 -174 -99
12 8.581 62 66 -66 174 -71 168 178 -170 179
00•=rTCOT 77
13 8.717 104 -66 70 173 -71 -62 -179 165 178 -67 -159 86
14 8.759 90 -178 -178 177 -69 -62 -178 168 179 119 -165 84
15 8.806 89 -179 -67 177 -69 -6t -178 169 179 1 OB 1 cn Ul -93
16 9.193 117 -64 -70 176 -75 169 179 -167 -179 -118 -149 -102
17 9.242 112 -62 66 172 74 58 -177 -153 -177 -114 -167 73
18 9.246 109 -70 -175 178 -32 -60 -178 166 179 -124 -161 -93
19 9.315 163 -169 59 78 -79 -54 178 170 179 118 -170 82
20 9.448 93 178 177 75 -76 -52 177 159 178 -118 -170 86
21 9.516 73 67 -173 67 -175 -63 -175 168 179 62 -171 83
22 9.601 104 -65 70 172 -73 172 179 -173 179 -69 -146 -103
TABLE 6. 17 •
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n 6- ^ 3 \ 9 / N1° ^
Homo - Phe - [N] - L - Phe - /3 AI a
TORSION ANGLES
1) C37 C38 C39 C40 2) C38 C39 C40 C2 3) C39 C40 C2 N6
4) C40 C2 N6 C13 5) C2 N6 C13 C9 6) N6 C13 C9 N10
7) C13 C9 N10 C11 8) C9 N10 C11 C12 9) N10 C11 C12 C14
rn r.17 -C14 015 11 ) 040 C2 C1 03 12) N6 C13 026 C25
TORSION ANCLES
MINIMA ENERGY
kCAL/MOL 1 2 3 4 5 6 7 8 9 10 11 12
1 4.946 64 61 -175 169 1 o 114 -177 103 63 113 61 -167
2 5.207 68 60 -176 176 -66 112 -173 116 63 61 60 -166
3 5.333 69 59 -71 172 -65 109 -172 124 *60 120 62 -164
4 5.436 69 58 -176 173 -66 111 -171 91 -179 62 61 -166
5 5.495 69 65 -72 176 -61 -56 176 142 -59 116 -119 -161
6 5.730 68 57 -176 173 -66 112 -172 116 -177 117 61 -165
7 5.738 68 59 -177 173 -65 112 -171 114 -176 64 63 -166
8 5.811 69 65 -72 179 -61 -56 179 144 -59 68 61 -162
9 5.980 110 -63 -68 172 -71 110 -171 121 62 62 62 -160
10 6.021 110 -61 -69 172 -70 110 -172 122 -178 63 62 -159
11 6.023 109 -62 -69 171 -71 108 -170 126 59 119 61 -158
12 6.175 110 -63 -68 171 -72 111 -171 120 65 117 63 -160
13 6.302 69 65 -72 179 -61 -57 179 120 -179 63 61 -165
14 6.318 69 60 -176 173 -66 111 -172 119 -178 -179 61 -165
15 6.3»3 69 66 -70 175 -66 108 -173 123 63 61 118 -164
16 6.524 108 -165 -69 178 -71 62 176 93 -71 123 62 -163
17 6.586 69 65 -72 179 -61 -56 179 143 -178 119 61 -161
18 6.708 69 66 -71 173 -68 109 -172 119 179 64 62 -164
19 6.709 69 63 -71 173 -65 109 -171 119 -177 118 62 -164
20 6.712 109 -63 -69 172 -71 108 -170 126 -177 -179 118 -158
21 7.015 108 -65 -70 178 -70 -61 -178 92 178 117 62 -163
22 7.025 108 -65 -69 177 -70 -62 -177 92 176 62 62 -162
23 7.074 108 -61 -67 179 -71 -58 -176 169 -62 63 63 -163
24 7.093 108 -64 -68 178 -71 -59 -177 168 -69 119 61 -160
25 7.178 70 65 -72 179 -61 -57 179 144 -178 -178 60 -161
26 7.323 109 -61 -69 177 -71 -59 -178 170 177 118 62 -162
27 7.404 109 -63 -67 178 -71 -57 -178 169 176 63 61 -161
28 7.606 69 67 -70 172 -66 106 172 128 178 -177 60 -163
29 8.068 108 -65 -70 178 -71 -60 179 170 177 179 63 -162
TABLE 6.18
180
13
79
75
78
75
81
75
76
81
76
76
75
76
75
74
78
75
81
79
76
77
86
85
87
86
80
87
78
77
87
03
017
37 39
Homo - Phe - [N]-L - Phe - 7  Aminob u t y r ic acid
TORSION ANGLES
1) C37
00O C39 C40 2) C38 C39 C40 02 3) C39 C40 C2 N6
4) C40 C2 N6 C13 5) C2 N6 C13 C9 6) N6 C13 09 N10
7) C13 C9 N10 C11 8) C9 N10 C11 C12 9) N10 C11 012 C14
10) C11 C12 C14 C16 11) C12 C14 C16 017 12) C40 C2 C1 03
13) N6 C13 026 C25 14) C13 C26 C25 C23
TORSION ANGLES
MINIMA ENERGY
kCAL/MOL 1 2 3 4 5 6 7 8 9 10 11 12 13 14
1 4.909 67 57 -177 172 -65 115 -174 117 64 -173 118 160 -166 79
2 5.354 69 56 -176 172 -64 115 -175 122 -175 61 61 60 -167 78
3 5.528 68 57 -178 171 -66 1121 -177 73 -176 178 118 60 -168 81
4 5.587 67 65 -70 173 -65 109 -175 104 -78 -66 118 -118 -165 78
5 5.590 66 57 -176 172 -65 . 116 -174 123 71 -174 68 61 -167 79
6 5.789 110 -63 -69 171 -71 110 -170 120 -176 -179 -119 -118 -160 -104
7 5.814 67 57 -171 172 -65 114 -175 125 -174 -170 62 60 -166 78
8 5.828 110 -63 -68 171 -70 111 -170 119 62 -176 118 -118 -160 -103
9 5.910 67 57 -178 172 -65 116 -175 124 67 62 60 62 -167 80
10 5.948 66 57 -177 172 -66 114 -176 120 -178 -60 117 61 -166 78
11 6.069 67 55 -175 173 -67 114 -175 125 -173 -60 117 61 -166 78
12 6.081 65 56 -177 172 -65 112 -175 121 -178 84 121 63 -164 79
13 6.206 109 -63 -69 171 -71 111 -170 120 62 61 -117 -118 -160 -104
14 6.271 111 -61 -68 171 -71 110 -171 121 -179 178 -179 62 -159 76
15 6.301 67 57 -177 171 -63 116 -173 115 64 78 117 60 -167 79
16 6.492 68 66 -71 172 -65 109 -173 118 -85 -63 119 -117 -164 78
17 6.591 69 65 -71 173 -64 109 -172 105 -178 -61 117 -118 -164 77
18 7.125 90 179 -175 67 -174 175 -175 -174 -179 180 180 61 -149 70
19 •7.321 67 66 -71 173 -65 109 171 120 -179 -177 -179 62 -164 78
TABLE 6 . 1 9
181
Homo -Ph e - (N ] •- L- Phe - <5Aminovale r ic acid
TORSION ANGLES
1) C37 C38 C39 040 2) 038 039 040 02 3) 039 040 02 N6
4) C40 C2 N6 013 5) 02 N6 C13 09 6) N6 013 09 N10
7) C13 C9 N10 C11 8) 09 N10 011 012 9) N10 011 C12 014
10) C11 C12 014 016 11) 012 014 016 018 12) 014 016 018 019
13) C40 C2 C1 03 14) N6 013 026 C25 15) 013 026 025 023
MINIMA ENERGY
kCAL/MOL 1 2 3 4 5
TORSION 
6 7
ANCLES 
8 9 10 11 12 13 14 15
1 4.151 110 -63 -67 172 -71 112 -172 114 62 -178 65 61 -120 -162 -103
2 4.745 110 -63 -68 172 -71 112 -172 115 60 -178 68 -178 -118 -161 -103
3 5.164 67 57 -178 171 -65 116 -174 122 63 173 -60 117 60 -167 80
4 5.544 68 65 -72 178 -61 -55 -179 140 -59 -176 -61 119 -118 -163 82
5 5.552 67 57 -178 171 -65 116 -174 122 63 -172 179 119 61 -167 80
6 5.779 68 65 -71 174 -64 113- -172 110 63 -178 69 112 -116 -166 78
7 6.010 68 65 -72 179 -61 -55 179 ' 140 -60 -177 179 117 -118 -163 82
8 6.143 67 57 -178 171 -65 115 -176 126 -175 -168 179 121 60 -167 79
9 6.154 68 65 -71 173 -64 111 -171 115 62 -175 178 117 -116 -165 78
10 6.382 110 -63 -69 171 -70 111 -170 120 -175 179 75 117 -118 -160 -103
11 6.408 68 65 -72 179 -61 -55 179 140 -60 -177 179 -179 -119 -163 82
12 6.464 110 -63 -69 172 -70 110 -170 120 -175 -179 -177 179 -118 -160 -104
13 6.525 68 65 -71 173 -64 110 -172 117 -179 -177 61 -119 -118 -165 78
14 6.586 110 -63 -69 171 -70 110 -170 119 61 -178 -179 179 -118 -160 -103
15 6.592 67 65 -72 178 -62 -55 178 140 -58 101 -177 123 -117 -164 86
16 6.701 109 -65 -69 178 -70 -59 -177 91 65 -177 -178 117 -119 -164 -94
17 6.819 109 -65 -69 178 -70 -60 -178 91 -85 179 178 118 -117 -163 -93
18 7.172 109 -65 -69 177 -70 -60 -177 92 177 -179 -179 118 -118 -162 -92
19 7.207 68 65 -72 179 -61 -56 178 141 -179 -177 -179 -179 -119 -163 82
20 7.248 109 -65 -69 178 -71 -59 -178 170 177 -179 61 -119 -118 -164 -93
21 7.351 68 66 -71. 173 -64 110 -172 117 -179 -176 -179 -178 -118 -165 78
22 8.188 109 -65 -69 179 71 -59 178 169 177 -178 179 -179 118 -164 -94
23 8.213 109 -65 -69 178 -72 -57 -178 169 176 -179 60 -120 -117 -169 -95
TABLE 6.20
182
38 39
Me^  s i  ' ^ 9^ 2^  N6 ^ / N10n ” 015
Met - IN] -  L -  Phe - |3 Ala
TORSION ANGLES
1) C38 S1 C39 C40 2) S1 C39 n o C2 3) C39 C40 C2 N6
4) C40 C2 H6 C13 5) C2 N6 C13 C9 6) N6 C13 C9 N10
7) C13 C9 N10 C11 8) C9 N10 C11 C12 9) N10 C11 C12 C14
10) C11 C12 C14 015 11) C40 02 C1 03 12) N6 C13
VOCMO C25
13) C13 C26 C25 C23
TORSION ANGLES
MINIMA ENERGY
kCAL/MOL 1 2 3 4 5 6 7 8 9 10 11 12 13
1 2.563 80 174 -175 149 -85 116 -176 111 -61 118 -120 -167 -104
2 3.137 75 73 -66 147 -87 115 179 114 65 116 -119 -167 -103
3 3.384 -177 179 -66 147 -87 116 -177 111 61 116 -120 -168 -104
4 3-502 78 175 -174 148 -85 116 -178 110 62 115 -118 -167 -103
5 3.635 74 77 -63 149 -83 115 -177 111 -178 118 -118 -168 -104
6 3.659 80 176 -62 150 -83 115 -176 110 -178 118 -118 -168 -104
7 3-971 79 174 -174 149 -85 114 -177 111 -178 118 -120 -167 -104
8 4.401 75 73 -66 147 -87 67 179 -116 65 116 -119 -167 -103
9 4.580 -178 177 65 145 -87 66 179 -115 65 116 -119 -166 -103
10 4.580 70 60 -178 75 -150 115 -176 109 61 116 -118 -162 -102
11 4.626 73 60 -172 153 -143 115 -177 111 -178 118 -118 -168 -104
12 4.676 72 173 -177 156 -147 116 -179 113 -60 118 -118 -158 -109
13 4.837 76 174 -172 152 -142 115 -177 109 62 116 -118 -164 -104
14 4.858 78 177 -170 144 -87 65 178 -113 64 115 -119 -166 -103
15 4.887 -74 171 -178 76 -149 115 -176 110 60 116 -118 -162 -103
16 4.888 -98 65 -171 78 -153 114 -175 109 61 116 -118 -164 -100
17 4.939 71 171 -179 75 -149 115 -176 110 60 116 -118 -161 -103
18 5.131 76 66 -178 74 -147 59 178 -116 65 116 -118 -160 -105
19 5.182 78 178 -170 143 -86 56 179 -113 -58 115 -118 -165 -104
20 5.306 80 176 -169 151 -84 -115 174 -127 58 116 -118 -171 -109
21 5.346 77 175 -113 149 140 58 175 -112 60 115 -118 -162 -104
22 5.362 79 173 -170 143 -87 59 178 -112 -178 118 -119 -165 -104
23 5.376 73 173 -178 . 155 -146 178 178 -67 -57 116 -116 -156 -110
24 5.392 72 61 -177 155 -146 178 178 -67 -57 117 -118 172 -110
25 5.416 -74 172 179 73 -147 58 178 -116 65 116 -118 -160 -110
26 5.466 75 172 179 73 -147 58 178 -116 65 116 -118 -160 -105
TABLE 6.21 
1 83
014
S1
0 
(RJ - Thiorphan
TORSION ANGLES
1) S1 C9 C8 C10 2) C9 C8 C10 N11 3) C8 C10 N11 C12
4) C10 N11 C12 C13 5) N11 C12 C13 014 6) C9 C8 C7 C6
7) C8 C7 06 C5
TORSION angles
MINIMA ENERGY
kCAL/MOL 1- 2 3 4 5 6 7
1 4.259 58 -116 -178 116 119 166 88
2 4.282 57 -114 177 118 57 167 82
3 4.553 62 67 175 -102 65 -168 133
4 4.612 168 -120 -178 134 177 171 102
.5 4.798 168 -121 -176 140 179 169 88
6 4.857 61 -119 -179 -105 62 178 -95
7 4.901 60 62 -178 121 119 168 85
8 5.077 167 62 177 -139 179 177 94
9 5.195 61 -116 178 -108 63 73 -99
.10 5.260 167 62 176 -141 -60 -165 -101
11 5.395 60 62 -178 -139 178 169 88
12 5.492 167 62 -178 136 178 167 89
13 5.866 167 -114 177 -163 178 162 87
14 6.007 64 -115 178 -167 179 -58 86
15 6.591 58 62 178 110 118 -149 122
16 7.565 168 -151 177 102 179 137 88
17 8.169 -58 -169 -178 174 179 -89 88
18 8.771 172 20 -179 141 178 -65 85
Table 6.22
184
014
S
015
(S) - Thiorphan
TORSION ANGLES
1) S1 C9 C8 C10 2) C9 C8 C10 N11 3) C8 C10 N11 C12
4) C10 N11 C12 C13 5) N11 C12 C13 014 6) C9 C8 026 C25
7) 08 026 025 023
TORSION ANGLES
MINIMA ENERGY
kCAL/MOL 1 2 3 . 4 5 6 7
1 3.773 -63 119 176 -109 62 -174 80
2 3.861 -63 119 176 -125 62 -174 80
3 3.897 -63 119 176 -109 119 -174 80
1» 4.212 -61 119 178 -130 61 -172 94
5 4.605 -61 -60 179 119 118 -166 -101
6 4.623 -60 -62 -178 117 60 170 92
7 4.664 -63 117 179 117 118 -167 -100
8 4.671 -167 120 177 -129 -178 -172 94
9 4.695 -61 -62 178 120 112 -170 91
10 4.691 -169 •125 '176 -128 -179 -164 89
11 4.723 -62 -60 -179 118 59 -165 -101
12 5.008 -60 -63 179 -130 62 -171 94
13 5.247 -167 -62 -179 158 179 -178 81
1*1 5.366 -167 -63 -176 148 178 -171 93
15 5.508 -167 121 177 154 178 -172 94
16 5.572 -167 -64 -177 -130 -177 -172 95
17 5.803 -167 113 -177 177 -178 -163 91
18 6.133 -155 121 176 -155 -178 -71 106
19 6.239 -171 167 178 -156 -179 76 94
20 6.345 -151 115 179 -130 -177 -72 99
21 6.347 -151 -65 -179 -131 -178 -72 100
22 6.404 -61 -58 176 -124 -42 -170 43
23 6.467 -151 -63 -179 153 179 -72 100
24 6.490 -151 117 -179 154 178 -72 96
25 6.562 -150 -62 -179 149 178 -73 97
TABLE 6.23 
t85
013
N9
Retro thiorphan
TORSION ANGLES
1) S1 C9 C8 N9 2) C9 C8 N9 C10 3) C8 N9 C10 C11
4) N9 C10 C11 C12 5) C10 C11.C12 013 6) C9 C8 C7 C6
7) C8 C7 C6 C5
MINIMA ENERGT
kCAL/MOL 1
TORSION ANGLES 
2 3 4 5 6 7
1 2.703 74 -129 -178 113 114 178 106
2 2.855 159 -130 -178 114 115 178 106
3 . 3-431 72 -119 -179 -61 117 -178 104
4 3.436 69 -117 179 -61 117 -179 101
5 3.848 71 38 178 -56 116 -59 81
6 3.885 65 61 179 -60 116 -179 99
7 3.923 155 38 178 -56 116 -59 81
8 3.966 • -51 -117 -179 -61 . 117 -178 104
9 4.070 157 -74 177 "59 117 -53 96
10 4.157 70 36 178 120 117 -60 82
11 4.179 100 -80 178 56 117 -53 98
12 4.303 110 -86 178 -58 116 -60 95
13 4.316 156 36 178 120 116 -59 81
14 4.453 128 -72 179 -61 116 60 94
15 4.536 -33 -71 178 -58 117 -58 97
16 4.546 66 60 179 120 116 -179 99
17 4.566 157 -75 179 0 115 -53 95
18 4.742 -51 -69 177 -61 117 58 96
19 4.800 -56 -67 179 -61 117 -178 103
20 4.835 76 57 178 -60 118 55 97
21 4.865 128 57 178 -60 118 55 95
22 5.107 -82 75 178 -65 116 173 101
23 5.107 64 60 177 2 116 -178 97
TABLE 6.24
186
6.25. contains a list of the torsion angle values for the lowest 
energy conformer of each of the Phe-[N]-L-X inhibitors compared with 
the torsion angles of the binding conformation of CLT. The majority of 
the lowest energy conformers showed at least some similar torsion 
angle values when compared with CLT especially for the binding of the 
phenyl group in the S^' subsite and it was noticable that Phe-[N]-L- 
Phe-pAB gave the best agreement. The low energy conformations of each 
of the inhibitors are discussed in more detail in the next section.
(S) Phe- [N ]-L-Phe-pAB
The torsion angle values of the lowest energy conformer of this 
compound are in reasonable agreement with the torsion angles from the 
binding conformation of CLT. This compound would therefore be expected 
to be able to bind well to Thermolysin in a low energy
conformation. However it is found to have a with Thermolysin of
—  6 —810 as opposed to 10 in EC 3.4.24.11. The reason for the decrease
in activity was proposed to be due to the loss of binding energy, 
since Thermolysin has no functional group to bind to the terminal 
carboxylate of this compound whereas EC 3.4.24.11. is predicted to 
have an arginine at the S2' subsite. However, when the minimum energy 
conformer of Phe-[N]-L-Phe-pAB is superimposed upon CLT (see Fig 6.17) 
it can be seen that the pAB group is oriented towards the hydrophobic 
area of the S2' subsite and due to the rigid nature of this group it 
is involved in bad interactions with the sides of this hydrophobic 
area. If the pAB side chain is to be accommodated in this hydrophobic 
region there must either be a considerable displacement in position of 
the rest of the molecule, or there must be major changes in the 
backbone torsion angles. Both of these rearrangements would probably
187
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lead to a decrease in binding energy and a resulting loss in potency. 
It is also possible that the terminal carboxylate group is causing bad 
interactions with the end of the hydrophobic pocket. Therefore the 
active site of EC 3.4.24.11. must have a hydrophobic pocket at the 
S2' which is both large enough to accommodate the 2-napthylamide 
derivatives and is also in a more favourable orientation to accommodate 
the p-aminobezoate derivatives. This is the first difference found to 
exist between the two active sites from examination of the low energy 
conformers.
Homo-Phe- [N] -L-Phe-Gly, Homo-Phe-[Nj-L-Phe- ffAla, Homo-Phe- [N]-L-Phe- 
YABA, Homo-Phe-[N]-L-Phe- flAVA and Phe-[N]-L-Phe- ft.Ala.
A comparison of the low energy conformers of these compounds with 
the binding conformation of CLT shows that the P^' phenyl ring is 
again optimally placed to bind with the hydrophobic pocket in a low 
energy position. Torsion angle values of roughly 90°, -90°, 180° and - 
60° for torsion angles 1, 3, 4 and 5 respectively are often found in
o
the low energy conformations. However, values in the region of 180 , - 
o o
70 and -120 for torsion angles 2, 6 and 8 are associated with high 
energy conformations. These torsion angles are very important since 
the value of torsion angle 2 dictates the position of the phenyl group 
in the Pj hydrophobic pocket. The value of torsion angle 6 determines 
the orientation of the P^' carbonyl group (which in Thermolysin is 
binding to Arg-203) and the value of torsion angle 8 determines the 
orientation of the P2' side chain which is occupying the S2' 
hydrophobic pocket. Assuming the active sites of EC 3.4.24.11. and 
Thermolysin are similar it is possible that the above compounds are
190
lower in potency than expected since they have to adopt relatively high 
energy conformations in order to maximise binding to the active site.
Met-[N]-L-Phe- BAla
As with other inhibitors the most favourable position for the 
phenyl of the P-j ’ Phe residue is where the two torsion angles are equal 
to -170° and 75° respectively. As was discussed previously this 
compound may be relatively more potent than the rest of this series of 
compounds and this could be related to the fact that the values found 
for torsion angles 1 to 5 of CLT are also found in the low energy 
conformers of Met-[N]-L-Phe- $Ala. Again, assuming that the S-j 
Hydrophobic pockets of Thermolysin and EC 3.4.24.11. are in similar 
orientations, Met-[N]-L-Phe- 3Ala, although unable to maximise binding 
to the S'] pocket, does not need to adopt a high energy conformation to 
do so and may well be able to bind in a relatively lower energy 
conformation than the other compounds in the series.
(R)-Phe-[N]-L-Phe-pAB
As previously mentioned the N linkeage of the Phe-[N]-L-X series of 
compounds inverts the stereochemistry of the P-| Phe (see Fig. 6.16). 
Therefore (R)-Phe-[N]-L-Phe-pAB is stereochemically equivalent to L-Phe 
of a normal substrate.
From Fig. 6.25 we see that the values of torsion angles 4 to 8 of 
the lowest energy conformer found for (R )-Phe-[N]-L-Phe are in 
reasonable agreement with those of CLT, but the values associated with 
the P-|T phenyl side chain are 59° and 86°, these are quite different 
from the values -170° and 80° which would be associated with binding in
191
Thermolysin. From Table 6.16 it can be seen that a value of -170° is not 
found in any of the low energy conformers of this compound.
Torsion angles 2 and 3 of (R)-Phe-[N]-L-Phe-pAB also seem to be in 
reasonable agreement with those of CLT however this is misleading since 
as previously mentioned this Phe has inverted stereochemistry to the 
other inhibitors and in fact if this phenyl group is to occupy the P-j 
hydrophobic patch torsion angles 2 and 3 would have to adopt values of 
80° and 120° respectively, values which are not found for any of the low 
energy conformers in Table 6.16. This may indicate that compounds 
containing R stereochemistry at this centre may have to undergo large 
conformational rearrangements to bind in EC 3.4.24.11 and this may 
partly explain why such compounds are generally two orders of magnitude 
less potent than their corresponding S isomers.
(S)-Thiorphan, (R)-Thiorphan and Retrothiorphan
The R and S isomers of Thiorphan are more potent inhibitors of 
EC 3.4.24.11. than Thermolysin (see Table 6.10). There may be many 
explanations for this phenomencaeg. a) Thiorphan binds to both enzymes 
in a similar manner, but it is better able to utilise the binding groups 
of EC 3.4.24.11. than of Thermolysin b) Thiorphan may be able to bind to 
EC 3.4.24.11. in a lower energy conformation than it can bind to 
Thermolysin c) the terminal carboxylate of Thiorphan may be able to form 
a salt linkage with the proposed arginine at the S2 T subsite of EC 
3.4.24.11. giving stronger binding and greater potency. Retrothiorphan 
is also a potent inhibitor of EC 3.4.24.11. and several low energy 
conformers of these three compounds were generated (see Tables 6.22 to 
6.24).
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The X-ray conformation of a similar inhibitor of Thermolysin, 
(2-benzyl-3“mercaptopropanyl)-L-Ala-glycinamide, BAG, is known and Fig 
6.18 shows a comparison of the torsion angles values for the binding 
conformation of BAG in Thermolysin with the lowest energy conformer of 
each of the three inhibitors: (S)-Thiorphan, (R )-Thiorphan and 
Retrothiorphan.
For (S)-Thiorphan the torsion angles for the Phe side chain are in 
good agreement with those of the previously mentioned inhibitors (-174°, 
80°). However, they are not exactly the same as those found for BAG 
since in BAG the Phenyl ring torsion angle has a value of 34°. This 
torsion angle value is necessary if BAG is to optimise binding to both 
the zinc and the S-j ’ hydrophobic pocket and it is possible that when 
Thiorphan binds in EC 3.4.24.11. it will also need to adopt a similar 
position. Comparing the other torsion angle values we see that the 
main differences between BAG and the minimum energy conformer of 
(S)-Thiorphan occur for torsion angles 2 and 4. In BAG these torsion 
angles have values of -69° and 115° and these are values associated with 
higher energy conformers of (S )-Thiorphan (see Table 6 .23 ).
(R)-Thiorphan is also a potent inhibitor of EC 3.4.24.11. This is 
slightly unexpected since this enzyme is known to be highly specific for 
those substrates possessing the naturally occuring L (equivalent to S 
stereochemistry) amino acid residue a the P1 ’ subsite. To superimpose 
(R)- Thiorphan upon BAG requires that the torsion angle values for the 
phenyl side chain (torsion angles 6 and 7 of Fig. 6.18) have values of 
150° and 80°. From Table 6.22 it can be seen that similar values are 
found for several low energy conformers.
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Due to inversion of the amide bond in Retrothiorphan the isomer 
which corresponds to the S stereochemistry of Thiorphan has R 
stereochemistry in Retrothiorphan. On comparing the torsion angles of 
Retrothiorphan and BAG it can be seen that once again the phenyl ring is 
optimally placed to bind in the S-| ’ subsite. Since the amide bond is 
inverted the values of torsion angles 2 and 4 would have to be - 120° 
and - -60° to give the correct directionality to the hydrogen bonding 
groups. From Table 6.24 it can be seen that although a value of *^ 60° is 
found for torsion angle 4 for one of the higher energy conformers, none 
of the conformers listed possess a torsion angle of 120° for torsion 
angle 2 and if Retrothiorphan is to bind to EC 3-4.24.11. in a 
comparable mode to BAG binding in Thermolysin it must bind in a 
relatively high energy conformation.
Discussion
Comparisons of the low energy conformers of the inhibitors of EC 
3-4.24.11. with binding conformations of similar inhibitors of 
Thermolysin show that there- are several possibilities for the structure 
of the active site of EC 3-4.24.11.
There is a distinct possibility that the active site of the renal 
endopeptidase shows a high structural similarity to that of Thermolysin 
r* having a slightly smaller hydrophobic pocket, a zinc atom involved 
in coordination to the carbonyl of the scissile bond, a functional group 
similar to Ala 113 of Thermolysin which will form a hydrogen bond to the 
nitrogen of the scissile bond, an S-j ’ hydrophobic pocket of exactly the 
same size as that of Thermolysin and an S2’ hydrophobic patch which is 
larger and slightly displaced from that of Thermolysin. It is not clear
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whether there are any residues in the active site of EC 3 - -4 - 2-h .11. 
capable of binding to the ’ amide bond since the enzyme is unable to 
hydrolyse terminal residues - unlike Thermolysin - and inversion of this 
amide bond, as in Retrothiorphan, seems to make little difference to the 
potency of the compounds. In addition all these groups would have the 
same spatial arrangements as those of Thermolysin giving a high homology 
for the three dimensional geometries of the functional groups of both 
compounds. Such similarity between a bacterial enzyme and a mammalian 
enzyme is not unlikely since enzymes which have similar substrate 
specificities and functions would be expected to present similar 
catalytic surfaces to the incoming substrates.
Another plausible structure for the active site of EC 3.4.24.11 . 
involves a different mode of inhibitor binding than is found for 
Thermolysin. Several of the inhibitors studied are much more potent in 
EC 3-4.24.1 1 . than in Thermolysin and it is possible that these 
inhibitors are binding to the endopeptidase in lower energy 
conformations than would be found for Thermolysin. For nearly all the 
inhibitors studied it was found that the major differences between the 
low energy conformers and the corresponding Thermolysin inhibitor 
binding conformation occured for the values of the two backbone torsion 
angles on either side of the ?<\ 1 amide bond. For Thermolysin inhibitors 
the values for these two torsion angles would have to be roughly ^60° 
and -120°. From Tables 6.14 to 6.24 it can be seen that for the low 
energy conformers there are two pairs of values for these torsion angles 
which seem to be highly favourable, namely (120°, 120°) and (-60°,120°). 
It is important to note that the first value dictates the directionality 
of the P-| f carbonyl group - the binding of which would appear to be more
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important in Thermolysin than EC 3-^• 24.11. The second value dictates 
the orientation of the ?2 ’ side chain.
From a comparison of CLT and (S)-Phe-[N]-L-Phe-pAB (see Fig. 6.17) 
it would appear that the para-aminobenzoate group is occupying the S2? 
hydrophobic patch in both Thermolysin and EC 3.4.24.11. Since the 
para-aminobenzoate group is totally rigid modeling of the other 
inhibitors on this group should give the torsion angles necessary for 
binding to EC 3.4.24.11. with the P2 1 side chain occupying the S2 f 
hydrophobi c patch.
(S)-Thiorphan was chosen as a likely candidate for this comparison 
since it was relatively more potent than expected (see Table 6.10) and 
was also known to be a more potent inhibitor of EC 3.4.24.11. both 
factors which may indicate binding of a relatively low energy 
conf ormation.
An (S)-Thiorphan conformation was built which had a value of -60° 
for torsion angle 2 (see Fig. 6.18). On superimposition of this 
conformation with the para-aminobenzoate group it was found that torsion 
angle 4 had to adopt a value of 80° or -100° to align a P2 f side chain 
with the para-aminobenzoate group. A torsion angle 4 value of 120° would 
not place the side chain in the correct direction and the binding of low 
energy A with the torsion angle pair (-60°,120°) can therefore be 
discounted as a possibility.
A Thiorphan conformation was then built with a value of 120° for 
torsion angle 2. when this was superimposed upon the para-aminobenzoate 
group it was found that torsion angle 4 had to adopt a value of -120° or 
60° to position the side chain correctly.
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There are therefore four possible pairs of torsion angle values for 
the torsion angles to either side of the P-| ’ amide bond which would 
correctly position a ?21 side chain in the S2 f hydrophobic region, 
namely (-60°,-100°), (-60°,80°), (120°,-120°) and (120°,60°). The values 
(-600,-100 °) are similar to those found for the binding conformations of 
the Thermolysin inhibitors and as previously discussed are associated 
with high energy conformers as are the values of (-60°,80°) and 
(120°,60°). Whilst it is possible that the inhibitors could bind with 
any of these values , if they bind in low energy conformation they may 
adopt the values (120° ,-120°). These values occur in the lowest energy 
conformer found for (S)-Thiorphan - the lowest energy conformer of 
Retrothiorphan and the third lowest energy conformer of (R)-Thiorphan 
are also very similar in structure to this (see Figs. 6.19 and 6.20) and 
similar torsion angle values are found for low energy conformers of all 
the other inhibitors.
During the time I spent working at Pfizer's low energy conformers 
of three other potent inhibitors were also generated. These compounds 
were not similar in structure to any of those described in this thesis, 
however it was found that the low energy conformers of these compounds 
had similar functional groups in similar positions to those conformers 
discussed above.
The active site prediction which arose from the modeling of low 
energy conformers was still very similar to that of Thermolysin except 
that its S2 ? hydrophobic patch was in the region which corresponds to 
the position of a P2 1 side chain when the backbone torsion angles on 
either side of the P-j ' amide bond have values of 120° and -120° 
respectively. The S-| ' hydrophobic pocket was identical to that of
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Thermolysin and there were still marked similarities in the position of 
the S-| hydrophobic patch , the zinc and the functional group which binds 
to the'nitrogen of the scissile bond.
Future Work
There is, of course, no way of knowing if either of the two active 
site predictions discussed in the previous section bear any resemblence 
to the active site of EC 3.4.24.11. since the enzyme has so far proved 
difficult to crystallise and very little is known of its structure.
Assuming that there will be future work on modeling the active site 
of EC 3.4.24.11. from Thermolysin there are two approaches which could 
provide valuable information on the active site of the endopetidase.
The first approach would involve a direct comparison of the kinetic 
parameters of several series of substrates and inhibitors of both 
Thermolysin and EC 3.4.24.11. This would give much information as to the 
differences in the subsites of the two enzymes and particular attention 
could be paid to the preference shown by each enzyme at the S*| ’ amide 
binding site and the S2 ’ hydrophobic binding patch as it would appear 
that there may be major differences between the two enzymes in these 
regions.
The second approach could involve the use of novel inhibitors. Such 
compounds could contain rigid groups which would restrict the allowed 
conformation of the molecule, carbon carbon double bonds in their 
backbones to explore the backbone torsion angles required for binding, 
replacement of the ’ amide bond by an ethylene group or methylation of 
the amide nitrogen to investigate whether or not this amide takes part 
in any hydrogen bonding interactions, bulky side chains could be used
201
to test the size and direction of the S2r hyrophobic region and since 
(R)r-Thiorphan is as potent as (S)-»Thiorphan, D^-amino acids could be 
substituted for their naturally occuring L counterparts to see if this 
phenomenon occurs elsewhere.
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Chapter Seven
Section 7.1.
Introduction
Much computer programming was done during the course of this 
project. This included debugging and modifying many existing 
programs, writing and converting programs to run in the FPS-100 
array processor and some graphics programming.
Section 7.2.
Program Development
The hardware and software used for this project has been 
discussed in detail in chapter 4. The MOL software package was 
originally used for modeling small molecules and cyclic peptides. 
When any software is used for a new application bugs tend to 
surface in the programs and several were found in the MOL system. 
Most of the problems which arose were caused by the size of the 
molecules beind studied and tended to fall into two catagories. 
Either the routines were not dimensioned to cope with such large, 
flexible molecules and all the associated variables, or the 
algorithms used were not particularily efficient. Therefore the 
system had to be extensively modified to cope with the 
applications described in this thesis.
One of the major changes made to the MOL system was the 
implementation of a new superimposition program with which several 
points could be fitted using a least squares fitting procedure in 
an iterative manner.
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A new force field was also implemented, since existing force 
fields did not contain the relevant parameters for the molecular 
systems which were being modelled. The majority of the force field 
constants were supplied by Dr. M. S. Tute although some had to be 
derived from experimental data.
Section 7*3.
The Array Processor
As discussed in Chapters One - Three molecular mechanics has 
proved to be an extremely powerful tool for modeling and 
understanding molecular structures. However it has one main 
drawback in that it is highly CPU intensive. Even dedicated 
mini and supermini computers (eg PDP 11 fs, VAX 11/780’s) can take 
days to compute the complicated functions involved. However with 
an array processor the time involved can be shortened quite 
dramatically since it performs far faster than any supermini 
computer of similar price. Several studies have shown that array 
processors have one of the best price/performance ratios to be 
f o u n d . ' ' *2,3 jn fact for the molecular mechanics calculations 
described in this thesis the array processor performed 35 40
times faster than the PDP 11/40 and this increase in speed could 
have improved even further by programming the machine in assembly 
language.
The reason why array processors are so much faster than other 
computers is due to their architecture. The typical elements of a 
minicomputer are shown in Figure 7.1. The single bus provides a 
pathway for access to all parts of the system. However the speed
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of a calculation is restricted, since each device must perform 
multiple functions and the single bus limits access to all the 
devices such that only one device can be accessed in one machine 
cycle. There are three ways of increasing the speed of this kind 
of system a)by increasing the speed of the logical elements, 
b)calculations can be spread out amongst parallel elements which 
have specific functions and cCalculation steps can be spread 
along a pipeline. The FPSM 00 array processor successfully 
combines all three approaches. It consists of several independent 
memories and arithmetic units with specialized functions - all of 
which are interconnected by a network of buses. Figure 7.2. gives 
an general overview of this type of architecture. This arrangement 
allows the array processor to be programmed with parallel code 
which allows all the units to be addressed, or initiated within a 
single line of code. For example, one line of code may contain 
instructions to deposit a number from a bus into one of the 
datapad registers, initiate an addition in the floating adder and 
initiate a multiplication in the floating point multiplier. This 
parallel assembly language is highly unusual and difficult to 
learn and is further complicated by many features of the machine’s 
architecture eg. the result of a multiplication requires to be 
pushed through the floating multiplier and will not appear on the 
FM bus until three cycles after the multiplication was initiated. 
Thus, although array processors are very efficient in terms of 
computing power versus price the cost of software development is 
significantly higher than that of standard computers.
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There is a way of overcoming this problem. A company called 
System Software Factors have produced a software package called 
the TOAST FORTRAN Development System. This software enables the 
user to write/convert standard FORTRAN programs to run in the 
FPS-100 array processor without having to learn how to program in 
complicated parallel assembly language.
The TOAST FORTRAN system is composed of several components. 
Of particular interest are the language, the compiler, the linker 
and the host/AP interface routines.
Creating executable array processor ’ programs with the TOAST 
system requires two separate source programs - a host program 
which will run in the host machine (eg a PDP 11/40) and an array 
processor program which will run in the array processor.
The FPS-100 array processor is incapable of any I/O, 
therefore the host program is required to fetch and initialise the 
array processor, find and load the array processor program, 
transfer any external variables to the array processor, run the 
array'processor program and recover the results from specific 
array processor addresses. All these operations are carried out 
using a set of host/array processor interface routines which are 
stored in a library as a set of FORTRAN callable modules.
The array processor program is written in TOAST FORTRAN. This 
is a subset of the FORTRAN IV language which contains no I/O 
statements such as READ, WRITE, OPEN, CLOSE etc. This source file 
is compiled and linked with the TOAST compiler and TOAST linker 
respectively to produce the binary file which will run in the 
array processor. The compiler has been designed to optimise the
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linear TOAST FORTRAN source code producing parallel code which 
makes much more efficient use of the machine’s parallel 
architecture.
In many ways this system can be thought of analogous to 
subroutine usage - the main (or host) program calls the subroutine 
(or array processor program), variables are transferred across, 
the subroutine runs, results are transferred back and the main 
program continues. This makes writing .(and converting existing 
programs) to run in the array" processor much simpler since the 
user is not required to know anything about parallel programming.
During the course of this project several programs were 
converted to run in the array processor. These include a rotation 
program, a least squares fitting routine, energy minimisation 
programs and a conformer generation program - the GLOMIN program 
which is given as an example of this type of programming in 
Appendix A.
Section 7.4.
Graphics Programming
The main graphics terminal on the system was a Megatek 7000S 
calligraphic terminal. Calligraphic terminals use the same 
technology as oscilloscopes, in that they draw vectors between 
specified points. For the purpose of programming the Megatek 
screen had 4096 x 4096 addressable points on its screen. 
Programming involved a library of FORTRAN callable routines - the 
MGS software and the input for these consisted of addresses, 
character strings and parameters describing character size,
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intensity etc. One important feature of the Megatek 7000S is that 
it has eight planes of memory *• each of which can contain a unique 
picture (display list) and each picture can be switched on or off 
individually. This feature proved very useful for maintaining 
menus whilst displaying structures and writing information to the 
screen and was also used for double buffering to give the effect 
of dynamic rotation.
Although the MOL system had already been set up before this 
project began several cosmetic alterations had to be made to the 
system in particular a windowing/clipping function was written to 
prevent wrapping of vectors which had exceeded the dimension of 
the screen. The rotation speed was also increased by packing two 
sixteen bit integers into a thirtytwo bit integer and sending that 
over to the Megatek with one call rather than two. Some 
statistical routines were also written to draw and give hardcopy 
of graphs and an example of this is given in Appendix B, Figures 1 
and 2.
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Chapter Eight
Section 8.1 
Introduction
This chapter contains a discussion of work carried out in 
conjunction with Professor A.Y.Meyer while he was on sabbatical 
leave at Glasgow University.
The work was an attempt to suggest a reasonable way of 
modifying existing force fieldsso that their non-bonding 
parameters will be more transferable. This work shows that the 
non-bonding potential functions and parameters currently used by 
different force fields give hugely different estimates as to the 
size and hardness of the hydrogen atom. However, if an 
electrostatic term is introduced in the calculation of the non­
bonded interactions, the different force fields give more 
consistant values for the non-bonded parameters. It is therefore 
proposed that the inclusion of this term would both improve the 
performance of the individual force field and make the non-bonded 
parameters more transferable.
This work was published as a paper in the Journal of 
Computational Chemistry and the paper is given in Appendix B.
Section 8.2
The Force Field Method
The force field method has been described in great detail in 
Chapters One to Three of this thesis. It originated in vibrational 
spectroscopy where it was developed in an attempt to predict
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vibrational frequencies from a simple mathematical model and was 
later developed for the calculation of other molecular properties.
In the force field method the molecule is regarded as a group 
of atoms held together by simple harmonic forces which can be 
represented by potential functions derived from classical 
mechanics. The set of functions chosen to reproduce particular 
molecular properties is called the force fieldJ
Setting up a force field involves selection of potential 
functions, parameterisation for the functions using reliable data 
and refinement of the force field functions and parameters such 
that they compare with observable properties for a group of test 
compounds.2
Section 8.3
The Divergence of Non-Bonded Functions and Parameters
Several force fields have been set up by individual groups 
which use different sets of potential functions. In general the 
.nature of the individual functions is regarded to be unimportant 
as long as the set of functions chosen gives good agreement with 
experimental data. However, certain functions can be used to 
calculate physical properties of the molecule. Comparison of such 
properties as calculated using different force fields show wide 
divergence in values. This is particularly noticable in the area 
of non«-bonded interactions^*1^ where several different functions 
are in use.
As discussed in Chapter Two non-bonded interactions are 
perhaps one of the most important forces in stabilising molecular
212
conformation. The non-bonded interaction arises from two 
independent forces which are related to interatomic separation.. 
There is a strong repulsive force at short distances, and a weak 
attractive force over larger interatomic separation. The non­
bonded function is a combination of these two forces and the 
general shape of this function is shown in Figure 8.1. Em is the 
minimum energy and is a measure of the depth of the potential well 
(the hardness of the atom) and Rm is the minimum energy distance 
i.e. the size of the atom.
Several functions have been formulated to describe non-bonded 
interactions and the following three are perhaps the most 
frequently used.
1) The Buckingham Potential^
Enb * -I, + Ae(‘Br) <1>
joO
2) The Lennard Jones Potential^
Enb - A - P <2>
r*1 r° n«9,12
3) A Modified Version of the Buckingham Potential
Enb = Em ((-2/Rm)6/r6) + e(12(1"(r/Rm))) <3>
where r is interatomic separation, B is constant for two 
interacting atoms and A and P are related to the fliinimum energy 
point, Em, of the function and its associated distance Rm.
All of these different equations can be used to calculate Em 
and Rm . This is further complicated by the fact that each force 
field will be parameterised using experimental data from sources
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which are of particular interest to each individual group. It is 
therefore easy to see why calculated values of physical properties 
such as Em and Rm vary so much between force fields.
To illustrate this point the non-bonding parameters for the 
H***H interaction were calculated using four different force 
fields. The first force field, FF1 , is from the MM2 program by 
Allinger? and is one of the most popular force fields in use 
today. The second, FF2, was developed at Glasgow University by 
Bovill and White^ and was parameterised paying particular 
attention to compounds with very short H***H non-bonded 
interactions. The third force field, FF3, is by Jaime and Osawa^ 
and modifies the MM2 package so that it can be applied to 
compounds with short H***H non^bonded interactions and the fourth 
force field FF4 is by Ermer and LifsonJO
FF1 and FF3 employ the Buckingham potential (eqn 1), FF2 uses 
a modified version of the Buckingham potential (eqn 3) and FF4 
uses a Lennard-Jones type potential (eqn 2).
Table 8.1 contains the values of Em and Rm for a hydrogen 
atom as calculated by each force field. When compared with FF1 the 
hydrogen is large and soft in FF2, somewhat small in FF3 and 
extremely large and hard in FF4.
Therefore it can be seen that the use of different non­
bonding functions and the way in which a force field is 
parameteri sed can have a major effect upon the values of the non­
bonding parameters produced.
2 1 5
Table 8.1
Rjjj Em . Ratio Rm Ratio Em
(A) (kcal mol^1)
FF1 1.50 0.047 1 1
FF2 1.55 0.016 1.03 0.34
FF3 1.426 0.047 0.95 1
FF4 1.816 0.064 1.21 1.36
Non bonding parameters for H*•*H interaction as calculated by 
four different force fields.
Table 8.2
(A) (kcal mol~1)
1.5 0.354
2.0 0.265
2.5 0.213
3.0 0.177
4.0 0.144
7.0 0.076
Coulmbic interaction between two hydrogen with partial
charges of 0.04 charge units.
Thus when parameterising a force field, concentrating on 
particular structures such as short H***H interatomic distances 
introduces a bias into the system.
It is therefore obvious that the functions currently used to 
calculate non-bonded interaction are not adequate. There is, 
however, another force involved in the attraction/repulsion of 
non-bonded atoms - namely the electrostatic interaction. None of 
the above fields contains a function with which this force can be 
implicitly calculated.
Section 8.4
Introduction of an Electrostatic Term
The electrostatic force between two non-bonded atoms is a 
measure of the interactions of the partial charges on the atoms 
and the energy involved in this interaction is given by the 
equation:-
Eq - 332.17 q^qj / Dr 
where q^ and qj are the partial charges for atoms i and j in 
charge units, r is the interatomic distance in Angstroms, 332.1 7 
is a conversion factor to return a value in kcal mol“  ^ and D is 
the Dielectric constant which has a value of one in vacuo.
Still considering the H***H interaction, Table 8.2 contains 
values for the energy associated with two non-bonded hydrogen 
atoms having partial charges of 0.04 units at different 
interatomic separations (0.04 is felt to be a reasonable value for 
the partial charge on a hydrogen in a saturated hydrocarbon.). As
2 1 7
expected the electrostatic force is far more repulsive at short 
interatomic distances than at larger separations.
Combining the electrostatic interaction Eq with the non- 
bonded interaction En^ to give a new non-bonded function En^f such 
that
^nb’ = ^nb “
since both Ent) and Eq are known En^f can be plotted point by point 
and Figure 8.2 shows the shape of this function. With this new 
non^-bonding pontential En^ f there is a greater repulsion at 
shorter distances due to the contribution made by Eq. The new 
values of Em * and Rm f can be calculated from the new function
^nb’
The effect of introducing an electrostatic term, to the four 
force fields previously used can be examined by recalculating the 
values of the non-bonding parameters. The new values are given in 
Table 8.3. This shows that when charge interaction is made 
explicit, all four fields give a more or less identical value for 
the hardness and size of the atom in FF1, FF2 and FF3 and although 
the hydrogen atom is still fairly large in FF4 the values are 
converging.
Since Eq + En^’ is equal to En^ the individual fields should 
still perform as well as before however it would appear that the 
new non^bonding parameters Em f and Rm ’ as calculated by the 
different force fields have been made more transferable.
The major problem with implementing this change is that there 
are many different ways of estimating partial charge. The most 
basic approach would be to assign a partial charge to each atom by
2 1 8
Table 3.3
Ratio Rm Ratio Ejtj
(A) (kcal mol~^)
FF1 ' 1.44 0.202 1 1
FF2 ’ 1.40 0.198 0.97 0.98
FF3' 1.37 0.210 0.95 1.04
FF41 1.76 0.213 1.22 1.05
Non-bonding parameters for H***H interaction on inclusion of 
electrostatic term.
0.2 -
-0.2 -
nb
Figure 8.2
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type - although this may prove to be somewhat approximate since 
it is known that the partial charge on an atom varies with its 
molecular environment.
A better approach might involve calculation of the partial 
charges for each molecular conformation using say a CNDO type 
method, but again this would lead to problems as it would impose a 
limit on the size of the molecules which could be studied.
It is however clear that a force field F can be converted 
into F f relatively easily without affecting its performance 
but giving improved calculation of non-bonding parameters.
To summarise, this work shows that the inclusion of 
electrostatic interactions in force fields is of great importance 
especially since force fields are now being used for calculations 
involving heteromolecules, peptides and even proteins in which the 
partial charge interactions play a fundamental part in stabilising 
molecular conformations.
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PROGRAM GLOMIN
COMMON/ROTAT/NATOM(10,4) ,NR(10),NRATOM(10,50),ISTART(16) 
COMMON/CONST/RADI,RAD2,RADI, NRING,NT,NRI,NTP,N P ,NAV 
COMMON/CHECK/IGEN,EXCLUD(10, 15),NEXCLD,J 1 ( 15),NBONDS,
1 DMAX,HOMOP
COMMON/TCHECK/NREST , ITREST(3 ,4),TVAL(3),TTOL(3)
COMMON/VARS/NATOMS,NAMES , X I , ICONN,ITYPES,TITLE,NTITLE 
COMMON/TAUS/TANGLE(9,2),TAU(10),NGEN,ICHEND , JCHEND,TDIST , 
1 TOL
LOGICAL IGEN,HOMOP 
LOGICAL*1 EXCLUD,TITLE(80)
DIMENSION NAMES(50,3),XI(50 , 3),ICONN(50,4) , ITYPES(50) ,
1 J1 S ( 15 )
DIMENSION DT(8),DELTAU(2 ) ,XS 1 (50),XS2(50) , XS3(50) ,NRA(50) 
DATA DT/5.,4. ,3. ,2. ,2. , 2 . , 1. , 1./
C
C INITIALIZE THE ARRAY PROCESSOR 
C
ICHAN=IGETC()
CALL SSFLDP(ICHAN,'GLOAP',0,0,ISTAT)
C
C*******GET CURRENT VALUE OF JSW 
IVAL=IPEEK("44)
CALL SETUP
C*******ENABLE INTERCEPTION OF CTRL/C USING SYSLIB SCCA ROUTINE 
IFLAG=0
CALL SCCA(IFLAG)
C*******OPEN A FILE WHICH WILL CONTAIN THE OUTPUT COORDINATES. 
TYPE 9000
9000 FORMAT( ' $OUTPUT FILE NAME ')
CALL ASSIGN( 1 , ' ' ,-1,'NEW','CC')
WRITE(1 , 9001 )
9001 FORMAT('+GLOBAL MINIMISATION - GENERATED CONFORMERS.')
C*******RADIANS TO DEGREES (AND BACK) CONVERSION FACTORS.
PI=3.1415926536 
RAD1=P1/180.
RAD 2 =RAD1 * RAD 1 
RADI=1./RAD 1 
ICNF=ISTART(16)
C*******SAVE ORIGINAL COORDINATES FOR REUSE AS STARTING COORDS.
DO 2 1=1,NATOMS
WRITE(1 ,9002) ITYPES(I) , (NAMES(I ,J ),J=1,3)
XS1(I)=XI(I,1)
XS 2(I)=XI(1,2)
XS3(I)=XI(1,3)
2 CONTINUE
9002 FORMAT(X,15,3A2)
C*******ALL DONE LETS GET STARTED 
J 1S(NTP)=0
DO 10 I1=ISTART(1),NGEN 
J1(1)=I1
DO 10 I2=ISTART(2),NGEN 
J1(2)=I2
DO 10 I3=ISTART(3),NGEN 
J 1 (3) = 13
DO 10 14=ISTART(4),NGEN 
J1(4)=I4
2 3 5
n
o
n
DO 10 15 = 1
J1 (5) = 15
DO 10 16 = 1
J1 (6) = 16
DO 10 17 = 1
J1 (7) = 17
DO 10 18 = 1
J1 (8) = 18
DO 10 19 = 1
J1 (9) = 19
DO 10 11 0 =
J1 (10 ) = I10
DO 10 11 1 =
J1 (11 ) = I11
DO 10 11 2 =
J1 (12 ) = I 12
DO 10 11 3 =
J1 (13 ) = I 13
DO 10 11 4 =
J1 (14 ) = I14
DO 10 11 5 =
J1 (15 ) = I 15
IF (J1 (NTP)
J1 S(NTP) = J
IS TART(5),NGEN
ISTART(6),NGEN
ISTART(7),NGEN
I ISTART(8),NGEN 
I ISTART(9),NGEN
TART(10),NGEN
II ISTART(11),NGEN 
1
I ISTART(12),NGEN
TART(13),NGEN
I ISTART(14),NGEN 
1
I1 ISTART(15),NGEN
5.J 1S(NTP ) ) GO TO 10 
>JTP )
C*******MODIFY JSW TO SET CONSOLE I/O TO SPECIAL MODE 
C*******AND TO ALLOW ITTINR TO RETURN A NEGATIVE 
C*******ARGUMENT IF NO CHAR AVAILABLE (SEE DEC 
C*******ADVANCED PROGRAMMERS GUIDE).
CALL IP0KE("44,"10100.OR.IVAL)
C*******IS THERE ANYBODY THERE?
I=ITTINR() 
c *******r e s e t  JSW
CALL IPOKE("44,IVAL)
C*******WAS A CTRL/C TYPED? IF SO GO TO ABORT ROUTINE 
IF(I.EQ.3) CALL CNTRLC(ICNF,NTP,J1)
IF(NEXCLD.E Q .0) GO TO 7 
CALL IMPOSS
IF(.NOT.IGEN) GO TO 10 
7 IF(.NOT.HOMOP) GO TO 71
CALL INVERS
IF(.NOT.IGEN) GO TO 10 
C*******GET ORIGINAL COORDINATES BACK.
71 CONTINUE
C
C BEGIN AP LOOP 
C INITIALISE AP PROGRAMME 
C
CALL SSFSGL( ' ' )
TRANSFER DATA
IADR=ISFADR('TRANS')
C
CALL SSFFTO(TANGLE ,IADR ,18 )
CALL SSFITO(NATOM(1,1) ,IADR+18 ,NT )
CALL SSFITO(NATOM(1,2) ,IADR+28 ,NT )
2 3 6
o 
u 
.
0
0
0
CALL
CALL
CALL
CALL
CALL
CALL
SSFITO
SSFITO
SSFITO
SSFFTO
SSFFTO
SSFFTO
IADR=ISFADR
NATOM(1,3) ,IADR+38 ,NT ) 
NATOM(1,4) ,IADR+48 ,NT ) 
NT ,IADR+58 ,1 )
XS1 ,IADR+59 ,NATOMS )
XS 2 ,IADR+109 ,NATOMS )
XS 3 ,IADR+159 ,NATOMS )
'ROTA')
CALL SSFFTO RADI , IADR ,1 )
CALL SSFITO NR ,IADR+1 ,NT )
IADR* ISFADR 'COOR' )
CALL SSFITO NRATOM ,IADR+150 ,500)
CALL SSFITO NATOMS ,IADR+6 50, 1 )
CALL SSFFTO RADI ,IADR+6 51, 1 )
IADR* ISFADR 'LSAR')
CALL SSFITO ICHEND , IADR ,2 )
IADR* ISFADR 'GLO')
CALL SSFFTO TDIST , IADR ,1
CALL SSFFTO TOL ,IADR+1 ,1
CALL SSFFTO DT ,IADR+2 ,8
CALL SSFITO NTP ,IADR+10 ,3
CALL SSFITO J1 ,IADR+13 ,15
CALL APWD
RUN GLOAP
CALL SSFRUN 
CALL APWR
GET NEW COORDS BACK FROM AP
I AD R*ISFADR( ' COOR' )
CALL SSFFFR(IADR ,XI
IADR=ISFADR('GLO')
CALL SSFFFR(IADR+28 ,A
CALL APWD
,150 )
,1 )
IF(A.EQ•1•) GOTO 105 
GO TO 10 
105 CALL BONDEX
IF(.NOT.IGEN) GO TO 10 
IF(NREST.L E .0) GO TO 106 
CALL CHECKT
IF(.NOT.IGEN) GO TO 10
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106 ICNF=ICNF+1
WRITE(7,9009)ICNF,(Jl(IN),IN=1,NTP)
WRITE(1,9010) (Jl(IN),IN=1,NTP)
DO 11 IA=1,NATOMS 
11 WRITE(1,9011) (NAMES(IA , IN) , IN= 1,3),(XI(IA,IN),IN=1,3)
10 CONTINUE
9009 FORMAT(110,5X,2011 )
9010 FORMAT(X,2011 )
9011 FORMAT(X,3A2,10X,3F15.5)
STOP
END
SUBROUTINE CHECKT
COMMON/ROTAT/NATOM(10,4) ,NR( 10),NRATOM(10,50) ,ISTART(16 ) 
COMMON/CONST/RADI,RAD2,RADI , NRING,NT ,NRI,NTP,N P ,NAV 
COMMON/CHECK/IGEN,EXCLUD( 10,15),NEXCLD,J 1 ( 1 5) , NBOND S ,
1 DMAX,HOMOP
COMMON/TCHECK/NREST,ITREST(3,4),TVAL(3) ,TTOL( 3)
COMMON/VARS/NATOMS,NAMES , X I , ICONN,ITYPES,TITLE,NTITLE 
COMMON/TAU S/TANGLE(9,2) ,TAU( 10) ,NGEN,ICHEND,JCHEND,TDI ST ,
1 TOL
LOGICAL IGEN,HOMOP 
LOGICAL*1 EXCLUD,TITLE(80)
DIMENSION NAMES(50,3),XI (50,3),ICONN(50,4) , ITYPES(50) ,
1 J1S(15)
IGEN=*.FALSE.
DO 10 1=1,NRE ST
CALL TCAL(ITREST(I,1) ,ITREST(I,2),ITREST( 1,3) ,ITREST(I,4), 
1 TA)
IF(ABS(ABS(TA)-TVAL(I)).LE.TTOL(I)) GO TO 10 
RETURN 
10 CONTINUE
IGEN=.TRUE.
-RETURN
END
SUBROUTINE CNTRLC(ICNF,NTP,J 1)
DIMENSION J 1(15 )
TYPE 1
1 FORMAT('1***ABORT REQUEST RECEIVED.')
TYPE 2,ICNF+1,(J1(I),1=1,NTP)
2 FORMAT(' RESTART INFORMATION:'/
+ ' NEXT CONFORMER TO BE GENERATED WOULD HAVE BEEN NO. ',16/
+ ' CURRENT GENERATOR SEQUENCE IS ',1511//)
CALL EXIT 
END
SUBROUTINE INVERS
COMMON/ROTAT/NATOM(10,4) ,NR(10),NRATOM(10,50)
COMMON/CONST/RAD 1,RAD2,RADI,NRING,NT ,NRI,NTP,N P ,NAV 
COMMON/CHECK/IGEN,EXCLUD( 10, 15),NEXCLD,J1(15),NBONDS,
1 DMAX,HOMOP
COMMON/VARS/NATOMS,NAMES , XI , ICONN,ITYPES,TITLE,NTITLE 
COMMON/TAUS/TANGLE(9,2) , TAU (10),NGEN,ICHEND,JCHEND,TD 1ST ,
1 TOL
LOGICAL IGEN
LOGICAL*1 EXCLUD,TITLE(80)
DIMENSION NAMES(50,3),XI(50,3),IC0NN(50,4) , ITYPES(50) 
IREM=MOD(NTP,2)
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NTP=NTP/2+1REM 
DO 10 1=1,NTP 2 
JTEM1=J1(I)
JTEM2=J1((NTP+1)-I)
IF(JTEM1.GT .JTEM2) GO TO 11
10 CONTINUE 
IGEN=.TRUE•
RETURN
11 IGEN=.FALSE.
RETURN
END
SUBROUTINE IMPOSS 
C THIS SUBROUTINE REMOVES CODE NUMBERS WHICH CONTAIN PARTIAL 
C GENERATOR SEQUENCES REPRESENTING TORSION ANGLE SEQUENCES 
C WHICH CANNOT POSSIBLY BE INCORPORATED IN THE CLOSED RING.
C THE PARTIAL SEQUENCES MAY CONTAIN UP TO FOURTEEN USER 
C SPECIFIED DIGITS.
LOGICAL IGEN
LOGICAL*1 IBUF(16),IEXCLD(15),EXCLUD
COMMON/CHECK/IGEN,EXCLUD(10 , 15),NEXCLD,J 1 ( 15),NBONDS, 
1 DMAX
COMMON/ROTAT/NATOM(10,4) ,NR(10),NRATOM(10,50)
COMMON/CONST/RADI,RAD2,RADI,NRING,NT ,NRI,N T P ,N P ,NAV 
C ENCODE THE INTEGERS COMPRISING THE CODE NUMBER INTO A 
C CHARACTER STRING.
ENCODE(NTP,1,IBUF) (J1(I) , 1=1,NTP)
I FORMAT(1511)
C TERMINATE CHARACTER STRING WITH A ZERO BYTE 
NTP1=NTP+1 
IBUF(NTP1)=0
C REMOVE ONE PARTIAL SEQUENCE AT A TIME FROM THE EXCLUSION 
C ARRAY AND USE THE LIBRARY ROUTINE INDEX TO CHECK IF THE 
C PARTIAL SEQUENCE APPEARS IN THE CODE NUMBER.
DO 10 1=1,NEXCLD 
DO 11 J=1,15
II IEXCLD(J)=EXCLUD(I,J)
CALL INDEX(IBUF,IEXCLD,,M)
IF(M.NE.O) GO TO 12
C IF M.NE.O GO TO 12 SO THAT WE CAN REMOVE CODE NUMBER 
IC = 0
C CLOCKWISE CHECKING ALL DONE REVERSE PARTIAL SEQUENCE 
C TO SEARCH IN AN ANTICLOCKWISE DIRECTION.
DO 20 J=1,15 
JREV=16-J
IF(EXCLUD(I ,JREV).E Q .0 ) GO TO 20 
IC=IC+1
IEXCLD(IC)=EXCLUD(I,JREV)
20 CONTINUE
C CHECK FOR ANTICLOCKWISE PARTIAL SEQUENCE 
DO 21 J=IC+1,15
21 IEXCLD(J )=0
CALL INDEX(IBUF,IEXCLD,,M)
IF(M.NE.O) GO TO 12 
10 CONTINUE
C PARTIAL SEQUENCE DOESN'T APPEAR ,PASS CODE NUMBER
2?9
IGEN=.TRUE.
GO TO 13
12 IGEN=.FALSE.
13 RETURN 
END
SUBROUTINE TCAL(J A ,J B ,J C ,J D ,WA)
DIMENSION AA(3,3),V 1(3),V2(3)
COMMON/ROTAT/NATOM(10,4) ,NR( 10),NRATOM(10,50)
COMMON/CONST/RADI,RAD 2 , RADI, NRING,N T ,NRI,NTP,N P ,NAV 
COMMON/CHECK/IGEN,EXCLUD( 10, 15),NEXCLD,Jl( 15),NBONDS,
1 DMAX
COMMON/VARS/NATOMS,NAMES , XI , ICONN,ITYPES,TITLE,NTITLE 
COMMON/TAUS/TANGLE(9,2) ,TAU(IO),NGEN,ICHEND,JCHEND,
1 TDIST,TOL 
LOGICAL IGEN
LOGICAL*1 EXCLUD,TITLE(80)
DIMENSION NAMES(50,3),X I (50 , 3 ) ,ICONN(50,4),ITYPES(50) , 
1 J1S(15)
R1=0.0 
R2=0.0 
COSW=0.0 
DO 401 1=1,3
AA( I,1)=XI(JA,I)-XI(JB,I)
AA( 1,2)=XI(J C ,I)-XI(JB,I)
401 AA(I,3)=XI( J C ,I)-XI(JD,I)
DO 402 J=1,3
JTEM=J 
K=MOD(JTEM,3)+l 
L=MOD(K,3)+l
VI(J )=AA( K , 1)* AA(L,2)-AA(L ,1)*AA(K,2)
V2(J )=AA(K,2)*AA(L,3)-AA(L ,2)*AA(K,3)
R1=R1+V1(J)**2
402 R2=R2+V2(J )**2 
R1=SQRT(R1)
R2=SQRT(R2)
DO 403 K=1 , 3
403 COSW=COSW+(Vl(K)/R1)*(V2(K)/R2)
COSW=ARGCHK(COSW)
WA=ACOS(COSW)*RADI
SIGN1=*AA( 1 , 1 ) * ( AA( 2,2) * AA( 3 , 3 )-AA( 2,3) * A A (  3,2)) -AA( 2,1)
1*(AA(1,2)*AA(3,3)-AA(1 ,3)*AA(3,2))+AA(3,1)*(AA(1,2)
2*AA(2,3)-AA(1,3)*AA(2,2))
WA=SIGN(WA,SIGN1)
RETURN
END
FUNCTION ARGCHK(X)
ARGCHK=SIGN( AMIN1(ABS(X),1.0),X)
RETURN
END
2 4 - 0
FUNCTION ACOS(X)
IF (ABS(X)-l.0000001) 5,5,6 
6 WRITE (7,10) X
10 FORMAT('OARGUMENT =',E15.6,' > 1 IN ARC COSINE')
CALL EXIT
5 IF (ABS(X).GT.1.) X=SIGN(1.,X)
IF(X) 3,4,3 
4 AC0S=1. 5707964
RETURN
3 ACOS=ATAN( SQRT(1.-X*X)/X)
IF(X)1,2,2
1 AC0S=AC0S+3.1415927
2 RETURN 
END
SUBROUTINE BONDEX !CHECKS A CONF. FOR THE NO OF BONDS 
COMMON/ROTAT/NATOM(10 , 4) ,NR(10),NRATOM(10,50)
COMMON/CONST/RAD 1,RAD 2,RAD I , N R ING,N T ,N R I ,N T P ,N P ,NAV 
COMMON/CHECK/IGEN,EXCLUD(10, 15),NEXCLD,J 1 ( 15),N B O N D S ,
1 DMAX
COMMON/VARS/NATOMS,NAMES ,X I , ICONN,ITYPES,T I T L E ,NTITLE 
COMMON/TAUS/T A N G L E (9,2) ,TAU(10),N G E N ,ICHEND,J C H E N D ,
1 TDIST,TOL 
LOGICAL IGEN
LOGICAL*1 E X C L U D ,T ITLE(80)
DIMENSION N A M E S (50,3),X I (50 , 3),ICONN(50,4),ITYPES(50) ,
1 J 1S ( 15 )
NBOND=0
DO 10 1=1,NATOMS 
DO 10 J=I,NATOMS 
IF(I.EQ.J) GO TO 10
DTEST=SQRT((X I (I ,1 )- X I (J ,1))**2+(XI(1 ,2)- X I (J ,2))**2 + 
1(XI(I,3)-XI(J,3))**2)
IF(DTEST.LE.DMAX) NBOND=NBOND+l 
10 CONTINUE
IGEN=.T R U E .
IF(NBOND.GT.NBONDS) IGEN=.FALSE.
RETURN
END
SUBROUTINE SETUP
COMMON/ROTAT/NATOM(10,4) , NR(10),NRATOM(10,50),I START(16 ) 
COMMON/CHECK/IGEN,EXC L U D ( 10,15),NEXCLD,J 1 ( 15) ,NBONDS ,
1 DMAX,HOMOP
COMMON/TCHECK/NREST,ITREST(3,4),TVAL(3),TTOL(3)
COMMON/CONST/RADI,R A D 2 ,RADI ,NRING,N T ,N R I ,N T P ,N P ,NAV 
COMMON/VARS/NATOMS,NAMES , XI , ICONN,ITYPES,T I T L E ,NTITLE 
COMMON/INPUT/INPLUN,LINNO, INBUF,INPNTR,NCHARS,ERROR,
1 EMPTY,ENDSEC
COMMON/TAUS/TANGLE(9,2) ,TAU(10),N G E N ,ICHEND,J C H E N D ,
1 TDIST,TOL
DIMENSION N A M E S (50,3) , X I (50, 3),ICONN(50,4),I TYPES(50) 
DIMENSION INDEXS(8)
LOGICAL*1 E X C L U D ,T I TLE(80) , INBUF(80),ANSWER,YES 
LOGICAL E R R O R ,E M P T Y ,E NDSEC,IGEN,HOMOP 
DATA YES /'Y ' /
C READ IN AND PRINT MESSAGE CONTAINED IN FILE 'GMINFO.DAT'
C WHICH SHOULD RESIDE ON THE SYSTEM DISK.THERE IS NO LIMIT 
C TO THE SIZE OF THIS FILE.
1
CALL ASSIGN(1,'GMINFO.DAT')
INPLUN=1 
LINENO=0 
INPNTR=0 
1 CALL NXLINE
IF(ENDSEC) GO TO 9
WRITE (7,3)(INBUF(I),I=1,NCHARS)
GO TO 1 
3 FORMAT(X,7 2A 1 )
9 CALL CLOSE ( 1 )
INPLUN=7
C ALL DONE WITH THE START-UP MESSAGE. LETS GET ON WITH IT. 
TYPE 9300
9300 FORMAT('$DOES THE FOLLOWING DATA REFER TO A
1 HOMOPOLYMER [Y/N] ')
READ(7,9402) ANSWER 
HOMOP=.FALSE.
IF(ANSWER.EQ.YES) HOMOP=.TRUE.
C GET THE NUMBER OF TORSION ANGLES 
403 TYPE 9403
9403 FORMAT('$NUMBER OF VARIABLE TORSION ANGLES [I] ? ')
CALL NXLINE 
CALL NUMBER(Q)
IF(ERROR) GO TO 403 
NT-IFIX(Q)
C FIND OUT WHETHER IT'S PAIRS OR SINGLES HE 'S AFTER.
TYPE 9401
9401 FORMAT('$TORSION ANGLES BY PAIRS [Y/N] ? ')
READ(7,9402) ANSWER
9402 FORMAT(A 1 )
C YES CHOOSES PAIRWISE TORSION ANGLES.
IF(ANSWER.EQ.YES) GO TO 410 
NP= 1
C MAKE SURE HE KNOWS WHAT HE HAS DONE.
TYPE 9410
9410 FORMAT('INDIVIDUAL TORSION ANGLES SELECTED .')
GO TO 411
410 NP=2
411 CONTINUE
C NOW FIND OUT IF THE BOND ANGLES ARE TO BE ALLOWED TO CHANGE 
C TO EFFECT RING CLOSURE (AS WELL AS TORSION ANGLES)
TYPE 9411
9411 FORMAT('$ARE THE BOND ANGLES TO REMAIN FIXED [Y/N]') 
READ(7,9402) ANSWER
IF(ANSWER.EQ.Y E S ) GO TO 420 
TYPE 9420
9420 FORMAT('BOND ANGLES WILL VARY DURING RING CLOSURE.')
NAV-2 
GO TO 421
420 NAV=» 1
421 CONTINUE
C READ IN NAMES AND COORDINATES OF THE RING ATOMS FROM FILE 
CALL GETFIL 
C READ IN TORSION ANGLE SPECIFIERS
2 4 2
N P 4 = N P * 4
NTP=NT/NP
DO 432 J = 1 ,NTP
430 TYPE 9430,NP
9430 FORMAT('$ENTER', 1 2 TORSION ANGLE[S ](ATOM LABELS)')
CALL NXLINE
CALL ATNAMS(N P 4,I N D E X S ,NATOMS,NAMES)
DO 431 1=1,NP4
.IF(INDEXS(I).LE.O) GO TO 8430 
IF(NP. E Q .2) GO TO 433 
NATOM(J,I)=INDEXS(I)
GO TO 431 
433 J2=J*2
J21=J2-1
IF(I .L E .4) NATOM(J 21 , 1 )=INDEXS(I )
IF(I.G T .4) NATOM(J 2,1-4) = INDEXS(I )
431 CONTINUE 
GO TO 432
8430 TYPE 9843
9843 FORMAT('ILLEGAL NAME IN TORSION SPECIFIER.TRY AGAIN.')
GO TO 430
432 CONTINUE
C SO NOW WE KNOW WHICH TORSION ANGLES ARE VARYING. WE NOW NEED 
C TO KNOW WHICH ATOMS TO ROTATE WHEN CHANGING THE TORSION 
C ANGLES.THIS CAN BE DECODED FROM THE CONNECTIVITY (IN ICONN)
C I.E. WE NEED TO KNOW WHO IS CONNECTED TO (BY WHATEVER ROUTE) 
C TO ATOM 3 ON THE SIDE AWAY FROM ATOM 2. (OBVIOUSLY 3 & 4 ARE 
THE FIRST TWO). (WHERE 1,2,3 & 4 REFER TO THE T.A. SPECIFIERS) 
DO 440 1=1,NT 
NR(I) = 2
NRATOM(1,1)=NATOM(1,3)
NRATOM(1,2) = NATOM(I , 4)
DO 441 INR= 3,50 
ICl=NRATOM(I,I N R-2)
IC2=NRATOM(I,INR-1)
NRI=NR(I)
DO 442 J = 1,4 
IC3=ICONN(IC2,J)
IF(IC3•E Q •0) GO TO 442 
IF(IC3.E Q .I C 1) GO TO 442 
NRATOM(I,INR)=IC3 
NR(I)=NR(I)+l 
442 CONTINUE
IF(NR(I).EQ.NRI) GO TO 440 
441 CONTINUE
440 CONTINUE
C GET NUMBER OF GENERATORS AND THEN THE GENERATORS THEMSELVES. 
INPLUN=7
500 TYPE 9500
9500 F0RMAT('$ENTER NUMBER OF GENERATORS [I] ')
CALL NXLINE 
CALL NUMBER(Q)
IF (ERROR) GO TO 500 
NGEN=IFIX(Q)
GO TO (501,502) NP
501 TYPE 9501
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9501 FORMAT(' ENTER A GENERATOR (IN DEGREES) [F] ')
GO TO 503
502 TYPE 9502
9502 FORMAT('ENTER A GENERATOR(BY PAIRS,IN DEGREES)[F ]' )
503 DO 504 I =1,NGEN
5032 TYPE 9503
9503 FORMAT('$>')
. CALL NXLINE
CALL NUMBER(T ANGLE(1,1))
IF(ERROR) GO TO 5031 
IF(NP.EQ.l) GO TO 504 
CALL NUMBER(TANGLE(1,2))
IF(ERROR) GO TO 5031 
GO TO 504 
5031 TYPE 9531
9531 FORMAT(' ***FORMAT ERROR. RETYPE GENERATOR.')
GO TO 5032
504 CONTINUE
C GET NUMBER OF EXCLUSION STRINGS I.E. THOSE PARTIAL 
C GENERATOR COMBINATIONS WHICH RESULT IN IMMEDIATE 
CONFORMER DISQUALIFICATION AND THEN THE STRINGS THEMSELVES.
600 TYPE 9600
9600 FORMAT('$ENTER NUMBER OF EXCLUSION STRINGS(MAXI 0)[I ]')
CALL NXLINE
CALL NUMBER(Q)
IF(ERROR) GO TO 600 
NEXCLD=IFIX(Q)
IF(NEXCLD.EQ.O) GO TO 700 
IF(NEXCLD.GT.10) NEXCLD=10 
C ZERO EXCLUSION ARRAY.
DO 601 1=1,10 
DO 601 J = 1 ,15
601 EXCLUD(I,J)=0 
TYPE 9601
9601 FORMAT(' ENTER EXCLUSION STRINGS (MAX 14 INTEGERS)')
DO 602 1=1,NEXCLD
TYPE 9503
READ(10,9602) J ,(E X C L U D (I,K),K=1,J)
9602 FORMAT(Q,14A1)
602 CONTINUE
C READ IN TARGET DISTANCE AND DECODE CHAIN END ATOMS.
700 TYPE 9700
9700 FORMAT('$ENTER TARGET END-TO-END DIST AND MAX 
+ DEVIATION THEREFROM [F] ')
CALL NXLINE
CALL NUMBER(TDIST)
IF(ERROR) GO TO 700 
CALL NUMBER(TOL)
IF(ERROR) GO TO 700 
IC1=0
DO 701 1=1,NATOMS 
IC-0
DO 702 J = 1 ,4
IF(ICONN(I,J).GT.O) IC=IC+1 
702 CONTINUE
IF(IC.G T .2) GO TO 999
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IF(IC.NE.l) GO TO 701 
IC1-IC1+1
IF(IC1.E Q .2) GO TO 703
ICHEND=I
GO TO 701
703 JCHEND=I 
GO TO 704
701 CONTINUE
704 CONTINUE
800 TYPE 9800
9800 FORMAT('$ENTER SHORTEST TOLERABLE NON-BONDED
+ DISTANCE [F] ')
CALL NXLINE 
CALL NUMBER(DMAX)
IF(ERROR) GO TO 800
801 TYPE 9801
9801 FORMAT('$ENTER MAXIMUM PERMISSABLE NUMBER OF
+ SUCH CONTACTS [I ] ' )
CALL NXLINE 
CALL NUMBER(Q)
IF(ERROR) GO TO 801 
NBONDS=IFIX(Q)+NATOMS 
C FIND OUT IF HE WANTS ANY RESTRICTIONS ON THE GEOMETRY 
C OF THE RING JUNCTION. (IN TERMS OF T.A.'S ONLY).
850 TYPE 9850
9850 FORMAT( ' $DO YOU WANT TO RESTRICT THE DEPENDENT 
+ TORSION ANGLES [Y/N] ')
READ(7,9402) ANSWER 
NREST=0
IF(ANSWER.NE.YES) GO TO 900
HE WANTS SOME RESTRICTIONS - SO....
851 TYPE 9851
9851 FORMAT ( ' $ ENTER THE NUMBER OF DEPENDENT T . A . " S  
+ TO BE RESTRICTED [I] ')
CALL NXLINE 
CALL NUMBER(Q)
IF(ERROR) GO TO 851 
NREST-IFIX(Q)
c******t h e r e  c a n  o n l y  b e t h r e e  s o j u s t  MAKE SURE. 
IF(NREST.L E .3) GO TO 855 
TYPE 9853
9853 FORMAT(' YOU HAVE SPECIFIED TOO MANY RESTRICTED
+ T .A. "  S. ' )
GO TO 851
855 DO 858 ITR=1,NREST 
8551 TYPE 9855
9855 FORMAT('$ENTER DEPENDENT T.A., DESIRED VALUE &
+ TOLERANCE ')
CALL NXLINE
CALL ATNAMS(4,IND E X S ,N ATOMS,NAMES)
DO 856 1-1,4
IF(INDEXS(I).LE.0) GO TO 857
856 ITREST ( ITR, I)=*INDEXS( I)
CALL NUMBER(T V A L (I T R ))
IF(ERROR) GO TO 857
2 4 5
CALL NUMBER(TTOL(ITR))
IF(.NOT.ERROR) GO TO 858
857 TYPE 9857
9857 FORMAT(' ***FORMAT ERROR. TRY AGAIN. ')
GO TO 8551
858 CONTINUE
C NOW THAT WE KNOW EXACTLY WHAT HE WANTS TO DO FIND OUT
C WHERE TO START IT ALL FROM.
900 TYPE 9900
9900 FORMAT('$ENTER STARTING CONFORMER NUMBER [I] ')
CALL NXLINE j
CALL NUMBER(Q) !
IF(ERROR) GO TO 900 |
ISTART(16)=IFIX(Q)-1 J
TYPE 9 901
9901 FORMAT( ' $ENTER STARTING GENERATOR STRING [I] ') |i
READ(7,9902)(ISTART(I ),1=1,NTP)
9902 FORMAT(1511) 1
DO 9001 1=(N T P + 1 ),15 f
9001 I START (I)=*NGEN |
RETURN ip
999 TYPE 9999 |
9999 FORMAT ( 'YOU HAVE INPUT A BRANCHED CHAIN!7) Ij
CALL EXIT |!|
END
C
c * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
C !
C I
SUBROUTINE GETFIL ;
C
C OPENS A CRYSTAL FILE, RETURNS THE ATOM NAMES, ORTHO COORDS,
C CONNECTIVITY, AND TYPES. THEN CLOSES THE FILE.
C
C NOTE: THIS MUST BE LINKED WITH SYSLIB BECAUSE OF THE CALL CLOSE 
C j
COMMON/VARS/NATOMS,NAMES,X,Y,Z,ICONN,ITYPES, TITLE,NTITLE 
COMMON / INPUT / INPLUN ,LINNO ,INPBUF, INPNTR, NCHARS , ERROR, EMPTi | 
1 ENDSEC i
DIMENSION N A MES(5 0 , 3 ) ,X(50),Y(50),Z(50),ICONN(50,4), |
+ ITYPES(50)
LOGICAL*1 TITLE(80) , INPBUF(80)
LOGICAL ERROR,EMPTY,ENDSEC 
LOGICAL E X I S T S ,GOTITL 
DATA LUNTTY/7/
C
C CHOOSE A CHANNEL FOR INPUT !|
LUN=11
c ;--|j
C PROMPT FOR NAME OF FILE |! jji
INPLUN=LUNTTY fj
1 TYPE 9000 |i !
9000 FORMAT ( ' $NAME OF INPUT FILE :') M;;
C
C READ REPLY TO INPBUF, SEE IF FILE EXISTS
23 CALL GFILN(EXISTS)
IF(EMPTY) RETURN !BLANK LINE MEANS EXIT
IF(EXISTS) GOTO 7 j
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C
C MESSAGE IF FILE DOSN'EXIST 
TYPE 9007
9007 F0RMAT( '+*** FILE D 0 S N " T  EXIST' )
GOTO 1 !GO PROMPT AGAIN
OPEN THE FILE, SWITCH INPUT FROM TTY TO FILE 
7 CALL ASSIGN(LUN,INPBUF,NCHARS)
INPLUN-LUN 
LINENO-O 
GOTITL-.FALSE.
TITLE(1)=0
PRINT TITLE IN COLUMN 1
CALL POSN('TITL') !FIND LINE BEGINNING WITH TITLE
IF(ERROR) GOTO 100 !NO SUCH LINE IN FILE
2 TYPE 9010, (INPBUF(I),1=1,NCHARS)
9010 FORMAT(X ,8 0A 1)
CALL NXLINE !PRINT ALL LINES UNTIL 1
IF(ENDSEC) GOTO 3 !FOUND ONE BEGINNING WITH **
IF(GOTITL) GOTO 2 
DO 6 .1-1 , NCHARS 
6 TITLE(I) -INP B U F (I ) !SAVE FIRST LINE OF TITLE
NTITLE-NCHARS
IF(NTITLE.G T .7 2) NTITLE-72 
TITLE(NTITLE+1)=0 
GOTITL-.T R U E .
GOTO 2
PRINT COMMENTS
3 CALL POSN('COMM') !FIND LINE BEGINNING WITH COMM
IF(ERROR) GOTO 10 !NO SUCH LINE IN FILE
5 TYPE 9010, (INPBUF(I),1-1,NCHARS)
CALL NXLINE !PRINT ALL LINES UNTIL
IF(.NOT.ENDSEC) GOTO 5 !FOUND ONE BEGINNING WITH **
0 CONTINUE
GET ATOM NAMES AND ORTHOGONAL COORDINATES 
CALL COORDS(N A T O M S ,N A M E S ,X , Y ,Z )
IF(ERROR) GOTO 130 ! NO LINE BEGINNING WITH COOR
GET CONNECTIVITY 
30 CALL CONECT(NATOMS,N A M E S ,ICONN)
IF(ERROR) TYPE 9030 !NO LINE BEGINNING WITH CONN
9030 FORMAT(' *** NO CONNECTIVITY SECTION IN FILE')
CHECK CONNECTIVITY 
TYPE 9040
9040 FORMAT ( ' NOW I " M  CHECKING FOR IRREGULARITIES')
CALL OKCONN(NATOMS,NAMES, X,Y,Z,ICONN,ITYPES)
GET TYPES
CALL GTYPES(NATOMS,N A M E S ,ITYPES)
IF(ERROR) TYPE 9060 ! NO LINE BEGINNING WITH ATOM
9060 FORMAT(' *** NO ATOM TYPES SECTION IN FILE')
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C CLOSE THE FILE AND RELEASE THE UNIT
99 CALL CLOSE(INPLUN)
C
C THATS ALL FOLKS
EMPTY*•FALSE .
RETURN
NO TITLE: PRESUME ,NOT A CRYSTAL FILE. ASK FOR ANOTHER
100 TYPE 9100
9100 FORMAT('NO TITLE. NOT AN ACCEPTABLE FILE')
99 CALL CL0SE(INPLUN)
GOTO 1 !GO TRY AGAIN
NO COORDINATES 
130 TYPE 9130
9130 FORMAT(' *** NO COORDINATES SECTION IN FILE') 
GOTO 999 
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SUBROUTINE COORDS(N ,N A M E S ,X ,Y ,Z )
READS IN THE ATOM NAMES AND FRACTIONAL COORDINATES.
THE COORDS ARE THEN ORTHONORMALISED (USING TMAT)
AND RETURNED IN X,Y,Z
N RETURNS THE NUMBER OF ATOMS READ IN
NAMES(I ,J ) J= 1 , 3 RETURNS THE NAME OF ATOM I IN 3A2
FORMAT PADDED WITH NULLS 
X(I),Y(I),Z(I) RETURN THE ORTHONORMAL COORDS OF ATOM I
MAXN MAXIMUM NUMBER OF ATOMS ALLWED IN
SET THIS TO THE DIMENSION OF X,Y,Z,NAMES ARRAYS
LOGICAL*1 INPBUF(80)
LOGICAL*1 OPBRAK
LOGICAL AGAIN,NEWPIC , HYDRO , BALLS,INTENS,LABEL,INVTED
LOGICAL ERROR,EMPTY,ENDSEC,CHARG
DIMENSION N A M E S ( 5 0 ,3),X(50),Y(50),Z(50),C(3)
COMMON /INPUT/INPLUN ,LINENO, INPBUF , INPNTR, NCHARS , ERROR , 
+ EMPTY,ENDSEC
DATA OPBRAK/'( ' /
DATA MAXN/50/
DATA ITAG/20/
DATA AGAIN,NEWPIC,H Y D R O ,BALLS,INTENS,LABEL,
+ INVTED/F,T,T,F,T,T,F/
DATA ISTAGE,CHARG /1,F /
POSTION FILE AT COORDINATES SECTION 
CALL POSN('COOR')
IF(ERROR) RETURN
GET EACH ATOM NAME AND COORDS 
N=0
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C — READ IN NEXT LINE—
10 CALL NXLINE
IF(ENDSEC) GOTO 30 !END OF LIST
IF(N.GE. M A X N ) GOTO 80 ! TOO MANY ATOMS
N=N+1
C — GET NAME —
CALL GETNAM( N A M E S (N , 1 ), NAMES(N ,2),NAMES(N ,3) )
IF(ERROR) GOTO 90 
C —  REPORT IF ALREADY GOT THAT NAME —
CALL NAMNUM(N-1,NAMES , NAME S (N , 1),NAMES(N,2 ) ,NAMES(N,3) , 
+ INDEX)
IF(INDEX.GT.0) TYPE 9010, (NAMES(N,I),1=1,3 )
9010 FORMAT(' ATOM NAME , ,3A2,/ IS USED MORE THAN ONCE')
C — READ FRACTIONAL COORDINATES INTO C(1),C (2),C (3)—
DO 20 1=1,3 
CALL NUMBER(C (I ))
IF(ERROR) GOTO 90
IF(INPBUF(INPNTR).EQ.OPBRAK) CALL NUMBER(SIGMA) 
IF(ERROR) GOTO 90 
20 CONTINUE
X(N) = C(1 )
Y(N)=C(2)
Z(N)=C(3)
GOTO 10 ’LOOP FOR NEXT ATOM
30 IF(N.EQ.O) E R R O R * .T R U E . !ERROR IF NO ATOMS
RETURN
TOO MANY ATOMS 
80 TYPE 9080, MAXN
9080 FORMAT(' ****TOO MANY ATOMS, ONLY FIRST',14,
1 ' HAVE BEEN ACCEPTED')
RETURN
ERROR
90 TYPE 9000, ( INPBUF(I ),1 = 1,NCHARS)
9000 FORMAT('FORMAT ERROR IN COORDINATE SECTION'/ X ,80 A 1 )
GOTO 10
END ! OF SUBROUTINE COORDS
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SUBROUTINE CONECT(N A T O M S ,NAMES,ICONN)
C
C READS IN THE CONNECTIVITY FILE AND SETS UP THE 
C CONNECTIVITY MATRIX 
C
C NATOMS NUMBER OF ENTRIES IN NAMES
C NAMES(I ,J ) J=l,3 GIVES THE NAME OF ATOM I IN 3A2
C FORMAT PADDED WITH NULLS
C ICONN(I ,J) J=l,4 GIVES INDICIES OF ATOMS BONDED TO
C ATOM I (L IMIT=4)
C ERROR SET .TRUE. IF KEYWORD CONN (ECTIVITY) IS MISSING 
C FROM INPUT FILE
C FORMAT ERRORS IN THE FILE DO NOT SET ERROR BUT THEY DO 
C CAUSE A MESSAGE TO BE PRINTED ON THE TTY.
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LOGICAL*1 INPBUF(80 )
LOGICAL ERROR,EMPTY,ENDSEC
DIMENSION NAME S (50,3 ) , IC0NN(50,4), INDEXS(6)
COMMON/ INPUT / INPLUN , LINENO , INPBUF , INPNTR, NCHARS , ERROR , 
1 EMPTY,ENDSEC
ZERO THE CONNECTIVITY ARRAY 
DO 1 1=1,NATOMS 
DO 1 J = 1 ,4 
1 ICONN(I ,J ) = 0
POSITION INPUT FILE AT CONNECTIVIY 
CALL POS N ('CONN')
IF(ERROR) RETURN
READ NEXT NON-BLANK LINE INTO INPUT BUFFER 
10 CALL NXLINE
IF(ENDSEC) GOTO 30 ! END OF CONNECTIVITY LIST
IF(NCHARS.E Q .0) GOTO 10 !IGNORE BLANK LINES
GET INDICIES FOR THE ATOM NAMES.
CALL ATNAMS(5,IND E X S ,N ATOMS,NAMES)
IF(ERROR) GOTO 90 
I=INDEXS(1)
FILL IN CONNECTIVITY MATRIX 
DO 20 J = 2 ,5 
20 ICONN(I,J-1)=INDEXS(J)
GOTO 10 !LQOP FOR NEXT LINE
FOUND END OF SECTION 
30 ERROR=.FALSE.
RETURN
FOUND AN ERROR 
90 TYPE 9000, ( INPBUF(I ) ,1 = 1,NCHARS)
9000 FORMAT('FORMAT ERROR IN CONNECTIVITY SECTION'/X,80A1 )
GOTO 10 !LOOP FOR NEXT LINE
END I OF SUBROUTINE CONECT
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SUBROUTINE GTYPES(N A T O M S ,NAMES,ITYPES)
RETURNS THE ATOM TYPES
NATOMS 
NAMES(I,J)
ITYPES(I)
NUMBER OF ENTRIES IN NAMES 
J=l,3 GIVES THE NAME OF ATOM I IN 3A2 
FORMAT PADDED WITH NULLS 
RETURNS THE TYPE CODE OF ATOM I
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ERROR SET .TRUE. IF KEYWORD "TYPE" IS MISSING
FORMAT ERRORS IN THE FILE DO NOT SET ERROR BUT THEY 
DO CAUSE A MESSAGE TO BE PRINTED ON THE TTY.
LOGICAL*! INP B U F (80)
LOGICAL E R R O R , E M P T Y ,ENDSEC 
DIMENSION N A M E S (50,3) ,ITYPES(50)
COMMON/INPUT/INPLUN,LINEN0 , INPBUF,INPNTR, N C H A R S ,ERROR, 
1 EMPTY,ENDSEC
ZERO THE ITYPES ARRAY 
DO 1 1=1,NATOMS 
1 ITYPES(I)= 0
POSITION THE INPUT FILE AT THE KEY WORD 'ATOM'
CALL POSN('ATOM' )
IF(ERROR) RETURN ! NOT THERE: ERROR RETURN
READ NEXT NON-BLANK LINE INTO THE INPUT BUFFER 
10 ERROR®.F ALSE.
ENDSEC=•T R U E .
CALL NXLINE 
IF(ENDSEC) RETURN !END OF LIST: NORMAL RETURN
IF(NCHARS.E Q .0) GOTO 10 !IGNORE BLANK LINES
GET TYPE
CALL NUMBER(TYPE )
IT=IFIX(TYPE)
IF(ERROR) GOTO 90
GET LIST OF NAMES, FILL IN ITYPES ARRAY 
—  GET NEXT NAME —
20 CALL GETNAM(NAM1,N A M 2,NAM3)
IF(EMPTY.AND.INPNTR.GE.NCHARS) GOTO 10 
IF(ERROR) GOTO 90 
C —  GET INDEX ASSOCIATED WITH NAME —
CALL NAMNUM( NATOMS , NAME S , NAM1, NAM2 , NAM3 , INDEX) 
IF(INDEX.L E .0) GOTO 90 
C —  FILL IN ITYPES ARRAY —
ITYPES(INDEX)=IT
GOTO 20 !LOOP FOR NEXT NAME
C FOUND A FORMAT ERROR 
90 TYPE 9000, ( INPBUF(I ),1=1,NCHARS)
9000 FORMAT('FORMAT ERROR IN TYPES SECTION'/ X ,80A1)
GOTO 10 !L00P FOR NEXT LINE
END !OF SUBROUTINE GTYPES
C******************************************
c
SUBROUTINE OKCONN(NATOMS , NAMES,X ,Y ,Z ,ICONN,I T Y P E S )
C
C CHECKS THE CONNECTIVITY MATRIX (ICONN) FOR THE FOLLOWING: 
C IF ATOM I IS CONNECTED TO J,
C IF NOT IF ATOM I IS CONNECTED 
C REPORT IF NOT IF DISTANCE I,J 
C REPORT IF NOT D .S .RICHARDSON 
C COLLEGE LONDON 12/75
2 5 1
IS J CONNECTED TO I. REPORT 
TO J, IS DISTANCE I,J < 1.8 
< 1.8, IS I CONNECTED TO J 
CHEMISTRY DEPT., UNIVERSITY
C NATOMS NUMBER OF ATOMS
C NAMES(I ,J ) J = 1 , 3 NAME OF ATOM I IN 3A2 FORMAT
C X(I),Y(I),Z(I) ORTHONORMAL COORDINATES OF ATOM I
C ICONN(I ,J) J-1,4 UP TO 4 ATOMS CONNECTED TO ATOM I
DIMENSION X ( 5 0 ) ,Y (5 0 ) ,Z(50),NAMES(50,3) , ICONN ( 50,4) 
DIMENSION ITYPES(50)
DATA DI S M A X ,H HMIN/1.8 , 1 . 3/
DO 30 1=1,NATOMS 
DO 10 K= 1 , 4 
C FIND CONNECTED ATOMS I,J 
J=ICONN(I ,K)
IF(J.EQ.O) GOTO 10 
C SEE IF TOO FAR APART
DISTIJ = SQRT( (X( I)-X( J) )**2 + (Y(I)-Y( J) )**2+(Z(I)- 
+ Z(J))**2)
IF(DISTIJ.GT.DISMAX) TYPE 9005,
1 (NAMES(I ,L ) , L = 1 ,3) ,(NAMES(J,L),L = 1, 3) ,DISTIJ 
9005 FORMAT(' BONDED ATOMS ',3A2,',',3A2 , ' SEPARATED BY',
1 F7.2)
C SEE IF J IS CONNECTED TO I 
DO 5 L = 1,4 
M=ICONN(J ,L )
IF(M.EQ.O) GOTO 9 !NOT CONNECTED
IF(M.EQ.I) GOTO 10 !ARE CONNECTED
5 CONTINUE
9 TYPE 9009 , (N A M E S (I ,L ) , L = 1 , 3),(NAMES(J ,L ),L = 1,3)
9009 FORMAT(' INCONSISTENT CONNECTIVITY FOR ',3 A 2 ,' ,' ,3A2 )
10 CONTINUE
C CHECK DISTANCE BETWEEN I AND ALL OTHER ATOMS 
IF(I.EQ.NATOMS) RETURN 
IP1=I+1
DO 30 J=IP1,NATOMS
DISTIJ = SQRT((X(I)-X(J) ) **2 + (Y(I)-Y(J))**2+( Z ( I )- 
1 Z(J))**2)
IF(DISTIJ.GT.DISMAX) GOTO 30 
DO 25 K-1,4
IF(ICONN(I,K).EQ.J) GOTO 30 
25 CONTINUE
C REPORT IF LESS THAN DISMAX AND YET NOT CONNECTED 
IF(ITYPE S(I).NE.15)GOTO 27 
IF(ITYPES(J).NE.15)GOTO 27 
C UNLESS I AND J ARE BOTH HYDROGENS CONNECTED TO THE SAME 
C ATOM THEN ONLY REPORT IF LESS THAN HHMIN
IF(ICONN(I,l).EQ.ICONN(J,l).AND.DISTIJ.GT.HHMIN) GOTO 30 
27 TYPE 9025 , (NAMES(I ,L ),L= 1 ,3),(NAMES(J , L) , L = 1,3) ,DISTIJ
9025 FORMAT(' NB ATOMS ',3A 2 ,',',3A2,' SEPARATED BY',F7.2)
30 CONTINUE
RETURN 
END
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SUBROUTINE GFILN( EXI STS)
C
C USES NXLINE TO INPUT A FILE NAME. IF THE NAME LOOKS 
C LEGAL THEN THIS ROUTINE CHECKS TO SEE IF SUCH A FILE 
C ALREADY EXISTS AND SETS EXISTS ACCORDINGLY. IF THE 
C NAME LOOKS WRONG THE USER IS ASKED TO TRY AGAIN.
C
C EXISTS 
C 
C
C (PASSED 
C INPBUF 
C NCHARS 
C EMPTY 
C ERROR 
C 
C 
C
LOGICAL*1 INP BU F (80)
LOGICAL ER R O R , E M P T Y ,ENDSEC 
LOGICAL EXISTS
COMMON / INPUT / INPLUN , LINENO , INPBUF , INPNTR, NCHARS , ERROR , 
1 EMPTY,ENDSEC 
LOGICAL ERR 
INTEGER DEVBLK(4)
READ LINE INTO INPUT BUFFER 
10 CALL NXLINE
IF(NCHARS.E Q .0) GOTO 40 !BLANK LINE
1 EMPTY*.FALSE.
MARK END OF LINE WITH ZERO AS REQUIRED BY ROUTINE FILR50 
INPBUF(NCHARS+1)=0
CONVERT FILE NAME INTO STANDARD RAD 50 FILE DESCRIPTOR BLOCK 
CALL FILR50(INPBUF,DEVBLK,ERR)
IF(ERR) GOTO 20
GET A FREE RTli CHANNEL, MARK IT IN USE TO FORTRAN 
LUN=IGETC()
IF(LUN.LT.O) GOTO 50
BE SURE THE SPECIFIED DEVICE HANDLER IS .FETCH'D 
IF(IFETCH(DEVBLK(1)).N E .0) GOTO 20 
IF(DEVBLK(2).E Q .0) GOTO 15
TRY TO OPEN THE FILE WITH A .LOOKUP
IF(LOOKUP(L U N ,D E V B L K ) .L E .0) GOTO 30
.LOOKUP WAS SUCCESFUL. CLOSE THE FILE, RELEASE THE CHANNEL 
CALL CLOSEC(LUN)
CALL IFREEC(L U N )
EXISTS*.TRUE.
SET .TRUE. IF THE FILE EXISTS
SET .FALSE. IF THE FILE DOSN'T EXIST
THROUGH COMMON)
TEXT STRING CONTAINING THE FILE NAME 
NUMBER OF CHARACTERS IN INPBUF 
SET .TRUE. IF THE USER INPUTS A BLANK LINE 
SET .TRUE. IF NO CHANNELS ARE AVAILABLE, OR 
IF A BLANK LINE IS INPUT
253
a
o 
o
o
o
o
n
n
o
o
o
n
o
n
o
o
 
o
o
o
 
o
o
 
o
o
15 ERROR®.F A L S E .
RETURN 
C FORMAT ERROR 
20 TYPE 9020
9020 FORMAT('$TRY AGAIN PLEASE:')
GOTO 10 
C FILE NOT FOUND 
30 EXISTS®.FALSE .
GOTO 15
BLANK LINE 
40 EMPTY®.TRUE.
GOTO 55
NO FREE CHANNELS 
50 TYPE 9050
9050 F0RMAT('+*** NO FREE CHANNELS')
5 5 ERROR®.TRUE.
EXISTS®.FALSE.
RETURN
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SUBROUTINE FILR50(F I L N A M ,DEVBLK,ERROR)
CONVERTS AN RT11 FILE NAME (TEXT STRING)NAME INTO 
A STANDARD FORMAT 4 WORD RAD 50 FILE DESCRIPTOR BLOCK 
FILNAM TEXT STRING CONTAINING THE FILE NAME
TERMINATED WITH A NULL (ZERO) BYTE. 
DEVBLK 4 WORD ARRAY WHICH RETURNS THE REQUIRED
RAD 50 FILE DESCRIPTOR BLOCK 
ERROR SET .TRUE. IF THE TEXT STRING CONTAINS A
FORMAT ERROR 
DEFAULT DEVICE IS GIVEN IN DEFDEV 
DEFAULT EXTENSION IS GIVEN IN DEFEXT 
DEFAULT NAME IS GIVEN IN DEFNAM
LOGICAL*1 FILNAM(81), COLN, BLANK, DOT 
LOGICAL LEAD, ERROR
INTEGER DEVBLK(4), DEFDEV, DEFEXT, DEFNAM(2) 
DATA BLANK,COLN,DOT/'
DATA DEFDEV/3RDK /
DATA DEFEXT/3RDA T /
DATA DEFNAM/2*0/
ZERO THE FILE DESCRIPTOR BLOCK 
DO 5 1=1,4 
5 DEVBLK(I)=0
C
C FIND POSITION OF FIRST NON-BLANK CHARACTER, POSN OF 
C COLN, POSN OF DOT, AND NUMBER OF CHARACTERS 
LEAD®.TRUE.
ICOLN=0
ID0T=0
N=0
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C —  GET NEXT CHARACTER —
9 IBLANK=N
10 IF(N .E Q .80) GOTO 20 
IF(FILNAM(N+1) .EQ.0) GOTO 20 
N=N+1
IF(LEAD.AND.FILNAM(N).EQ.BLANK) GOTO 9 
LEAD=.FALSE.
IF(FILNAM(N).EQ.COLN) ICOLN=N !FOUND :
IF(FILNAM(N).EQ.DOT) IDOT=N !FOUND .
GOTO 10 
C DEVICE SECTION 
20 IF(LEAD) GOTO 90 !BLANK LINE
IF(ICOLN.E Q .0 ) GOTO 25 !USE DEFAULT
NDEV=ICOLN-IBLANK-1 
IF(NDEV.LE.O.OR.NDEV.GT.3) GOTO 90 
C —  CONVERT TO RAD 50, PUT INTO DEVBLK(l),
1 GOTO 90 IF ERROR —
IF(NDEV.NE.IRAD5 0(N D E V ,FILNAM(IBLANK+1) ,
1 DEVBLK(l))) GOTO 90
GOTO 30 
C USE DEFAULT DEVICE 
25 DEVBLK(1)=DEFDEV
ICOLN=IBLANK 
C EXTENSION SECTION 
30 IF(IDOT.EQ.O) GOTO 35
NEXT=N-IDOT 
IF(NEXT.LE . 0) GOTO 90 
IF(NEXT.G T .3) NEXT=3 
C —  CONVERT TO RAD 50, PUT INTO DEVBLK( 4) ,
1 GOTO 90 IF ERROR —
IF(NEXT. NE . IRAD50(N E X T ,FILNAM(IDOT+l) , DEVBLK( 4))) 
1 GOTO 90
GOTO 40 
C USE DEFAULT EXTENSION 
35 DEVBLK(4)=DEFEXT
ID0T=N+1 
C FILE NAME 
40 NUM=IDOT-ICOLN-1
IF(NUM.EQ.0) GOTO 45 
IF(NUM.LT.0.O R .N U M .G T .6) GOTO 90 
C —  CONVERT TO RAD 50, PUT INTO DEVBLK(2&3),
1 GOTO 90 IF ERROR —
IF(NUM.NE.IRAD 50(N U M ,FILNAM(ICOLN+1),DEVBLK(2)))
1 GOTO 90
44 ERROR=.FALSE.
RETURN
C USE DEFAULT NAME
45 DEVBLK(2)=DEFNAM(1)
DEVBLK(3)=DEFNAM(2)
GOTO 44
C FOUND AN ERROR 
90 ERROR*.T R U E .
DO 95 1=1,4 
95 DEVBLK(I)=0
RETURN 
END
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PROGRAM GLOAP
COMMON /TRANS/ T A N G L E (9,2),NATOM(10,4) , NT , XS ( 50,3)
COMMON /ROTA/ RAD1,NR(10)
COMMON /COOR/ X I (50,3 ) , NRATOM( 10,50),N ATOMS,RADI 
COMMON /LSAR/ I C H E N D ,JCHEND
COMMON /GLO/ T D I S T ,TOL ,D T (8),N T P ,N P ,N A V ,J 1 (15),A 
DIMENSION D E L T A U (2),T A U (10)
DO 8 1=1,NATOMS 
DO 8 J = 1 ,3 
XI(I,J ) =XS(I ,J )
8 CONTINUE
DO 9 1=1,NTP 
DO 9 J = 1,NP 
IJ=I
IF(N P •E Q •2) IJ = 2 * ( I - 1)+J 
TAU(IJ)=TAN G L E (J 1(I ),J)
9 CONTINUE
C
A=0.
DO 100 1=1,NT 
ITEM=I
CALL CFRAME(ITEM)
CALL TCAL( NATOM( 1,1) , NAT0M( 1 , 2 ) , NATOM( 1,3) ,NAT0M(I,4) ,WA) 
CALL ROT(ITEM,-WA,0)
CALL ROT(ITEM,TAU(I ) ,0)
100 CONTINUE
C
CALL L S Q C A L(ICHEND,JCHEND,DIST2)
DIST=SQRT(DIST2)
IF(ABS(TDIST-DIST).LE.TOL) GOTO 105 
DO 101 1=1,8 
DELTAU(1)=DT(I)
DELTAU(2)=-DT(I) •
DO 101 L = 1,NAV 
DO 102 J = 1,NT 
JTEM=J
IF(NP.E Q .2.A N D .L .E Q .2 . AND .MOD(JTEM,2).E Q .0) GOTO 102 
CALL CFRAME(JTEM)
DO 103 K = 1,2
CALL R O T (J T E M ,D E L T A U (K),L-1)
CALL LSQCAL(ICHEND,JCHEND,DIST2)
DISTN=SQRT(DIST2)
DELDIS = ABS(TDIST-DIS T N )
IF(DELDIS.GE.ABS(TDIST-DIST)) GOTO 104 
DIST=DISTN
IF(DELDIS.LE.TOL) GOTO 105 
GOTO 102
104 CALL ROT(JTEM,-DELTAU(K),L-1)
103 CONTINUE
102 CONTINUE
101 CONTINUE
105 A-l.
RETURN
END
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SUBROUTINE CFRAME(I)
COMMON /TRANS/ T A N G L E (9,2),NATOM(10,4) ,NT ,XS ( 50,3) 
COMMON /COOR/ XI ( 50,3),NRATOM(10,50),N ATOMS,RADI 
DIMENSION D C ( 3,3),XX(3),XOA(3),XA( 3)
R12 SQ = 0 •0 
R23SQ=0. 0 
RSQ=0.0 
. COSANG=0.0
Nl=NATOM(I , 1 )
N2=NATOM(1,2)
N3=NATOM(1,3)
DO 9 J= 1 ,3 
9 XOA(J)=-XI(N2,J)
DO 10 J= 1 , 3
DC(3,J)=XI(N3,J ) - X I ( N 2 ,J)
DC(2,J)=XI(N1,J)-XI(N2,J)
IF(ABS(DC(3,J)) .LT.1.0E-10) DC(3,J)=0.0 
IF(ABS(DC(2,J ) ).LT.1 .0E-10) DC(2,J)=0.0 
R23SQ=R2 3SQ+DC(3,J)*DC(3,J)
R12SQ=R12SQ+DC(2,J)*DC(2,J)
10 CONTINUE 
R23=SQRT(R2 3SQ)
R12 = SQRT(R12 S Q )
DO 11 K = 1,3 
DC(3,K)=DC(3,K)/R23 
DC(2,K)=DC(2,K)/R12 
COSANG=COSANG+DC(3,K)*DC(2,K)
11 CONTINUE 
RX=-R12*COSANG 
DO 12 L = 1 , 3
XX(L)=XI(N 3 ,L )-(R2 3+RX)*DC(3,L)
D C (2,L )=X I (N 1,L )- X X (L )
IF (ABS(DC(2,L)) .LT.1.0E-10) DC(2,L)=0.0 
RSQ=RSQ+DC(2,L)*DC(2,L)
12 CONTINUE 
R=SQRT(RSQ)
DO 13 M = 1,3 
DC(2,M)=DC(2,M)/R
13 CONTINUE
DO 14 N-1,3 
NTEM=N 
K=MOD(NTE M ,3)+1 
L*MOD(K,3)+l
DC(l,N)a*DC(2,K)*DC(3,L) -DC( 2 , L ) *DC ( 3 , K)
14 CONTINUE
DO 16 J-l,NATOMS 
DO 15 K=l,3 
XA(K)=0•0 
DO 15 L-1,3
15 XA(K)-XA(K)+DC(K,L)*(XI(J,L)+XOA(L))
DO 16 M-1,3
16 XI(J,M)»XA(M)
RETURN
END
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SUBROUTINE T C A L (J A ,J B ,J C ,J D ,WA)
COMMON/C00R/XI(50,3) , NRATOM( 10,50),NATOMS,RADI 
DIMENSION A A (3,3), V 1 ( 3 ) ,V2(3)
R1=0.0 
R2=0.0
cosw=o.o 
DO 401 1=1,3
AA(I,1)=XI(JA,I)-XI(JB,I)
AA( 1 ,2)=XI(J C ,I )- X I (J B ,1)
401 AA(I,3)=XI(JC,I)-XI ( J D ,I)
DO 402 J = 1 ,3
JTEM=J 
K=MOD(JTEM,3)+l 
L=MOD(K,3)+l
V I (J)=AA(K,1)*A A ( L ,2)- A A ( L ,1)*AA(K,2)
V2 ( J) =AA(K, 2 ) * AA( L , 3 ) -AA(L , 2 ) *AA(K, 3)
R1=R1+V1(J )* * 2
402 R2=R2+V2(J )**2 
R1=SQRT(R1)
R2=SQRT(R2)
DO 403 K=1 , 3
403 C0SW=C0SW+(V1(K)/R1)*(V2(K)/R2)
CALL ARGCHK(COSW)
CALL ABCOS(COSW,WA)
WA=WA*RADI
SIGN1=AA( 1 ,1)*(A A ( 2 ,2)*AA(3,3)-AA(2,3)*AA( 3,2))- 
1A A (2,1 )* ( AA (1,2)* A A (3,3)-A A (1,3)* A A (3,2)) +AA (3,1) 
1*(AA(1,2)*AA(2,3)- A A ( 1,3 )*AA(2,2))
WA=SIGN(WA,SIGN1)
RETURN
END
C
SUBROUTINE ARGCHK(X)
X=SIGN(AMIN 1(ABS(X),1.0),X)
RETURN
END
SUBROUTINE ABCOS(X,WA) 
IF(ABS(X)-1.0000001) 5,5,6
6 CONTINUE
RETURN
5 IF(ABS(X).GT.1.) X=SIGN(1.,X)
IF(X) 3,4,3
4 WA=1.5707964
RETURN
3 WA=ATAN(SQRT(l.-X*X)/X)
IF(X ) 1,2,2
1 WA-WA+3.14159 2 7
2 RETURN 
END
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SUBROUTINE R O T (I ,A N G ,I J )
COMMON/ROTA/RAD 1 ,NR(10)
COMMON/COOR/XI(50,3), NRAT0M( 10,50),NATOMS,RADI
COSANG=COS(ANG*RADI)
SINANG=SIN(ANG*RAD 1)
IF(IJ.E Q .1)GOTO 20 
N=NR(I)
DO 10 J = 2 ,N
XI =XI(NRATOM(I ,J ) ,l)*COSANG-XI(NRATOM(I,J ) ,2)*SINANG 
X2 = XI(NRATO M ( I ,J ) ,1)* SINANG+XI(NRATOM(I ,J ) ,2)*COSANG 
X I (NRATOM(I,J ),1)=X1 
XI (NRATOM(I,J ) ,2)=X2 
10 CONTINUE 
RETURN
20 DO 21 J= 1 , N
XI =»XI ( NRATOM( I , J) , 2 ) * CO SANG-XI ( NRATOM( I , J ) , 3)*SINANG 
X2=XI ( NRATOM ( I , J ) , 2 ) * S INANG+XI ( NRATOM( I ,J ),3)* CO SANG 
XI(NRATOM(I,J ),2)=X1 
XI (NRATOM(I,J),3)=X2
21 CONTINUE 
RETURN 
END
SUBROUTINE L S Q C A L (I ,J ,D I S T 2 )
COMMON/COOR/XI(5 0,3) ,NRATOM( 10,50),NATOMS,RADI 
DIMENSION D I R ( 3 ) ,DIR2(3)
DO 703 K-1,3 
DIR(K)=XI(I,K)-XI(J,K)
703 DIR2(K)=DIR(K)*DIR(K)
DIST2=DIR2(1)+ D I R 2 (2)+DIR2(3)
RETURN
END
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C
c -----------------
C DESCRIPTION OF THE INPUT BUFFER AND ITS ASSOCIATED 
C VARIABLES AND FLAGS. THESE ARE USED BY THE FOLLOWING TEXT 
C PROCESSING ROUTINES NXLINE, NUMBER, GETNAM, POSN 
C
C ALL ARGUMENTS ARE HELD IN LABELLED COMMON /INPUT/
C
C INPLUN LOGICAL UNIT NUMBER OF INPUT DEVICE
C LINENO CURRENT LINE NUMBER IN FILE
C INPBUF INPUT BUFFER: HOLDS 80 CHARACTERS IN A1 FORMAT
C NOTE THIS IS A BYTE ARRAY
C INPNTR BUFFER POSITION POINTER. SET TO ZERO WHEN A NEW LINE
C IS PUT INTO THE INPUT BUFFER. POINTS TO THE LAST
C CHARACTER PROCESSED.
C NCHARS NUMBER OF CHARS IN THE INPUT BUFFER. RESET WHEN NEW 
C LINE IS PUT INTO THE BUFFER.
C ERROR LOGICAL FLAG SET .TRUE. IF THE LOOKED-FOR ITEM HAS A
C FORMAT ERROR OR IS 'EMPTY' OR IF A SEARCH OPERATION
C FAILS.
C EMPTY LOGICAL FLAG SET .TRUE. IF THE LOOKED-FOR ITEM IS 'EMPT'
C (USEFUL WHEN SUPPLYING DEFAULT VALUES)
C EG. 1, ,3,4, ,6 THE SECOND AND FIFTH ITEMS ARE 'EMPTY
C C ENDSEC SET .TRUE. IF LINE STARTS WITH **
C (** USED TO MARK END OF SECTION IN CRYSTAL DATA FILES)
C
C
c 
c
SUBROUTINE NXLINE
C
C READS THE NEXT LINE FROM THE CURRENT INPUT DEVICE (UNIT 
C NUMBER=INPLUN) INTO THE BYTE ARRAY INPBUF (THE INPUT BUFFER).
C LINENO IS INCREMENTED. INPNTR IS SET TO ZERO AND NCHARS “NUMBER 
OF CHARACTERS READ IN. IF THE FIRST TWO CHARACTERS ARE ** OR 
IF END-OF-FILE IS ENCOUNTERED THEN ENDSEC IS SET .TRUE.,
C OTHERWISE IT IS SET .FALSE.
C D.S.RICHARDSON 12/75 CHEMISTRY DEPT., UCL LONDON 
C
LOGICAL*1 INPBUF(80)
LOGICAL E R R O R ,E M P T Y ,ENDSEC 
LOGICAL*1 ISTAR
COMMON/INPUT/INPLUN , LINENO , INPBUF,INPNTR,N C H A R S ,ERROR,
1 EMPTY,ENDSEC 
DATA ISTAR/'*'/
C
1 READ(INPLUN,9000,END=10) NCHARS,(INPBUF ( I ) , 1=1,N C H A R S )
9000 FORMAT(Q ,80A1) !RETURNS NUMBER OF CHARACTERS READ IN
INPNTR*0 
LINENO=LINENO+l
IF(INPBUF(1 ) .EQ.ISTAR.AND. INPBUF(2).E Q .ISTAR) GOTO 10 
ENDSEC*.FALSE.
RETURN
FOUND END OF SECTION OR END OF FILE
10 ENDSEC*.TRUE.
2 6 0
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RETURN
END ! OF S U B R O U T I N E  NXLIN E
*****************************************
SUBROUTINE NUMBER(X)
X RETURNS THE VALUE OF THE NUMBER REPRESENTED BY THE 
CHARACTER STRING STARTING AT THE CURRENT POSITION OF INPBUF. 
!!! X MUST BE REAL. IF YOU WANT TO INPUT AN INTEGER 
THEN DO
CALL NUMBER(X)
INTEGER*IFIX(X ) OR INTEGER=INT(X)
ON ENTRY INPNTR = POSN-1 OF FIRST CHARACTER OF No IN INPBUF 
ON EXIT INPNTR = POSN OF TERMINATOR (NCHARS IF LINE END FOUND)
LEADING SPACES ARE IGNORED AND THE NUMBER IS TERMINATED BY 
ONE OF:- END OF LINE 
A SECOND DECIMAL POINT 
A NON LEADING + OR - OR SPACE 
ANY OTHER NON-NUMERIC CHARACTER 
EMPTY IS SET .TRUE. IF THE FIRST CHARACTER ENCOUNTERED IS 
NOT NUMERIC. (IN THIS CASE THE VALUE OF X IS UNCHANGED - 
ALLOWS X = DEFAULT VALUE) ERROR IS SET IN THE SAME WAY AS 
EMPTY NOTE THIS ROUTINE DOES NOT FLAG ILLEGAL CHARACTERS - 
THE CALLING ROUTINE SHOULD INSPECT THE TERMINATOR TO SEE IF 
IT IS LEGAL.
LOGICAL*1 INPBUF(80)
LOGICAL ERROR,EMPTY,ENDSEC
LOGICAL*1 IBLANK,IPOINT,IPLUS,IMINUS,I0, 19
COMMON/INPUT/INPLUN,LINENO, INPBUF,INPNTR, NCHARS,ERROR,
1 EMPTY,ENDSEC
DATA IBLANK,IPOINT,IPLUS,IMINUS,10 ,
1 19/' ,'0' ,'9'/
EMPTY*.TRUE.
SIGN*+1.0 
VAL*0.0 
C*0. 0
GET NEXT CHARACTER
i IF(INPNTR.GE.NCHARS) GOTO 10
INPNTR*INPNTR+1 
ICHAR*INPBUF(INPNTR)
IF(EMPTY.AND.ICHAR.EQ.IBLANK) GOTO 5 
IF(ICHAR.EQ.IMINUS) GOTO 30 
IF(ICHAR.EQ.IPLUS) GOTO 40 
IF(ICHAR.EQ.IPOINT) GOTO 50 
IF(ICHAR. G E .10.A N D .ICHAR.LE.19) GOTO 20
! END OF BUFFER
! ITS 
1 ITS 
! ITS 
! ITS
A MINUS 
A PLUS 
A DECIMAL 
NUMERIC
261
uu 
oo 
oo 
oo 
oo 
o
o
o
o
o
o
C IT'S A TERMINATOR
C (ANY NON NUMERIC CHARACTER OR END OF LINE 
C OR NON LEADING SPACE, SIGN OR POINT)
10 ERR0R*EMPTY
INPNTR*INPNTR-1 
IF(EMPTY) RETURN 
X=VAL* SIGN 
RETURN
ITS NUMERIC 
20 EMPTY*.FALSE.
IF (C.GT.O.) GOTO 25 
VAL=10.*VAL+ICHAR-I0 
GOTO 5
FRACTIONAL PART 
25 C=0.1*C
VAL=(ICHAR-IO)*C + VAL 
GOTO 5
IT'S A MINUS SIGN 
30 IF (.NOT.EMPTY) GOTO 10
SIGN*-1.0
IT'S A PLUS SIGN 
40 IF (.NOT.EMPTY) GOTO 10
EMPTY*•FALSE•
GOTO 5
IT'S A DECIMAL POINT 
50 IF(C.NE.O) GOTO 10
C=1.0
EMPTY*.FALSE.
GO TO 5
END !OF SUBROUTINE NUMBER
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SUBROUTINE GETNAM(N1AND2,N3AND4,N5AND6)
C
C RETURNS THE NEXT NAME FROM THE INPUT BUFFER AND UPDATES 
C THE POSITION POINTER 
C
C LEADING SPACES ARE IGNORED. THE NAME SHOULD START WITH A 
C LETTER AND THEREAFTER BE EITHER LETTERS OR NUMBERS. IT 
C IS TERMINATED BY A NON-LEADING SPACE OR ANY NON-ALPHANUMERIC 
C CHARACTER OR END-OF-LINE. THE NAME IS TRUNCATED TO 5 
C CHARACTERS - ALL CHARACTERS AFTER THE FIFTH ARE IGNORED.
C
C ON ENTRY INPNTR = POSITION-1 OF FIRST CHARACTER OF THE 
C NAME IN INPBUF
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ON EXIT
INPNTR POSITION OF TERMINATOR (NCHARS IF LINE END FOUND) 
N1AND2 RETURNS THE 1ST 2 CHARACTERS OF NAME IN A2 FORMAT
N3AND4 RETURNS THE THIRD AND FOURTH CHARACTERS
N5AND6 RETURNS THE 5TH CHAR.+ A SPACE IN THE 6TH POSITION
IF THE NAME IS LESS THAN 5 CHARACTERS THE UNUSED CHARACTER
POSITIONS IN N 1AND2,N3AND4,N 5AND6 ARE SET TO SPACES
IF THE NAME DOSN'T START WITH A LETTER THEN ON EXIT 
ERROR-EMPTY-.TRUE.
N1AND2,N3AND4,N 5AND6 ARE UNCHANGED
LOGICAL*1 INP B U F (80)
LOGICAL ERROR,EMPTY,ENDSEC
LOGICAL*1 I CHAR,IBLANK,10 ,19,I A ,I Z ,NAMTEM(6)
COMMON /INPUT/ INPLUN ,LINENO , INPBUF , INPNTR, NCHARS , ERROR, 
+ EMPTY,ENDSEC
EQUIVALENCE (N12,NAMTEM( 1 )),(N 3 4 ,NAMTEM( 3)),
+ (N56,NAMTEM(5))
DATA IBLANK,IA,IZ/ Z '/
EMPTY=.TRUE. 
ICOUNT-1 INUMBER OF CHARACTERS IN THE NAME + 1
GET NEXT CHARACTER 
5 IF(INPNTR.GE.NCHARS) GOTO 10
INPNTR-INPNTR+1 
ICHAR=INPBUF(INPNTR)
IF(EMPTY.AND.ICHAR.EQ.IBLANK) GOTO 5 
IF(ICHAR.GE.I A . A N D .ICHAR.LE.IZ) GOTO 30
! END OF BUFFER
IGOT THE CHAR.
! IGNORE BLANKS 
I ITS ALPHABETIC
IF(ICHAR.GE. "41 .AND. ICHAR. LE .11100 ) GOTO 20 IITS PRINTABLE
IT'S A TERMINATOR
10 ERROR-EMPTY 
IF(EMPTY) RETURN 
DO 11 1 = ICOUNT , 6
11 NAMTEM(I)-IBLANK 
N1AND2=N12 
N3AND4-N34 
N5AND6-N56 
RETURN
IPAD REST OF NAME WITH SPACES
INOTE EQUIVALENCE WITH NAMTEM 
I(CAN'T EQIVALENCE DUMMYS VARS)
IT'S NUMERIC 
20 IF(EMPTY) GOTO 10 I TERMINATOR IF FIRST CHARACTER
IT'S O.K. STORE CHARACTER IN NAMTEM.
30 EMPTY-.FALSE.
IF(ICOUNT.G E .6) GOTO 5 !IGNORE CHARS AFTER 5TH
NAMTEM(ICOUNT)-ICHAR 
ICOUNT-ICOUNT+1 
GOTO 5
END ! OF SUBROUTINE GETNAM
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S U B R O U T I N E  P O S N ( K E Y T E X )
C
C POSITION INPUT FILE AT LINE BEGINNING WITH THE 
C CHARACTER STRING GIVEN IN KEYTEX (ONLY THE NUMBER 
C OF CHARACTERS GIVEN ARE MATCHED, THE REMAINDER OF 
C THE LINE IS IGNORED).
C
C INPLUN = LOGICAL UNIT NUMBER FOR THE INPUT FILE 
C
C ON ENTRY LINENO = CURRENT LINE NUMBER IN FILE (0 MEANS 
C NO LINES YET READ) ON EXIT LINENO = LINE NUMBER IN FILE 
C WHERE MATCH FOUND IF NO MATCH IS FOUND THEN ERROR IS SET 
C .TRUE. AND LINENO RETAINS IT'S INITIAL VALUE 
C
C KEYTEX MUST END WITH A NULL (ZERO) BYTE. (RT11 FORTRAN 
C STRING CONSTANTS SATISFY THIS REQUIREMENT)
C
C EG: CALL POSN('UNITCELL' ) POSITIONS THE INPUT FILE AT THE 
C NEXT LINE BEGINNING WITH THE CHARACTERS 'UNITCELL'
C
C THE SEARCH STARTS AT THE CURRENT POSITION AND GOES FORWARD 
C LINE BY LINE. IF THE END OF THE FILE IS REACHED THEN THE 
C FILE IS REWOUND AND THE SEARCH CONTINUES UNTIL THE WHOLE FILE 
C IS SEARCHED. USE WITH CARE IF THE DEVICE IS NON-REWINDABLE.
C
LOGICAL*1 INP BUF(80)
LOGICAL ERROR,EMPTY,ENDSEC 
LOGICAL*1 KEYTEX(80),INULL
COMMON/INPUT/INPLUN,LINENO , INPBUF,INPNTR,NCHARS,ERROR ,
1 EMPTY,ENDSEC 
DATA INULL/0/
C START SEARCH AT BEGINNING OF FILE 
REWIND INPLUN 
LINENO=0 
ERROR=.FALSE.
READ NEXT LINE
1 READ(INPLUN, 9001 ,END=900) NCHARS,(INPBUF(I), 1=1,NCHARS)
9001 FORMAT(Q ,80A1)
LINENO=LINEN0+1 
INPNTR=0
SEE IF CHARACTERS MATCH 
DO 2 1=1,NCHARS
IF(KEYTEX(I).EQ.INULL) RETURN IFOUND A MATCH
IF(KEYTEX(I).NE.INPBUF(I)) GOTO 1 !NO MATCH
2 CONTINUE
IF(KEYTEX(NCHARS+1).EQ.INULL) RETURN IFOUND A MATCH 
GOTO 1 ITOO FEW CHARS IN LINE
END OF FILE, IE KEYTEX NOT IN FILE. SET ERROR FLAG 
900 ERROR=•TRUE.
RETURN
END I OF SUBROUTINE POSN
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S U B R O U T I N E  A T N A M S (N ,I N D E X S ,N A T O M S ,N A M E S )
C
RETURNS ASSOCIATED INDICIES FOR THE NEXT N ATOMS NAMED IN 
THE INPUT BUFFER
N NUMBER OF NAMES WE'RE LOOKING FOR (LIMIT-20)
INDEXS (K) RETURNS THE INDEX OF THE KTH NAME FROM THE
CURRENT POSITION IN THE INPUT BUFFER.
SET TO 0 IF THE NAME IS EMPTY( TERMINATOR)
SET TO -1 IF THE NAME IS NOT IN NAMES ARRAY 
OR IF A FORMAT ERROR IS FOUND 
SET TO -2 IF THE NAME IS '*' 'WILD CARD'
THE FIRST FORMAT ERROR ABORTS THE ROUTINE, SO 
ONLY ONE -1 WILL BE FOUND IN THE INDEXES ARRAY 
NATOMS NUMBER OF ENTRIES IN THE NAMES ARRAY No ATOMS
NAMES(I ,J ) J= 1 , 3 GIVES NAME OF ATOM I IN 3A2 FORMAT
PADDED WITH SPACES
ERROR SET .TRUE. IF A FORMAT ERROR IS FOUND, OR IF
.ANY NAME IS NOT IN THE NAMES ARRAY, OR IF A 
'WILD CARD' IS FOUND. ELSE SET .FALSE.
REFER TO SUBROUTINE NXLINE FOR A DESCRIPTION OF THE INPUT BUFFEI
LOGICAL*1 INPBUF(80)
LOGICAL*1 STAR,FILL 
LOGICAL ERROR,EMPTY,ENDSEC 
LOGICAL ERRTEM 
DIMENSION NAMES(50,3)
DIMENSION INDEX S (20)
COMMON/INPUT/INPLUN, LINENO , INPBUF , INPNTR, NCHARS , ERROR,
• 1 EMPTY,ENDSEC
DATA STAR/'*' /
C
ERROR-.FALSE.
ERRTEM-.FALSE. ! SET .TRUE. IF NAME NOT IN NAMES ARRAY
C
.DO 10 1=1,N 
C — GET NEXT NAME INTO NAM1 , NAM2 , NAM3 —
CALL GETNAM(NAM1,NAM2,NAM3)
IF(.NOT.ERROR) GOTO 9 
C ERROR CAUSES CORRESPONDING INDEX TO BE SET TO -1
8 INDEXS(I)= — 1
C AND THE ROUTINE IS ABORTED WITH ERROR SET .TRUE.
IF(.NOT.EMPTY) RETURN 
C UNLESS IT WAS EMPTY, THEN INDEX IS SET TO 0
INDEXS(I)=0 
ERROR-.FALSE.
C — WILD CARD (*) IS SPECIAL CASE —
IF(INPBUF(INPNTR).N E .STAR) GOTO 10
CALL GETNAM(NAM1,NAM2,NAM3) IMOVE TO NEXT ONE
IF(.NOT.EMPTY) GOTO 8
INDEXS(I )=-2 ! SET INDEX TO -2
GOTO 10
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GOTO 10
C — LOOK UP NAME AND RETURN CORRESPONDING INDEX—
9 CALL NAMNUM( NATOMS , NAMES, NAM1 , NAM2 , NAM3 , INDEXS ( I ) ) 
IF(INDEXS(I).LT.O) ERRTEM=.TRUE.
10 CONTINUE 
ERROR=ERRTEM 
RETURN
END ! OF SUBROUTINE ATNAMS
*****************************************
SUBROUTINE NAMNUM( NATOMS , NAMES , N1AND2 , N3AND4 , N 5AND6 , INDEX
SEARCHES THE NAMES ARRAY UNTIL IT FINDS A MATCH WITH THE 
NAME HELD IN N 1AND2,N3AND4,N 5AND6. THE CORRESPONDING NAMES 
ARRAY INDEXIS RETURNED IN INDEX. IF NO MATCH IS FOUND 
INDEX IS SET TO -1.
NATOMS NUMBER OF ENTRIES IN THE NAMES ARRAY
NAMES(I ,J ) J=1,3 GIVES NAME OF ATOM I IN 3A2 FORMAT 
PADDED WITH SPACES 
N1AND2 HOLDS THE FIRST TWO CHARS OF NAME IN A2 FORMAT
N3AND4 HOLDS THE THIRD AND FOURTH CHARACTERS
N5AND6 HOLDS THE 5TH CHARACTER + A SPACE IN THE 6TH POSN
INDEX RETURNS THE INDEX OF THE CORRESPONDING ATOM.
SET TO -1 IF THERE IS NO ATOM OF THAT NAME
IF THE NAME IS LESS THAN 5 CHARACTERS THE UNUSED CHARACTER 
POSITIONS IN N1AND2,N 3AND4,N 5AND6 MUST BE SPACES
LOGICAL*1 INP BUF(80)
LOGICAL ERROR,EMPTY,ENDSEC 
DIMENSION NAMES(50,3)
COMMON/INPUT/INPLUN, LINENO , INPBUF, INPNTR, NCHARS , ERROR,
1 EMPTY,ENDSEC
INDEX=0 
1 INDEX=*INDEX+1
IF(INDEX.GT.NATOMS) GOTO 90 
IF ( NAMES(INDEX,1).NE.N1AND2
1 .OR.NAME S(INDEX,2).NE.N3AND4
2 .OR.NAMES(INDEX,3).NE.N5AND6 )GOTO 1 ILOOP IF NO MATCH
RETURN !EXIT WHEN FOUND
NO MATCH IN WHOLE ARRAY 
90 INDEX--1
RETURN
END !OF SUBROUTINE NAMNUM
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